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ABSTRACT 
 
 
 
Expression of the Bovine DNA (cytosine 5) Methyltransferase Family During 
Preimplantation Development and Aberrations Induced by Somatic Cell Nuclear 
Transfer. (December 2003) 
Michael Cameron Golding, H.B.Sc., University of Western Ontario 
Chair of Advisory Committee:  Dr. Mark Westhusin 
 
 
Bovine preimplantation embryos derived from nuclear transfer experiments 
exhibit a global state of genomic hypermethylation that likely account for the large 
number of developmental abnormalities observed to date. The central hypotheses of this 
work is that the genomic hypermethylation and improper epigenetic reprogramming 
reported in studies of bovine nuclear transfer, are in large part due to abnormal 
expression and regulation of the DNA methyltransferase proteins.   
Bovine Dnmt mRNAs display strong sequence homology to those of human and 
mouse and similar to other species, exist as multiple isoforms.  Two of these splice 
variants, which have been termed Dnmt2γ and Dnmt3a4 represent previously unreported 
sequence combinations.  Investigation of bovine DNA methyltransferase expression in 
the bovine oocyte and early preimplantation development has revealed an intricate 
system divergent from observations previously reported in the mouse.  Specifically, the 
somatic version of Dnmt1 along with Dnmt2, 3a and 3b are all expressed during these 
initial stages of bovine development.  Further, real time analyses of the Dnmt transcripts 
 iv
in cloned and in vitro produced embryos reveal significant differences in the mRNA 
expression levels of Dnmt1 and 2 but not Dnmt3a and 3b suggesting that the de novo 
methyltransferases may be functioning normally while Dnmt1 and Dnmt2 are aberrantly 
methylating the genome during a critical time when methylation levels should be 
receding.  Real time PCR analysis of the Dnmt transcripts in fetal and adult tissues has 
revealed a developmental and tissue specific expression pattern suggesting that proper 
expression and function of these enzymes is a key element in the process of 
differentiation.  These results are further supported by studies of Dnmt expression in 
aging bovine fibroblast cultures, which suggest that the Dnmts may play some as yet 
unidentified role in cellular senescence.    
Recently, it has been postulated that the cause of abnormal methylation observed 
in cloned embryos may be due in part to misexpression of the Dnmt1o isoform during 
preimplantation development.  Work presented here raises new and significant 
hypotheses that must be considered both regarding the cadre of DNA methyltranferases 
that direct epigenetic programming during normal development and regarding the 
implication of abnormal DNMT expression in cloned embryos.   
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CHAPTER I 
INTRODUCTION 
 
 It is fitting that a work examining the epigenetic events of early bovine 
development begin with a brief description of the history of this science and its far-
reaching impact.  Although description of epigenetic phenomena can be identified much 
earlier, it was the work done on maize by Barbara McClintock that began to crystallize 
epigeneitcs into a scientific discipline.  Her description of transposable “controlling” 
elements and their capacity to silence genes based on the proximity of their specific site 
of integration, suggested that the genome contains transcriptionally permissive and 
suppressed regions and that their allocation is dynamic. 
      
Some system of gene regulation must be present that is able to order the action of 
genes in such a manner that these patterns will be produced.  Until these 
problems find some adequate solution, our understanding and our experimental 
approach to many phenomena will remain obscured.  (Cold Spring Harbor 
Symposium 1951 – Comfort 1999) 
 
This was the first experimental evidence to suggest that genomic loci have the 
ability to shift between differing transcriptional capacities.  Soon after this work, a 
similar phenomenon was identified in Drosophila eye development, which has since 
been referred to as position effect varigation.  Here it was recognized that genes in close 
proximity to heterochromatic regions of the genome could be silenced, owing not to any  
_________________  
This dissertation follows the style of Genes to Cells. 
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gene specific regulatory mechanism but simply due to their proximity to densely 
packaged DNA.  Recognition of this phenomenon and its potential role in regulation of 
gene expression served as a catalyst for other experiments to demonstrate how 
widespread and fundamental this epigenetic phenomenon was to the cell’s ability to 
control transcription.  However, it was several years before a biochemical mechanism 
could be envisioned that would allow the cell to dynamically control the establishment 
and modulation of the epigenetic marks that impart this large-scale control of gene 
expression.  Today, numerous examples of epigenetic gene regulation have been found 
in virtually all organisms studied and it is likely that we have only just begun to 
comprehend the breadth and significance of these phenomena. 
The two major mechanisms identified to date that impart epigenetic control of 
mammalian gene expression are DNA methylation and post-translational histone 
modifications.  Both work in concert to provide a general mechanism by which the 
differing transcriptional states of chromatin are achieved.  The modifications to DNA or 
to the chromatin in which it is packaged serve to compartmentalize the genome into 
other areas, which are accessible to the transcriptional machinery necessary for gene 
expression and into other areas, which are not.  This compartmentalization is much more 
efficient and secure than relying on trans regulatory factors to control the transcriptional 
activity of the entire genome.  Each mammalian cell has a very specific transcriptional 
program owing to its function within the specific cell group, tissue and organ system that 
it is located.  Epigenetic marks serve as a fundamental basis for this varying tissue and 
developmental specific expression pattern.  Thus the mechanisms responsible for 
 3
generating these patterns have significant consequences on not only the physiology of 
the cell, but also on the development and metabolism of the entire organism.  Moreover, 
there is evidence to suggest that aberrant epigenetic programming during early 
mammalian development results in a large number of developmental abnormalities 
(Young et al. 1998; Hill et al. 2000a; 2000b; Sinclair et al. 2000), in addition to 
predisposing the organism to early onset of a variety of diseases later in life (Barker, 
1990).   
This work focuses on the epigenetic events of early bovine development.  A large 
number of studies of bovine embryos produced by somatic cell nuclear transfer have 
identified abnormalities in the transcriptional control of numerous, seemingly random 
genes.  These large-scale transcriptional disturbances are thought to be the result of 
abnormal DNA methylation and thus, this aberrant methylation has been hypothesized to 
be the leading cause of developmental failure of cloned animals.   Epigenetic defects 
observed in these studies are similar on the whole to abnormalities reported in 
Angelman, Beckwith-Wiedemann, and Prader-Willi syndromes, which have been 
associated with human assisted reproductive technologies.  In order to thoroughly 
discuss the role of DNA methylation in epigenetic control of gene expression during 
mammalian embryonic development, a brief review of the enzymatic mechanisms of 
transcription will be given followed by a detailed discussion of the enzymes that impart 
genomic methylation, the DNA methyltransferases.  This will be followed by a 
discussion of the function of these enzymes during early mammalian development and 
their relation to studies of somatic cell nuclear transfer. 
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Part 1 Transcription 
 
Regulation of Eukaryotic Gene Expression 
 
Mammalian biology, be it normal development or disease status, is the sum total 
of the dynamic regulation of genes encoded by the genome and production of the 
resultant proteins.  Differential patterns of gene expression determine the structural and 
functional phenotype of the cells, which in turn directly affect the physiology of the 
organism.  Mechanisms that govern which sets of genes are turned on, and those, which 
are turned off, are fundamental to the processes of development and differentiation.  
Mechanisms, which modulate gene expression, are diverse and occur at various points in 
the pathway from gene to protein.  This medium can be subdivided into three major 
areas, transcriptional control of gene expression, post-transcriptional gene regulation and 
translational control of gene expression.  Accordingly, each of the areas listed can 
further be divided into multiple levels that collectively serve to enhance the ability of the 
cell to regulate the spectrum of gene expression in a developmentally and tissue specific 
manor. 
The first level of control is transcriptional.  It is on this level that the vast 
majority of control is asserted through the ordered structure of chromatin, DNA 
modifications, and the assembly and interaction of trans components on a multitude of 
cis DNA regulatory elements.  Post-transcriptional gene regulation serves to modulate / 
modify the RNA molecule so as to affect both its physical structure and its capacity to 
interact with the translational machinery.  Translational control of gene expression is the 
final level of control and centers on the dynamics of the conversion of mRNA to protein.  
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All of these elements form a functional hierarchy that permits regulation at numerous 
points thus enabling the cell to quickly respond to the environment or to developmental 
queues using generic cellular factors modulated in such a away as to give rise to a 
specific response (Figure 1).   
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multistage process that requires the interaction of hundreds of proteins with varying 
degrees of post-translational modification.  The process is collectively referred to as the 
transcriptional cycle and occurs sequentially in five different stages: preinitiation, 
initiation, promoter clearance, elongation and termination.  Each stage of the 
transcription cycle is subject to regulation and thus an enormous diversity of regulatory 
factors contribute to the production of a single RNA molecule (Ogbourne and Antalis 
1998; Dvir et al. 2001; Beckett 2001; Shilatifard 1998). 
Pre-initiation 
This stage is defined by the local alteration of DNA via the interaction of 
regulatory proteins that serve to permit access of the transcriptional machinery to the 
promoter.  This phase is also called the activation phase as regulatory sequences within 
the promoter are then able to interact with and activate the assembly of their appropriate 
trans-regulators (Dvir et al. 2001; Shilatifard 1998). 
Initiation 
The regulatory factors that function at this stage all serve to position RNA 
polymerase II (polII) on the promoter and to initiate RNA synthesis.  The complete RNA 
polymerase holenzyme is a huge complex with a molecular mass in excess of 2500 
kilodaltons.  RNA pol II is completely dependent on auxiliary factors to initiate 
transcription.  The basal proteins required to initiate transcription are called general 
transcription factors (GTFs) and these proteins form an ordered complex at the promoter 
in a regulated and defined order.  Assembly of these factors serves as a platform for the 
recruitment of RNA polymerase and the kinetic events that initiate its function.  In most 
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eukaryotic promoters an element referred to as the TATA box is first recognized by the 
TATA binding protein.  The TATA box is a DNA regulatory element with the consensus 
sequence 5’-TATAAAA–3’ that is located approximately 25 base pairs upstream of the 
transcriptional start site and is surrounded by GC rich sequences which are subject to 
regulation through DNA methylation (Ogbourne and Antalis 1998).  Activation of a 
promoter exposes the TATA box and permits binding of the TATA binding protein and 
thus initiation of the GTF assembly.  A group of proteins collectively called TATA-
binding associated factors (TAFs) then bind the TATA binding protein and make a 
complex known as transcription factor IID (TFIID).  A central component of TFIID is 
TAF250.  This protein specifically binds acetylated lysines in active euchromatin thus 
stabilizing the TFIID complex and also seems to have some inherent acetylating activity 
of its own (Ogbourne and Antalis 1998; Dvir et al. 2001; Shilatifard 1998).  Thus, 
exposure of the TATA box and binding of TFIID may be sufficient to induce chromatin 
priming, at least in the vicinity of the promoter.  Binding of TFIID induces a 90° bend in 
the DNA centered at the TATA box which permits binding of the additional general 
transcription factors (Beckett 2001).   
 The assembly of the general transcription machinery continues with recruitment 
of TFIIA which complexes with TFIID, inducing a conformational change that permits 
binding of the second GTF.  Binding of TFIIB serves as an adaptor molecule that 
recruits a preasembled TFIIF-RNA polymerase to dock on the assembling protein 
complex (Ogbourne and Antalis 1998; Dvir et al. 2001).  The polymerase binds with a 
large unphosphorylated carboxy-terminal domain.  TFIIE serves as an adaptor recruiting 
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TFIIF and TFIIH to the carboxy terminal domain of RNA polymerase.  Entry of TFIIH 
into the polymerase complex tightens the DNA around the holoenzyme and induces the 
unwinding of a short stretch of DNA near the transcriptional start site.  TFIIF serves to 
stabilize the interactions between these large protein subunits and is required for 
initiation to proceed.  At this point, initiation is technically complete, however before 
transcription can proceed, the carboxy-terminal domain of polymerase must be 
phosphorylated to permit promoter clearance. It is phosphorylation of this carboxy-
terminal domain that imparts the largest degree of regulation over transcriptional 
initiation.  Phosphorlyation of the carboxy terminal domain induces a conformational 
change that promotes the oligoimerization of nucleotides within the active site of RNA 
polymerase.  Numerous proteins working in concert catalyze the phosphorylation of this 
C-terminal domain.  TFIIH and positive transcription elongation factor (P-TEFb) are two 
such proteins that display very strong pol II C-terminal domain phosphorylating activity 
and thus regulate the progression of transcription initiation (Ogbourne and Antalis 1998; 
Dvir et al. 2001; Beckett 2001; Shilatifard 1998). 
Some mRNAs have variable 5’ untranslated regions indicating that their 
transcription can begin at multiple sites over a large region; 20 – 200 base pairs in size.  
These genes often encode proteins involved in intermediary metabolism and are 
transcribed at relatively low rates (Beckett 2001).  The control region for most genes of 
this type does not contain a classical TATA box initiator site but instead contains a 
stretch of 20-50 nucleotides composed almost exclusively of cytosine and guanosine.  As 
a dinucleotide, CG is statistically underrepresented in vertebrate genomes and thus the 
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presence of these long CG repeats just upstream of transcription initiation sites is not a 
random phenomenon.  These CG rich regions are referred to as “CpG islands” given that 
they occur sporadically in a “sea” of DNA low in this specific repeat.  These CpG 
islands are the binding sites for the SP1 and SP2 transcription factors and thus 
transcriptional initiation is dependant on the binding of these transcription factors.  Sp1 
can bind at either an element known as the ETS motif (5’-GGCTTCCTGTCT-3’) or 
another element known as the pyrimidine rich initiator motif (5’-CTCANTCT-3’).  
Binding of Sp1 to these elements facilitates the stabilization and assembly of the general 
transcription factors and allows transcription to initiate despite the absence of a defined 
TATA box (Beckett 2001).    
 Assembly of the preinitiation complex and its subsequent phosphorylation 
induced activity are regulated by a host of protein-protein interactions between members 
of the complex and additional proteins that serve to alter the stability of the complex and 
its binding to the DNA helix.  In fact, regulated assembly is a central component to the 
control of transcriptional initiation (Ogbourne and Antalis 1998; Dvir et al. 2001; 
Beckett 2001; Shilatifard 1998).  Tissue specific and developmental regulation of 
transcription can thus be achieved via altering the capacity of the GTF to assemble at the 
promoter.  Binding of inhibitors and enhancers as well as the post-translational 
modification of the GTFs serves to collectively regulate this process.  For example, the 
NtrC transcriptional activator in E.coli is a transcription factor that assembles only after 
phosphorylation.  This post-translational modification results in the formation of stable 
DNA-protein complexes linking two regulatory DNA elements.  An additional example 
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would be the regulation of the SMAD proteins by cellular signaling events.  
Phosphorylation of the SMAD proteins results in altered properties of association in that 
the tendency to form homodimers is shifted to form heterodimers with other members of 
the SMAD family (Beckett 2001). 
Repressors generally alter the binding affinity of the GTFs and thus decrease the 
rate initiator complex assembly but many have also been identified which can bind to the 
forming initiation complex and act as a steric block to its formation.  An example of this 
interaction is given by the transcription factor that regulates biotin production in 
bacteria.  This protein is found bound to either a repressor or an enhancer protein.  
Repressor binding induces a disorganization of the DNA binding loops as where binding 
of the enhancer ligand induces a conformational change where the binding loops align to 
allow DNA-protein complex formation (Shilatifard 1998).   
Binding of transcription factors is generally thought to stabilize or enhance the assembly 
of the initiator complex through protein-protein interactions or delivery of a (or portions 
of) preassembled initiation complex.  Transcription factors may also act by inducing the 
correct conformation in the DNA helix so as to permit either initiator complex assembly 
or transcription elongation.  Generally speaking though, transcription factors can be 
thought of as molecules, which induce the appropriate conditions in the DNA, that allow 
it to serve as a platform for complex assembly (Shilatifard 1998). 
A large percentage of vertebrate genes have variable 5’ untranslated regions 
given that their transcription can begin at multiple sites over a large region; 20 – 200 
base pairs in size.  Often, these genes encode proteins involved in intermediary 
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metabolism and are transcribed at relatively low rates.  The control region for most 
genes of this type do not contain a classical TATA box initiator site but rather do contain 
a stretch of 20-50 nucleotides composed almost exclusively of cytosine and guanine.  As 
a dinucleotide, cytosine-guanine (CpG) is statistically underrepresented in vertebrate 
genomes and thus the presence of long CpG repeats just upstream of transcription 
initiation sites is not a random phenomenon.  These CG rich regions are referred to as 
“CpG islands” given that they occur sporadically in a “sea” of DNA low in this specific 
repeat.  These CpG islands are the binding sites for the SP1 transcription factor and thus 
the vast majority of genes following this paradigm are responsive to SP1 initiation.  
However, CpG islands are also found in the regulatory regions of many if not most other 
genes and are the sites of a unique regulatory phenomenon, DNA methylation (Bestor 
2000).   
Methylation of the number five position of cytosine in these CpG islands 
produces a localized conformational and electrostatic change in the DNA double helix 
that influences a diverse number of biological processes.  These methylated regions have 
been implicated in transcriptional regulation both in a global and tissue specific manner, 
X-chromosome inactivation, genomic imprinting, silencing viral retrotransposons, as a 
mechanism for monitoring cellular ageing and in neoplastic transformation.  Disruption 
or massive alteration of these carefully controlled methylation patterns are incompatible 
with normal growth and development (Bestor 2000; Li et al. 1992).   
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Part 2 Post-transcriptional Gene Regulation 
 
While gene silencing mediated by DNA methylation exerts its affect on the level 
of transcription initiation, it is necessary to review two specific elements of post-
transcriptional gene regulation as they pertain to DNA methyltransferase function.  
These two elements are alternative splicing and post-transcriptional gene silencing or 
RNA interference (RNAi).  Several mechanisms of post-transcriptional gene regulation 
have been identified in eukaryotic cells and even more have beeen suggested by recent 
experimental data.  Regulation of RNA stability, regulation of secondary structure, 
splicing (“normal intronic”, alternative splicing and intergenic splicing), poly(A) tailing, 
termination, RNA editing, RNA trafficking mRNA localization and post-transcriptional 
gene silencing represent the major mechanisms identified to date (Akker et al. 2001).  
These methods are diverse in their specific mechanism of action however, they all serve 
to chemically modify, trim or rearrange the RNA transcript to produce new exon 
arrangements / translational boundaries that can result in the generation of multiple 
protein species from a single gene.  The end result provides a level of gene regulation 
beyond the level of transcriptional initiation and thus expands the capacity of the cell to 
modulate gene expression.   
Splicing 
Splicing is the process of removing introns and joining exons to create a coherent 
coding sequence.  Numerous elements common to nearly all eukaryotes work in concert 
to achieve gene splicing.  Splicing occurs via two sequential trans-esterification 
reactions where one ester bond is exchanged for another.  The first reaction forms a 
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lariat structure where the 5’ guanine of the intron is joined in a 2’ – 5’ phosphodiester 
bond to an adenine near the 3’ end of the intron to produce a “branch point”.  Over 100 
proteins have been identified in association with the process of splicing and these 
various proteins are found in differing concentrations depending on developmental stage 
and cell type thus providing the basis for prospective gene specific regulation of this 
process.  Uricil rich, ribonucleoparticles 1 to 6 (U1,U2,U4,U5 and U6) are some of the 
major components that participate in the formation of the splicosome and mediate RNA 
splicing.  U1 binds to the universal splice site (5’ -  GAGGUAAGU - 3’) located on the 
3’ side of the exon-intron boundary through a complimentary sequence in the 5’ end of 
the U1 snRNA.  U2 binds the upstream pyrimidine rich site near the 3’ end of the intron 
through the targeted binding action of the U2 snRNP auxiliary factor (U2AF).  Docking 
of the U2 protein with U2AF induces a buldge in the U2 protein allowing the 2’ 
hydroxyl to participate in the first trans-esterification reaction and formation of the 
lariate structure.  U4 and U6 pair up and bind the intron in a sequence independent 
manor allowing U5 to associate and complete the formation of the splicosome.  
Spliceosome assembly occurs in a highly ordered and stepwise fashion, upon which U1 
and U5 are released via a rearrangement that moves the splice sites into close proximity 
and allows the second trans-esterification reaction to be completed.  Upon completion of 
the second trans-esterification reaction, the two exons are now joined in frame and the 
intron is released, still complexed with U2, U4 and U6 (Akker et al. 2001; Caceres and 
Kornblihtt 2002; Lopez 1998; Zhao et al. 1999).  
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The protein machinery necessary to carry out RNA splicing are physically 
associated with the nuclear matrix, thus splicing occurs in compartmentalized regions 
and localization of specific factors to these regions contributes to the overall regulation 
of the process.  As well, different splice sites within introns have varying amounts of 
strength in their capacity to recruit the spliceosomal machinery.  Some introns in fact, 
contain very weak splice sites that require the activity of accessory proteins to activate 
splicing in these regions.  The translational capacity of the transcript can thus be 
regulated by its propensity to attract these splicing factors, as unspliced RNA molecules 
are not exported from the nucleus (Lopez 1998; Zhao et al. 1999).  A wide variety of 
splicosomal enhancer proteins have been found and shown to mediate these interactions 
(Caceres and Kornblihtt 2002; Lopez 1998; Zhao et al. 1999).  
Alternative Splicing 
With the sequencing of the human genome it has become apparent that the 
complexity and sheer diversity evident in the proteome cannot be attributed to the 
limited number of genes identified.  This observation highlights the importance of post-
transcriptional methods of gene regulation, which are now hypothesized to be crucial to 
generation of the observed protein diversity.  Alternative splicing is a method of 
generating alternative exon combinations within a single RNA by utilizing alternative 5’ 
splice sites, alternative 3’ splice sites, optional exons, mutually exclusive exons, retained 
introns and alternative poly(A) tail splice sites.  All of these serve to change the coding 
sequence to allow the generation of multiple protein domain combinations from a single 
primary RNA transcript.  A large number of cis regulatory elements and trans-splicing 
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factors modulate the alternative selection and omission of exons from specific pre-
mRNAs.  These methods are diverse in their specific mechanism of action however, they 
all serve to chemically modify, trim or rearrange the nascent RNA (nRNA) transcript to 
produce new exon arrangements / translational boundaries that can result in the 
generation of multiple protein species from a single gene (Akker et al. 2001; Caceres 
and Kornblihtt 2002; Lopez 1998; Zhao et al. 1999).  The mechanisms by which these 
heterogeneous RNA transcripts are produced is an expanding area of research and 
abnormalities identified at many of the steps involved are now being correlated with 
disease phenotypes.   
Since the sequencing of the human genome it has been conservatively estimated 
that 60% of the genes identified are alternatively spliced (International Human Genome 
Sequencing Consortium 2001).  The methods that mediate alternative exon selection are 
diverse and many are subject to regulation by extra-cellular signaling pathways.  
However, a significant portion of alternative splicing can be accounted for by the 
variations in strengths between 5’ and 3’ splice sites within a single intron and their 
relation to the strength of surrounding splice sites.  Enhancing or repressing the relative 
strength of splice sites is the major mechanism by which alternative splicing is asserted.  
A simple mechanism where by the strong 3’ splice site of the downstream exon 
competes effectively with the weak 3’ splice site of the upstream intron can result in 
exon exclusion.  Repetitive di- or tri-nucleotide sequences within or in close to these 
splicing regulatory sequences strongly influence their strength.  Cystic fibrosis, and 
myotonic dystrophy are all classic examples of how repeats located in intergenic regions 
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can negatively influence splicing and their resultant protein products (Akker et al. 2001; 
Caceres and Kornblihtt 2002; Lopez 1998; Zhao et al. 1999). 
Alternative splicing is a highly regulated process where patterns of exon splicing 
can be modulated in response to developmental and physiological signals, however the 
majority of splicing events seem to be constitutive, with mRNA variants coexisting at 
constant ratios cell to cell.  This consistency is a reflection of the generic nature of the 
spliceosome and the involvement of the ubiquitous splicing factors in the majority of 
alternative splicing reactions.  However several trans acting proteins attenuate the 
recognition of the correct splice sites involved by either acting as enhancers or repressors 
influencing the coordinated selection of the 5’ and 3’ splice sites across an exon.  
Several proteins have been identified in this capacity and more are emerging as our 
understanding of the molecular nature of splicing increases.  Thus, the decisions that 
govern the alternative splicing of a mRNA can be attributed to competition between and 
among potential splice sites and as such, any mechanism that alters the relative rate of 
selection for a splice site serves to regulate the selection or omission of that exon.  The 
proteins that govern the selection or repression of a splice site can basically be separated 
into two classes, splicing enhancers and splicing repressors (Akker et al. 2001; Caceres 
and Kornblihtt 2002; Lopez 1998; Zhao et al. 1999). 
Spliceosomal Enhancers 
The SR family of proteins are a group of eight (or more) proteins characterized 
by RRM type RNA binding domains in their carboxy-terminal domains and serine-
arginine repeats in the amino-terminal domains that mediate protein-protein interactions 
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with various components of the spliceosomeal machinery.  Members of this subclass of 
splicing proteins function via the recognition of exonic splicing enhancer elements and 
lead to the activation of weak adjacent 3’ splice sites.  Two SR proteins, termed splicing 
factor 2 and alternative splicing factor (SF2 and ASF) are two of the main members of 
this family involved in mammalian alternative splicing.  The concentrations of both of 
these factors and their ratios with respect to each other are important factors in 
determining the combination of exons during pre-mRNA processing of alternatively 
spliced genes. 
Spliceosomal enhancers function by enhancing U1 and U2AF splice site 
recognition as well as by stabilizing their binding by forming a protein bridge between 
the 5’ and 3’ splice site complexes.  The strength of splice site recognition by U1 and 
U2AF is relative to the similarity of the cis splice site to the consensus sequences listed 
above.  Binding of spliceosomal enhancers not only enhances binding of U1 and U2AF, 
but it also serves to stabilize the interaction between these two components and serves to 
recruit other spliceosomal components.  Several enhancer proteins bind to purine rich 
elements within the exons of the regulated gene and promote the use of a proximal splice 
site, whereas others are pyrimidine rich and are located in intergenic regions.  The splice 
sites of RNA molecules subject to alternative splicing often exhibit poor matches to the 
consensus sequences, or their recognition is hampered by the secondary structure of the 
proximal region.  Additionally, the exon itself may be too large for the protein bridge 
between U1 and U2AF to form.  Spliceosomal enhancer proteins alleviate these 
impediments by enhancing U1/U2AF binding, removing secondary structure, or by 
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facilitating the formation of a bridge between U1-U2AF directly.  The molar amount and 
activity of these enhancer proteins is different from cell to cell and changes over 
development.  Thus, spliceosomal enhancer proteins can determine which protein 
isoforms are present in which cell and at what time (Akker et al. 2001; Caceres and 
Kornblihtt 2002; Lopez 1998; Zhao et al. 1999).   
A well-defined example of SR protein mediated alternative splicing is found in 
studies of Drosophila sex determination.  There are three main genes involved in sex 
determination of the fly: sex lethal (Sxl) doublesex (Dsx) and transformer (Tra). Each of 
these genes produces a pre-mRNA that has two possible splicing patterns, depending 
upon the sex of the fly.  In the male, mRNA production proceeds as normal, which 
causes the inclusion of two exons in Sxl and tra that produce mRNAs, which have 
“premature” stop codons and yield inactive proteins.  In females, the Dsx protein, a 
member of the SR family of alternative splicing factors binds the mRNA and induces the 
alternative splicing of this RNA such that the exons containing the stop codons of Sxl 
and tra, are skipped thus producing functional protein products (Lopez 1998; Zhao et al. 
1999).   
Spliceosomal Repressors 
Splice site selection can be blocked by inhibitory cis elements that induce the 
formation of secondary structure, recruiting repressor proteins that sterically block 
access of U1/U2AF to the splice site or by providing a competitive site for spliceosomal 
factor binding, thus sequestering the component from the splice site.  All of these 
mechanisms impart a repressive affect upon the selection of the proximal splice site and 
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thus promote its exclusion from the processed mRNA.  In contrast with the SR group of 
proteins, the hnRNP family of proteins appears to mediate their affect by interfering with 
U1/U2AF binding to the splice site of the intron and thus shifting the spliceosome to a 
distal splice site.  The hnRP family binds pyrimidine rich regions and are also known as 
pyrinidine tract binding proteins (PTB).  The relative abundance of the SR and hnRNP 
proteins varies between cell types and developmental stages leading to the production of 
cell type and developmental specific transcripts.  In addition, the activities of these 
proteins are affected by post-translational phosphorylation, linking alternative splicing to 
environmental induced or developmental extra cellular signals.  The Drosophila SXL 
protein binds pyrimidine rich regions of introns and blocks access of the U2AF protein 
to the 3’ splice site and thus promotes the use of a weaker downstream splice site.  SXL 
is a very strong repressor that physically blocks access of U2AF and can displace 
molecules already bound to the 3’ splice site.  Other repressor proteins function either by 
recruiting U1 to sub-optimal splice sites or by directly binding and blocking the action of 
spliceosomal components.  In summary, spliceosomal repressors function by interfering 
with splicosome assembly or by reducing the efficiency of splicosome assembly such 
that selection of a downstream splice site is preferred (Lopez 1998; Zhao et al. 1999). 
The molar range of enhancer and repressor proteins varies over a range of 100 
fold between different tissues in the adult rat (Hanamura et al. 2002).  Variations in the 
relative concentration or activities of competing and cooperative factors and the strength 
of their target cis elements to recruit them all serve to regulate the spectrum of 
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alternative splicing for a given cell (Akker et al. 2001; Caceres and Kornblihtt 2002; 
Lopez 1998; Zhao et al. 1999). 
Post-transcriptional Gene Silencing 
 RNA interference (RNAi) is an evolutionary conserved process, which leads to 
posttranscriptional suppression of gene expression.  Among other functions, it is thought 
to serve as a natural defense mechanism against a variety of microorganisms, including 
viruses (Denli and Hannon 2003; Hannon 2002).  RNAi was first discovered as a result 
of experiments on the flat worm Caenorhabditis elegans, which demonstrated sequence-
specific gene silencing in response to double-stranded RNA (dsRNA).  Numerous 
studies have been performed since, which clearly demonstrate RNAi is operational in 
many, if not most, eukaryotic organisms (Hannon 2002).  
 In brief, RNAi seems to involve a two-step process.  In the first step, dsRNA is 
recognized by an RNAse III family nuclease termed Dicer.  This enzyme cleaves dsRNA 
into small interfering RNAs (siRNA) containing 21 – 29 nucleotides (Bernstein 2001).  
The siRNAs are then incorporated into a multicomponent nuclease complex, RNA-
induced silencing complex (RISC), which targets specific mRNAs for destruction based 
on their homology to the siRNA (Denli 2003).  The process begins with two anti-parallel 
dimmers of the Dicer protein utilizing ATP to cleave the long double stranded RNA into 
oligonucleotides 21-29 base pairs in length.  All vertebrates studied today contain a 
homologue of Dicer and numerous Dicer homologues have been identified in 
Arabidopsis (Bernstein et al. 2001).  These short interfering RNAs (siRNA) serve as a 
trigger eliciting a response that culminates in the sequence directed destruction of RNA 
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molecules containing homologous regions to the siRNA (Hannon 2002).  Upon cleavage 
by Dicer, these RNAs can enter one of three possible pathways.  In the first, the siRNA 
is directed to bind the 3’ untranslated region of target mRNAs and inhibit their 
translation at the level of protein synthesis.  The mechanism by which this phenomenon 
occurs is still unknown as is the reason behind the lack of a requirement for exact 
complimentarity between the siRNA and the target 3’ UTR.  This pathway has been 
termed the miRNA pathway as the precursor molecules that initiate it are formed from 
short 70mers, which are processed by Dicer in the nucleus (Hannon 2002).   
 The second mechanism by which RNAi directed gene silencing can occur is via the 
selective destruction of mRNAs complimentary to the siRNA which occurs in the 
cytoplasm.  This process is mediated by the RNA induced silencing complex (RISC).  
This protein complex is formed of various proteins in different combinations depending 
on species and cell type (Denli and Hannon 2003).  The first protein to be identified was 
Argonaute II, which is a member of highly basic proteins linked to studies of RNAi in 
plants.  Mutations of these proteins result in abnormal shoot apical meristem 
development that resembles squid like tentacles, ergo the French word for squid 
(Argonaute) was used to describe their appearance.  Since the identification of the first 
Ago proteins, numerous mammalian homologues have been identified including several 
germ cell specific forms.  These proteins can associate with either the siRNA or the 
miRNA triggers.  Upon purification of RISC, several other proteins were identified and 
many have distinct correlations with human disease.  These include the Fragile X Mental 
Retardation Protein (FMRP), gemin-3 a DEAD Box containing protein and the Tudor 
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protein, which contains the RNase component of the RISC holoenzyme.  The specific 
interactions that control RISC assembly and function have not been established but it is 
clear from the wide variety of proteins involved and the numerous isoforms and tissue 
specific homologues found that this is a highly regulated process.  It is likely that similar 
to transcriptional initiation, the regulated assembly of the RISC complex is subjected to 
combinatorial control based on the abundance and form of the different RISC 
components (Bernstein et al. 2001; Denli and Hannon 2003; Hannon 2002). 
 The third mechanism by which RNA mediated post-transcriptional gene silencing 
mediates its effect is by RNA directed DNA methylation.  The first suggestion that this 
phenomenon existed was the observation that in plants, PTGS was heritable.  Later is 
was found that in yeast, several components of the RNA machinery are required for 
centromeric silencing (Denli and Hannon 2003).  Finally, an experiment where double 
stranded RNA homologous to the promoter of a gene was able to elicit gene silencing 
revealed that the mechanism by which this effect is asserted is through DNA 
methylation.  The N-terminal domains of the DNA methyltransferases contain numerous 
highly conserved protein domains that are separate from their catalytic methyltransferase 
domain.  It is possible that the RNAi directed chromosomal silencing utilizes a specific 
domain on the Dnmts to carry out this effect, however such a link has not been 
definitively identified. 
Part 3 Mammalian Preimplantation Development 
Development of the fertilized zygote through several morphologic changes, 
ultimately forming a blastocyst occurs via the execution of a preprogrammed 
 23
developmental plan that results in the differentiation of two separate cell lineages, one 
forming the placenta and the other, which will give rise to the embryo proper (Camous et 
al. 1986; Frei et al. 1989).  In all species, development beyond these early cleavage 
divisions is completely dependent upon the switch from a reliance on maternal stores of 
mRNA within the oocyte to transcription of the zygotic genome; a process termed 
zygotic genome activation (ZGA) (Camous et al. 1986; Frei et al. 1989; Kopecny et al. 
1989).  
In bovine embryos, zygotic gene activation occurs by the 8-16 cell stage 
(Camous et al. 1986; Frei et al. 1989; Kopecny et al. 1989) although several studies 
have revealed transcriptional activity earlier in development (Plante et al. 1994; Viuff et 
al. 1996).  However, bovine development can proceed only to the 8-cell stage in the 
presence of a transcriptional inhibitor suggesting that progression beyond this stage is 
dependent upon gene products derived from the embryo’s genome (Liu and Foote, 
1997). These findings follow similar observations in other species, including humans 
(reviewed in Telford et al. 1990). During these early stages the mechanisms that govern 
which sets of genes are turned on and those, which are turned off, are absolutely 
essential to the processes of development and differentiation.  Fundamental to these 
precise mechanisms of control is the phenomenon of epigenetics. 
Part 4 Epigenetics and Transcription 
Mammalian biology, be it normal development or disease status is the sum total 
of the dynamic regulation of genes encoded by the genome and production of the 
resultant proteins.  Differential patterns of gene expression determine the structural and 
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functional phenotype of the cell, which in turn directly affect the physiology of the 
organism.  Mechanisms that govern which sets of genes are turned on and those, which 
are turned off are fundamental to the processes of development and differentiation.  The 
oocyte and early embryo contain a specific preprogrammed developmental plan that 
once initiated by the process of fertilization, sets in motion the machinery that will build 
a complete and independent organism from a single cell.  Fundamental to this process is 
the phenomenon of epigenetics.   
Epigenetic refers to differential patterns of gene expression based solely on the 
local physical and biochemical properties of chromatin without a change in DNA 
sequence.  Two major mechanisms appear to be responsible for these specific properties, 
DNA methylation and post-translational histone modification. (Brown & Strathdee 
2002; Bird & Wolffe 1999; Jenuwein & Allis 2001).  DNA methylation refers to the 
addition of a methyl group to cytosine residues at CpG islands (adjacent cytosine and 
guanine nucleotides) in the double helical structure of DNA.  The addition of this side 
chain results in a local alteration of the DNA double helix reducing the ability of the 
DNA to be transcribed and thus decreased production of the associated gene product 
(Hausheer et al. 1989).  Post-translation covalent histone modifications refer to the 
addition or removal of phosphate, acetyl and/or methyl groups to the histone proteins in 
which DNA is packaged.  Modification of DNA packaging can act as a local switch 
resulting in transcription or repression of a specific gene based on whether it lies in an 
open (acetylated) or closed (phosphorylated, methylated or unmethylated depending on 
the specific position) conformation (Jenuwein & Allis 2001).  The mechanisms listed 
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above appear to control the vast majority of genes in the genome and, at the very least, 
influence the rest (Brown & Strathdee 2002; Bird & Wolffe 1999; Jenuwein & Allis 
2001).  These observations have spawned the creation of the term “epigenome” to 
describe this intricate control system, which appears to be almost as important as the 
actual base pair sequence of the genes themselves (Jenuwein & Allis 2001).  Cracking 
this “histone code” is likely to be the next major achievement in molecular biology.   
Epigenetics thus represents a heritable mark that can be passed down through 
progeny but which may also be modified in response to environmental and 
developmental phenomena thereby modulating the transcriptional program of a cell.  
Modification of either DNA methylation or histone status that results in differential gene 
expression is referred to as genetic reprogramming. Patterns of DNA methylation and 
the resultant histone dynamics have been implicated in transcriptional regulation both in 
a global and gene specific manner, X-chromosome inactivation, genomic imprinting, 
silencing viral retrotransposons, as a mechanism for monitoring cellular aging and in 
neoplastic transformation.  A recent wave of research has thus been focused on the 
identification and characterization of specific factors that both establish these epigenetic 
marks and control their dynamics.  The oocyte and early preimplantation embryo 
represent perhaps the largest repository of epigenetic factors as it is from here that the 
epigenetic foundation is laid down, setting the transcriptional basis for the development 
of mammalian life.  
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Part 5 Epigenetic Events of Early Development 
Mammalian preimplantation development is a critical stage for the generation of 
the genomic methylation pattern.  During the first few cleavage divisions, a genome 
wide drop in methylation occurs as the nucleus is remodeled to take on the task of 
supporting embryonic growth and differentiation (Monk et al. 1991).  This removal of 
methyl groups is thought to “reset" the genome to a plastic state where it can be 
reprogrammed to direct embryonic development. A de novo wave of methylation then 
asserts a new pattern during preimplantation or postimplantation development depending 
on the species.  These processes appear to be conserved across mammalian species and 
are essential for normal development to proceed (Dean et al. 2001; Li et al. 1992; Okano 
et al. 1999).   
Part 6 Epigentic Events of Early Bovine Development 
Relatively little is known about the early epigenetic events of bovine embryonic 
development.  Studies pioneered by Dean et al (2001) demonstrated that during bovine 
preimplantation development, the genomic methylation pattern is erased during the first 
few cleavage divisions and then reasserted during the 8cell to 16-cell transition.  This 
developmental pattern is similar to the mouse in that methylation levels begin to drop 
just prior to syngamy, however de novo methylation is seen during the 8cell to 16cell 
transition, which is in stark contrast to the epigenetic events observed in the mouse 
(Figure 2).  During murine development, methylation levels do not begin to rise until 
after implantation.  In the bovine it would seem that remethylation is initiated during 
preimplantation development.  The biochemical and enzymatic basis for this difference 
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is presently unknown as are the developmental consequences as they pertain to studies of 
somatic cell nuclear transfer. 
 
 
 
Figure 2  Epigenetic events of bovine preimplantation development.  A schematic 
diagram depicting the timing of the epigenetic alterations to the male and female 
pronucleus over the course of bovine preimplantation development.  The male 
pronucleus undergoes a rapid, genome wide demethylation immediately following 
fertilization, whereas the female pronucleus passively demethylates over the course of 
development to the eight-cell stage.  During the eight to sixteen-cell transition, the 
embryonic genome remethlyates.  The enzymes responsible for the dynamics depicted in 
this diagram are currently unknown.   
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Part 7 The DNA (Cytosine 5) Methyltransferases 
 
The specific mechanisms by which the dynamics of genomic methylation are 
controlled during this critical period remain largely unknown, however a family of 
structurally related proteins termed DNA (cytosine - 5) methyl-transferases (DNMTs) 
have been identified which catalyze the production and modulate dynamics of the global 
genomic methylation pattern (Bestor, 2000).  DNMT1 is the most abundantly expressed 
methlytransferase and is responsible for maintaining methylation patterns through DNA 
replication.  This enzyme is constitutively expressed and localizes to the replication foci 
of actively dividing cells (Leonhardt, 1992). Studies in mice have shown that Dnmt1 
employs a stage specific alternatively spliced isoform during preimplantation 
development to carry out tasks specific to this crucial stage. This isoform has been 
termed DNMT1o due to its restricted pattern of expression to the oocyte and early 
preimplantation development (Mertineit et al. 1998; Howell et al. 2001; Ratnam et al. 
2002).  Murine DNMT1o is the sole isoform of DNMT1 expressed in the 
preimplantation embryo (Ratnam et al. 2002).  The Dnmt1o transcript has a unique 5’ 
end that results in the production of a truncated protein.  This protein is excluded from 
the nucleus during the one to eight cell stage, is allowed briefly to enter the nucleus to 
maintain the maternal imprint patterns, and is then excluded again at the sixteen cell 
stage until after implantation (Howell et al. 2001; Ratnam et al. 2002).  Knockout 
studies of DNMT1 in mice are embryonic lethal and fail to progress beyond the 1st 
trimester (Li et al. 1992).  Whereas, replacing the oocyte specific DNMT1o with the 
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somatic form of DNMT1 disrupts genomic imprinting and causes developmental failure 
in the last third of gestation (Howell et al. 2001). 
DNMT3a and DNMT3b both possess de novo methylating ability, transferring 
methyl groups to previously unmethylated regions (Okano et al. 1999; Okano et al. 
1998a).  Inherent in this, these enzymes have the ability to redirect gene expression 
patterns by altering the topology of DNA to a transcriptionally repressive state.  Studies 
of the epigenetics of preimplantation development to date strongly suggest a model 
where DNMT3a and 3b cooperate to re-establish the genomic methylation pattern during 
early development and thus build the epigenetic foundation necessary to direct normal 
embryonic development.  DNMT3a and 3b are abundantly expressed in embryonic 
tissues and stem cells but appear at low levels in somatic tissue.  Both appear to form 
complexes with histone deacetylase 1 and 2 (HDAC1 and 2) and thus play a key role in 
recruiting all the known factors necessary to impart transcriptional repression (Fuks et 
al. 2001).  Gene knockout studies of both DNMT3a and 3b in mice showed that the 
embryos arrested shortly after gastrulation and the differentiation of the three embryonic 
tissue types.  Individual knockouts of DNMT3a and 3b were not as profound, however, 
this is likely due to functional redundancy between these and other members of the 
methyltransferase family (Okano et al. 1999).  Recently, several alternatively spliced 
isoforms have been identified for DNMT3a and 3b, the expression of which is tissue 
specific and abnormalities therein linked to cancer (Robertson et al. 1999; Chen et al. 
2002; Saito et al. 2002).  The isoform distribution of DNMT3a and 3b has not been 
analyzed in the preimplantation embryo and it remains to be seen if these two enzymes 
 30
employ stage specific splice variants (isoforms) similar to DNMT1o.  DNMT3a and 3b, 
along with the newly discovered methylation regulatory protein DNMT3L, in which 
knockout studies involving this gene have also resulted in failed development, are 
thought to be the major players in the establishment of the epigenome, in particular the 
unique tissue specific expression patterns and genomic imprints of particular genes 
(Bourc’his et al. 2001a; Hata et al. 2002).  Further characterization of these de novo 
methyltransferases and their unique splice variants will likely yield great insight into the 
building of the epigenetic foundation of mammalian life.  
DNMT2 is widely expressed in a variety of tissues and although it contains all 
the conserved methyltransferase motifs, it has only very recently been demonstrated to 
posses DNA methylating ability (Herman et al. 2003, Tang et al. 2003 and Kunert et al. 
2003).  In fact, until late this year, DNMT2 had no known function (Okano et al. 1998b). 
No specific study has yet addressed the function of DNMT2 within the oocyte, 
preimplantation embryo or in the gonads.  It is likely that, given that DNMT2 is the most 
conserved methyltransferase it does play some critical role in the epigenetic control of 
the genome.  Methyl-binding protein 2 is a protein that may or may not have the capacity 
to strip DNA of methyl groups but does not appear to be involved in preimplantation 
development specifically.  This protein appears to specifically bind methylated DNA and 
then recruit histone-modifying enzymes to alter the transcriptional activity of the 
methylated region (Jones et al. 1998). Through this mechanism, DNA methylation 
serves as a mark to signal the post-translational modification of histones and thus 
modulate gene expression patterns in a tissue specific response to developmental and 
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environmental cues. Proper function of all the proteins listed above appears to be 
essential for normal development to proceed.  
Part 8 Structural Domains of the Dnmts 
Catalytic Domain and Mechanism of Action 
Catalytic domains of all the DNA methyltransferases studied to date share ten 
structural motifs that have been remarkably conserved through evolution.  These motifs 
consist of six highly conserved (motifs I, IV, VI, VIII, IX and X) and four moderately 
conserved motifs (motifs II, III, V and VII).  These form the catalytic domain of the 
DNA methyltransferase enzymes by folding into two domains; one large domain 
consisting of motifs I through VIII and most of motif X and a smaller domain consisting 
largely of motif IX.  The DNA double helix fits in the resultant cleft between the large 
and small domains.  The variable region in between motifs VIII and IX confers 
specificity for the enzyme’s binding to the DNA helix (Bestor and Verdine 1994; Kumar 
et al. 1994; Kilmasauskas et al. 1994).   
The substrate of the DNA methyltransferase is the carbon at the number five 
position of the base cytosine.  In its natural sate, the cytosine is deeply buried in the 
DNA helix and thus not able to allow the reaction to proceed.  Binding of DNA 
methyltransferase to the DNA helix induces a conformational change in motif IV, which 
is situated on a flexible loop referred to as the “catalytic loop” that results in motif IV 
coming into contact with the DNA helix.  A conserved proline-cysteine dipeptide 
induces the targeted cytosine residue to release its Watson-Crick base pairing and flip 
out of the double helical structure into the catalytic pocket of the DNA methyltransferase 
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enzyme (Kilmasauskas et al. 1994).  Residues in motif IX form direct hydrogen bonds 
with the O2 and N atoms in the targeted cytosine ring giving it the correct orientation 
(Bestor and Verdine 1994; Kumar et al. 1994; Kilmasauskas et al. 1994).   
During this flip out process, the enzyme itself undergoes a major conformational 
change where the catalytic loop moves deeper into the cleft and ultimately into the minor 
grove of the DNA helix.  With this conformational change a cysteine in motif IV is now 
in its proper orientation to serve as the active site for the enzyme.  This inducible 
conformational change brings a nucleophilic cysteine thiol into close proximity to 
carbon 6 of the cytosine ring.  Immediately upon induction of this conformational 
change a nucleophilic attack of the thiol group on the number six carbon is imitated and 
results in the formation of a covalent (thioether bond) DNA-protein intermediate.  Thus, 
the binding of the methyltransferase enzyme induces a conformational change on both 
the protein and the DNA double helix providing a most eloquent example of the 
induced-fit-mechanism for enzyme-substrate interactions (Bestor and Verdine 1994; 
Kumar et al. 1994; Kilmasauskas et al. 1994).   
Formation of this stable intermediate permits the methyl-donor, S-adenosyl-L- s-
methionine (AdoMet) to be brought into close proximity to both the active site of the 
enzyme and the targeted carbon five of the cytosine ring.  AdoMet binds the large 
domain of the methyltransferase enzyme through specific interactions with amino acids 
in motifs I to V.  A phenalalanine in motif I specifically interacts with the aromatic ring 
structure of the adenosyl moiety and serves to hold the cofactor in the correct 
orientation.  The addition of the nucleophile to carbon six in the previous step activates 
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carbon five and allows the transfer of the methyl group from AdoMet.  After the transfer 
of the methyl group, S-adenosyl-L-homocysteine (adoHyc) is released.  The proton now 
at the 5 position is abstracted by a basic residue on the enzyme which is quickly 
eliminated via β-elimination (Bestor and Verdine 1994; Kumar et al. 1993; 
Kilmasauskas et al. 1994).   
The mechanism discussed above suggests a kinetic cycle where the variable 
domain of the enzyme first binds its target upon which the active site loop clamps down 
upon the DNA helix, flipping targeted cytosine into the active site via the formation of a 
C4’ exo sugar pucker and thus forming a covalent reaction intermediate.  A rapid 
transfer of a methyl group from AdoMet results in the methylation of carbon 5 of 
cytosine and the release of AdoHyc.  The proton abstraction likely releases the enzyme 
allowing both the DNA helix to return to the β conformation and the enzyme to proceed 
to its next substrate.  
Mechanism of Action of the Dnmt Inhibitor 5-Azacytidine 
5-Azacytidine is a nucleoside analogue similar to the natural substrate of the 
DNA methyltransferases, cytosine with the exception of a nitrogen atom in place of 
carbon atom number 5 in the ring structure of the base (Figure 3).  The initial stages of 
the methylation cycle are initiated, however the nitrogen atom prevents completion of 
the reaction and leaves the Dnmt protein covalently bound to the DNA helix via carbon 
6 of cytosine, as a reaction intermediate (Santi et al. 1984).  As a result, Dnmt protein is 
rapidly depleted from the nucleus and methylation levels drop.  However, it is thought 
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that the removal of the reaction intermediates by the DNA repair machinery results in 
localized mutations that may be of further harm to the cell. 
 
 
 
 
 
 
 
 
 
  
Figure 3 S
right – cy
 
 
 
Cysteine R
  Th
catalytic m
methyltra
identifiab
contain a 
in structur
which is i
trithorax p
matrix, th
cysteine r
with DNA 
 
           C        H                       C          CH3                C 
     N          C                     N          C                   N           N 
        │                 │                                │                 │                             │                  │ 
     C           CH                 C           CH               C           CH 
O        N                       O        N                     O        N 
                 │                                                    │                                                 │                 
           R                                  R                                R 
 
chematic diagram representing the chemical structures of cytosine.  Left to 
tosine, methyl-cytosine and 5-Azacytidine.   
ich Zinc Finger 
e carboxy terminus of all the known DNA methyltransferases contains the 
otif discussed above whereas the amino terminal domains of each 
nsferase are unique.  With the exception of Dnmt2, which contains no 
le domain structures besides the catalytic one, all of the remaining Dnmts 
cysteine rich, zinc-binding region of unknown function.  This region is similar 
e to a region in mammalian homologues of the Drosophila Trithorax protein, 
nvolved in maintaining homeotic gene expression.  It is hypothesized that the 
rotein anchors transcriptionally active chromosomal domains to the nuclear 
us playing a role in maintaining their transcriptionally active state.  The 
ich domain of the Dnmts (with the exception of Dnmt2) physically interacts 
 and likely other proteins as well which may prevent the enzymes from 
 35
methylating transcriptionally active sequences via interacting with other protein factors 
present at these sites, sequestering the Dnmts from their substrate.   
Domains Unique to Dnmt1 
 The amino terminus of Dnmt1 is essential for enzymatic activity and 
surprisingly, is toxic when expressed independently of the catalytic methyltansferase 
domain (Tucker et al. 1996).  Additionally, cleavage of the amino terminus activates de 
novo methylation, but this de novo methylation is completely dependant on an 
interaction with the cleaved amino terminus as alone, the catalytic domain posses no 
enzymatic activity (Zimmermann et al. 1997 and Fatemi et al. 2001).  Within the amino 
terminus are four major identifiable domains including the cysteine rich domain 
common to all other Dnmts (except Dnmt2), a nuclear localization signal, a polybromo 
domain and a PCNA binding site.  The nuclear localization signal is located between 
amino acids 72-92 and is responsible for shuttling the enzyme to the nuclei in 
coordination with DNA replication during S-Phase of the cell cycle.  A second domain 
proximal to this localization signal (amino acids 161-174) interacts with the proliferating 
cell nuclear antigen (PCNA) in a cell cycle coordinated fashion.  This region targets 
Dnmt1 to DNA replication foci via a direct protein-protein interaction with PCNA.  The 
cysteine rich region which is located between amino acids 643-688 has been 
demonstrated to bind Zinc and is hypothesized to be involved in DNA binding 
interactions but its exact function has yet to be determined (Bestor 1992 and Chuang et 
al 1996).    The Bromo Adjacent Homology Domain or Polybromo domain is located 
between amino acids 752-877 and 975-1097 (two adjacent domains) and is involved in 
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protein-protein interactions with other DNA binding factors, repressors and proteins 
whose function are currently unknown. 
 The amino terminus of DNA methyltransferase 1 also interacts with a number of 
other molecules, however the exact domains and binding sites have yet to be identified.  
As mentioned above, the N-terminal domain physically interacts with the carboxy-
terminal catalytic domain imparting a tertiary structural arrangement that activates the 
catalytic methyltransferase function.  No one sequence motif can be identified that does 
this solely, rather it is thought multiple sites bind inducing the correct alignment for 
enzymatic function (Margot et al. 2003).  The retinoblastoma protein (Rb) binds Dnmt1 
somewhere between amino acids 416-913 and an as yet undefined region in the amino 
terminus (amino acids 1-1,125) interacts with Histone Deactylase 1 and 2 (HDAC1 & 
HDAC2) along with the co-repressor DMAP at DNA replication foci.  Through these 
protein-protein interactions Dnmt1 becomes intimately involved with gene specific 
repression and histone modifying proteins thus tying together DNA methylation and post 
translational histone modification. 
Domains Unique to Dnmt3a and Dnmt3b 
 Domain structures present in the amino termini of DNMT3a and DNMT3b have 
been less extensively characterized than those of DNMT1, but nonetheless several 
highly conserved domains have been identified and correlated with diverse functions.  
The most highly conserved domains present in the Dnmt3 family of methyltransferases 
are the PWWP and PHD finger domains.  The PWWP domain is a 135-residue structure 
located between amino acids 265 to 321 in DNMT3a and amino acids 231 to 305 in 
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DNMT3b.  This domain is hypothesized to specifically interact with heterochromatin 
and is probably involved in a physical interaction with the DNA backbone allowing 
methyl transfer to hemimethylated DNA.  This protein domain has been identified in a 
wide variety of eukaryotic proteins from yeast to mammals, all of which in some way 
interact with DNA.  When expressed alone this domain binds a 12 base pair region of the 
DNA sugar-phosphate backbone via the positively charged surface of the folded PWWP 
domain.  The PWWP domain shares structural similarity to the SAND domain, which is 
believed to be involved in chromatin dependent transcriptional regulation.  Evidence that 
both DNMT3a and DNMT3b interact with specific yet distinct pericentromeric 
heterochromatic loci supports the notion that this domain is involved in protein-
chromatin interactions (Bachman et al. 2001).  Indeed, this hypothesis was further 
supported by studies by Qiu et al. (2002) that demonstrated deletion of the PWWP 
domain abolished the association of Dnmt3a with heterochromatin.  Since DNMT3a and 
DNMT3b are targeted to differing chromatic regions, there must be some as yet 
unidentified protein domain(s) responsible for their specific localization.  What proteins 
mediate this specificity and the functional consequences to the alternative splicing of the 
amino terminal domains of Dnmt3a and 3b remains to be examined. 
 The Plant Homeodomain finger (PHD) domain is a conserved zinc-binding motif 
identified in more then 300 eukaryotic proteins.  The majority of PHD domain 
containing proteins localize to the nucleus and are involved in modulating transcription 
through a variety of biochemical processes.  The PHD finger domain of the human 
Dnmt3 family of proteins has also been called the ATRX like domain as it shares 
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remarkable identity (97/98 amino acids) with the same domain found in the human 
ATRX protein.  Human ATRX is a chromatin-remodeling complex, mutation of which 
causes X-linked mental retardation with α-thalassemia or ATR-X syndrome (Gibbons et 
al. 1995).  Examination of PHD domains in numerous proteins using multiple 
alignments failed to discern any common positioning of this domain with relation to 
other protein domains or specific termini.  Biochemical studies of this domain in other 
proteins have demonstrated that the PHD finger domain requires Zn2+ binding for proper 
folding and that this Zinc binding is mediated by a conserved Cys, Cys, Hys motif 
common to numerous other proteins across evolutionarily distant species.  Recent 
studies have also revealed that this PDH finger domain is a metal dependent folding 
motif that mediates numerous protein-protein interactions.  It is hypothesized that within 
this context, the PHD finger domains of the Dnmt3 family of proteins mediate their 
incorporation into multi-component complexes involved in transcriptional regulation.  
Recently, biochemical fractionation experiments have demonstrated an association 
between Dnmt1 and Dnmt3b as well as associations between Dnmt3a and a histone 
methyltransferase and histone deactylase 1 (HDAC1) (Datta et al. 2003).  It is very 
likely that the PHD finger domain mediates the assembly of the DNMTs into multi-
component complexes that are involved in loci specific transcriptional silencing.   
Part 9 Regulation of Genomic Methylation by the Dnmts 
 Function of the Dnmt family of methyltransferases can be subdivided into three 
distinct regulatory roles.  Their catalytic action during early embryonic development sets 
up the epigenetic foundation for a given cells transcriptional program.  A maintenance 
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function ensures proper transmission of this cell specific methylation pattern through cell 
division and finally the Dnmts have the capacity to mediate a certain degree of a cells 
transcriptional response to the environment, viral infection, neoplastic transformation 
and aging.  None of these characteristics are understood very well but recent work in 
stem cells and tumors has suggested that each of the Dnmts or, more specifically, each of 
their individual isoforms plays distinct roles in this capacity.  All of the Dnmts identified 
to date exist as multiple isoforms and each of these contain unique protein domain 
combinations that likely impart a unique catalytic function.  Many of the splice variants 
identified produce enzymes that possess no methylating ability suggesting that the amino 
terminus may posses some as yet unidentified catalytic or regulatory role within the cell.  
However, the isoforms identified that do posses methylating ability all seem to localize 
to distinct chromosomal regions, have differing preferences for hemi-methylated and 
non methylated substrates and developmental and tissue specific expression patterns.   It 
is likely that the cell uses alternative splicing to increase the repertoire of DNA 
methylating enzymes to achieve a more dynamic and precisely controlled system. 
 During early preimplantation mouse development Dnmt1o translocates to the 
nucleus during the S-phase of the 8-cell stage and is essential for maintenance but not 
establishment of maternal specific imprinting patterns (Howell et al. 2001).  Further, 
studies of the human reproductive syndrome that results in a condition known as a 
hydatidiform mole have discovered that the genomes of these affected individuals suffer 
from a failure to establish maternal specific imprint patterns and thus the phenotype 
resembles an androgenome.  However, study of the Dnmt1 and Dnmt1o genes of these 
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malformed embryos did not reveal any mutations in the Dnmt1/Dnmt1o gene (Hayward 
et al. 2003).  Given that Dnmt1o is not required for establishment of either the paternal 
or maternal gene specific imprint patterns laid down during preimplantation 
development, and that Dnmt3a and Dnmt3b are not expressed during this developmental 
stage, there must be some as yet unidentified methyltransferase that mediates the 
establishment of the gene specific methylation for imprinted loci (Judson et al. 2002).   
 Studies of both human and murine cells suggested that Dnmt1 serves solely as a 
maintenance methyltransferase and the activity of Dnmt3a and 3b restricted to de novo 
methylation.  However, recent studies by Chen et al. (2003) revealed that in the absence 
of the Dnmt3a and Dnmt3b, Dnmt1 alone cannot maintain methylation levels and further 
that overexpression of Dnmt1 from an artificial plasmid cannot remethylate lost 
epigenetic marks.  Further, these studies revealed that the Dnmt3 family of 
methyltransferases plays a much more intricate role then first suspected.  Examination of 
Dnmt3a and Dnmt3b activity alone and together in Dnmt3a-/Dnmt3b- knock out stem 
cells has revealed specific methylating functions and targets for each of the different 
isoforms of Dnmt3a and Dnmt3b.   
Dnmt3a predominantly localizes to retroviral sequences, major satellite repeats, 
IAP repeats, non-imprinted genes as well as paternally imprinted genes, and the Xist 
gene on the X-chromosome.  Dnmt3a2 however, appears to specifically methylate 
paternally imprinted genes whereas Dnmt3a and Dnmt3b1 were not able to remethylate 
these sequences once the original methyl-mark had been lost.  In addition, it appears that 
over the long term both the Dnmt3a and 3b family of enzymes are required for 
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maintenance of these paternal imprints and that no amount of overexpression of Dnmt1, 
Dnmt3a, Dnmt3b or their associated isoforms has been able to restore maternal specific 
imprint patterns (Chen et al. 2003). 
Dnmt3b is an enigmatic methytransferse in that the majority of its isoforms are 
enzymatically inactive.  To date six Dnmt3b isoforms have been identified in the human 
and eight in the mouse.  Of these identified isoforms (dnmt3b1 – Dnmt3b6) only 
Dnmt3b1 and Dnmt3b2 possess any DNA methylating ability.  It has been speculated 
that alternative splicing of the other isoforms serves in some way to negatively modulate 
the expression of the enzymatically active ones as over expression of Dnmt3b3 has been 
correlated with hepatocarcinogenesis (Saito et al. 2002).  However, there are numerous 
reports of interactions of domains within the amino-terminus with other 
methyltransferases, gene specific repressors and histone modifiying enzymes. Before 
any conclusion can be drawn as to the function of these non-methylating isoforms, 
further characterization of the amino terminal domains and their functional interactions 
needs to occur. 
Human Dnmt1, Dnmt3a and Dnmt3b each have multiple differing types of 
promoters that regulate their expression, each with differing CpG contents.  These 
multiple promoters are thought to provide a feedback mechanism that serves to regulate 
the expression of the Dnmts.  Human Dnmt1 is regulated by at least four independent 
promoters; one of which is located in a CpG rich region while the remaining three are 
CpG poor (Bigey et al. 2000).  Human Dnmt3a is regulated by two CpG rich promoters 
and one poor promoter while; Dnmt3b is regulated by one CpG rich and one CpG poor 
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promoter (Yanagisawa et al. 2002).   The biological reasoning for control of these genes 
utilizing differing types of promoters with differing CpG contents is not known for 
certain however, a negative feedback mechanism that serves to modulate their own 
expression can be envisioned.  Perhaps a threshold level of methylation is obtained 
during the growth of a cell such that the Dnmts begin to methylate their own promoters 
and suppress their capacity to initiate transcription.  Since these genes are controlled by 
multiple promoter types, it is likely that methylation of the CpG rich promoters, which 
are under the control of the SP1 transcription factor and thus constituatively active, shifts 
transcriptional control to the CpG poor promoters that may be more tightly regulated.  
Via this hypothesized mechanism the Dnmts could respond to genomic methylation 
levels by modulating their own expression.  Given that Dnmt3a is driven off two CpG 
rich promoters suggests that it is the lowest abundance methyltransferase in highly 
methylated adult cells and the most abundantly expressed in embryonic cells or stem 
cells, which in fact, it is.  Conversely, given that Dnmt1 is predominantly regulated by 
CpG poor promoters would suggest that at the very least this methyltransferase would be 
the most abundantly expressed methyltransferase in adult cells and intermediary in 
embryonic, which it appears to be (Chen et al. 2003).   
Indeed, reported observations of Dnmt expression levels suggest that the 
postimplantation mouse embryo, developing germ cells and embryonic stem cells all 
abundantly express Dnmt3a and Dnmt3b but that these genes are only minimally 
expressed in most somatic tissues.  Dnmt1 however is ubiquitiously expressed in somatic 
tissues and equally abundant as the Dnmt3 family during early development.  Of further 
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note is the fact that Dnmt3a and Dnmt3b can be absent in tumor cells but absence of 
Dnmt1 is induces apoptosis (Chen et al. 2003).  The functional nature of this 
discrepancy is currently unknown and is the subject of intense investigation.   
Taken together, the analysis of Dnmt expression and function to date suggests the 
following model: During early preimplantation development, Dnmt1o serves to maintain 
imprint specific methylation patterns established either by some as yet undefined 
methytransferase or by the current Dnmts during gametogenesis.  How these methylation 
marks, or the mechanisms that demarcate them pass through the initial wave of 
embryonic demethlyation is presently unknown.  Once established however, they are 
maintained by both Dnmt1 and the Dnmt3a enzymes.  During murine postimplantation 
development, Dnmt3a and Dnmt3b serve to carry out the de novo methylation of the 
genome establishing heterochromatin, retroviral specific silencing and maintaining the 
proper expressional paradigm of the given cell.  This fine-tuned differential regulation 
that serves to compartmentalize the genome into heavily methylated areas and 
hypomethlyated areas is likely achieved by the regulation of Dnmt isoform expression 
through their alternative splicing.   Both the Dnmt1 and Dnmt3 families of enzymes are 
required for establishment and stable maintenance of these specific patterns and further, 
each cell likely has a specific repertoire of Dnmt splice variants unique to its methylation 
requirements.  These enzymes are all highly transcribed during early development from 
CpG rich promoters.  However, once a cell begins to terminally differentiate, its 
methylation levels increase to the point where the de novo methylation enzymes are 
down regulated to basal levels.  At this point, Dnmt1 assumes the predominant role as 
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the maintenance methyltransferase, while Dnmt3a and Dnmt3b serve as proofreaders, 
filling in the gaps missed by Dnmt1.  This minimal expression of Dnmt3a/3b and 
reliance on Dnmt1 to maintain methylation levels can be thought of as the somatic 
expression profile.  As a cell ages, there is evidence to suggest that methylation levels 
increase, repressing more and more genes until the cell becomes quiescent and dies.  
Thus there also appears to be a role in cellular aging. 
The Dnmts have also been implicated in mediating a portion of the cells response 
to the environment.  Evidence to support this hypothesis comes from studies examining 
the transcriptional profiles of cells exposed to environmental insults and viral infection.  
The nature of this response is as yet unclear and only strong correlative data have been 
presented.  However, given that viral sequences appear to be aggressively methlylated 
and that environmental toxins induce hypermethylation of the genome it is clear that the 
Dnmts are in some capacity involved in the cell’s ability to respond to infection and 
environmental insult.  There is evidence to suggest that Dnmt3a is the lead 
methyltransferase that carries out methylation specific responses to environmental 
stimuli as its expression is the most widely varied and has the greatest diversity of target 
sequences.  However, direct experimental evidence to support these hypotheses has yet 
to be fostered (Suetake et al. 2003).   
At present, there has been no specific functionality yet ascribed to Dnmt2 within 
the context discussed.  Given that of all the methyltransferases, Dnmt2 is the most highly 
conserved; it is likely that this enzyme plays some essential function.  However, there 
are currently no experimental reports of this enzyme examining function in 
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gametogenesis, embryonic development or correlation with any specific gene loci.  
Given that we now know that this enzyme has the capacity to methylate DNA (Herman 
et al. 2003; Tang et al. 2003 and Kunert et al. 2003) it is likely that dissection of the 
molecular targets and function of DNMT2 will expand our current understanding of the 
function of this gene family as a whole and of the epigenetics of early mammalian 
development.   
Part 10 Nuclear Transfer  
The most popular report of mammalian somatic cell nuclear transfer was by 
Wilmut et al. (1997) which was first to describe the cloning of a mammal from an adult 
cell.  Nuclei of epithelial cells derived from an adult ewe were transferred into 
enucleated oocytes, activated and transferred to recipients ultimately resulting in the 
birth of Dolly.  Since this milestone was achieved in 1996, cloned mice, goats, cattle, 
pigs, rats, deer and cats have been reported (Baguisi et al.  1999; Cibelli et al. 1998; 
Prather et al. 1996; Prather et al. 1999; Wilmut et al. 1997; Yong & Yuqiang 1998; Shin 
et al. 2002). 
Although live animals can be cloned by nuclear transplantation using somatic 
cells, the efficiency of the technique is very low in comparison to natural mating and 
current IVF technology.  In cattle where the vast majority of this work has been done, 
pre-attachment development appears to proceed normally and does not seem to be the 
major factor affecting the efficiency.  Development to the blastocyst stage in vitro is 
similar to that of embryos produced by in vitro fertilization.  Maternal recognition and 
the establishment of pregnancy are also similar between in vivo embryos and those 
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produced by somatic cell cloning.  After 35 days of gestation however, the drop in 
pregnancy rates is dramatic and very few of these fetuses survive to term.  Moreover, 
many of the calves that do make it to term often exhibit developmental abnormalities 
and die at birth or shortly thereafter (Cibelli et al. 1998; Garry et al. 1996; Kato et al. 
1998; Renard et al. 1999; Vignon et al. 1998; Wilson& Wyatt 1995;).  The ones that do 
survive frequently exhibit cardiovascular abnormalities, immature lung development, a 
compromised immune system, and diabetes.  These diseases are now being correlated 
with insults during early embryonic development (Hill et al. 2000; Pace et al. 2002; 
Barker 1990). 
Part 11 Nuclear Transfer and Epigenetic Reprogramming 
Some of the most convincing evidence supporting the hypothesis that abnormal 
epigenetic reprogramming by factors in the oocyte / early embryo results in failed 
development comes from studies involving somatic cell nuclear transfer.  Mammalian 
development is driven by highly specific temporal and spatial patterns of gene 
expression.  The ability of a transferred nucleus to recapitulate these precise patterns is 
essential for proper development.  However, abnormal patterns of gene expression are 
the norm for reconstructed embryos and aberrant gene expression can even be seen in 
adult clones (Wrenzycki et al. 2001; Schultz et al. 1996; Daniels et al. 2001; DeSousa et 
al. 1999; Humpherys et al. 2002).  Several recent studies in cattle have further 
demonstrated genomic hypermethylation and aberrant patterns of X-chromosome 
inactivation in animals produced by nuclear transfer, suggestive of incomplete  
epigenetic reprogramming (Kang et al. 2001, Dean et al. 2001, Bourc’his et al. 2001b, 
 47
Xue et al. 2002).   This epigenetic instability correlates with the fact that no one 
particular set or class of genes seems to be specifically and consistently affected by the 
process of nuclear transfer, rather the transcriptional disruption seems to be random and 
genome wide.  A recent survey of the transcriptional activity of cloned bovine embryos 
using cDNA microarray analysis failed to identify any consistently misexpressed genes 
and instead concluded that the abnormalities are unique to each embryo (Donovan et al. 
2003).  Several imprinted genes have been consistently found to be abnormally 
expressed but again, these differences are tissue specific and highly varied. (Inoue et al. 
2002; Humpherys et al. 2001).   
The genetic and epigenetic reprogramming that must occur after nuclear transfer 
is the critical element in the developmental success of a reconstructed embryo.  To date, 
little research has been directed towards correcting or attributing some causality to the 
aberrant patterns of gene expression observed in clones.  As a cell differentiates from a 
state of totipotency to a specific functional endpoint, the methylation pattern of the 
genome changes with it, reflecting a change in the transcriptional program.  Different 
cell types have different transcriptional requirements and thus their methylation patterns 
are unique to their functional phenotypes.  A technique called restriction landmark 
genome sequencing has recently been used to identify unique patterns of methylation 
specific to different cell types and developmental stages (Shiota et al. 2002 and Rush & 
Plass 2002).  In essence, each cell type has a unique “methylation fingerprint” owing to 
differences in which specific genes are transcriptionally active as compared to those 
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which are in a state of repression.  This fingerprint can be followed through 
differentiation and through environmental responses.   
The methylation pattern of stem cells is significantly different than that of 
somatic cells and the pattern of an early preimplantation embryo even more divergent.  
Each successive stage of development seems to impart a greater level of methylation 
upon the genome and thus a more restrictive developmental plan.  The early 
preimplantation embryo begins with the erasure of the methylation pattern and then 
reestablishing gene specific imprint patterns, thus creating embryonic stem cells.  These 
unique cells have been demonstrated capable of generating all the cell types necessary 
for proper development and as such are the focus of an entire branch of therapeutic 
medicine.  It is hypothesized that as embryonic stem cells develop they are exposed to 
wave after wave of de novo methylation until a “tissue specific stem cell” methylation 
pattern exists.  The final stages of development are achieved when a cell is directed 
towards a specific functional endpoint by methylation of the genome in such a way as to 
endorse the transcription of only those genes required of this specific cell type.  Via this 
mechanism the process of differentiation is carried out, placing strict developmental and 
transcriptional blocks upon a cell. 
Owing to the fact that a cloned embryo’s nucleus comes from a somatic cell with 
its own specific methylation pattern, it is likely that the large portion of the 
transcriptional and developmental abnormalities observed in clones are attributable to 
the failure of this methylation pattern to be reset to the demethylated base state.  Passage 
of somatic neuclei through the process of gametogenesis serves to strip the majority of 
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the methylation pattern and repackage the genome so as to be easily demethylated 
following fertilization.  With the techniques currently employed in somatic cell nuclear 
transfer, it is extremely unlikely that the nucleus is properly remodeled and the 
epigenetic state reset.  Moreover, it is also likely that the normal methyltransferase 
activity inherent to early development compounds the issue by the addition of more 
methyl groups to a genome that should have been stripped but which are in fact already 
hypermethylated as compared to the natural state.  This appears to indeed be the case in 
cloned embryos as they exhibit a drastic increase in the methylation levels of their 
genomes as compared in vivo controls.  However, that several nuclear transfer 
experiments have been successful strongly suggesting that the capacity exists within the 
oocyte to redirect this methylation pattern to the point where development can proceed.  
It is possible that proper function of a few key epigenetic factors can restore 
developmental potential to a differentiated nucleus and allow proper development. 
Part 12 Research Project Rationale 
In recent years the study of epigenetic control of gene expression has been 
recognized for its fundamental role in disease and development and has thus moved to 
the forefront of developmental biology.  This is due simply to the abundance of studies 
demonstrating the importance of epigenetics as relates not only to normal development 
but a number of human disease conditions including cancer but also its fundamental role 
in embryo patterning and development. Aberrant gene expression as a result of improper 
epigenetic reprogramming by the oocyte following fertilization has become a key target 
for investigating the causes of failed development.  Moreover, it is a primary suspect for 
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increasing the susceptibility to disease later in life (Brown & Strathdee 2002).  The 
Barker hypothesis suggests that adverse environmental conditions during fetal 
development may lead to adult diseases later in life including cardiovascular disease and 
diabetes (Barker, 1990).  Undernutrition in pregnant women leading to low birth weight 
babies has been associated with an increased incidence of heart attacks, diabetes and 
high blood pressure as adults (Barker 1990; McCance, 1962; Mott et al. 1991; Smart, 
1990).  It is likely that all these disease phenotypes have strong epigenetic undercurrents.   
The key modulators of DNA methylation are the DNMTs.  Clearly understanding 
the factors and mechanisms controlling epigenetic reprogramming during early 
mammalian development, in particular those involving DNMTs, is important.  A recent 
paper by Ding and Chaillet (2002) demonstrated that overexpression of the embryonic 
murine DNMT1o was tolerated and resulted in the production of live offspring whereas, 
another paper by Biniszkiewicz et al. (2002) demonstrated that overexpression of the 
somatic form of DNMT1 is embryonic lethal.  These observations strongly suggest that 
the critical element allowing survival of mice overexpressing DNMT1o is proper 
function of the protein during preimplantation development.  Somatic tissues are perhaps 
better able to regulate DNMT1 activity and DNA methylation in general but early 
embryonic tissues may not be.  Indeed, expression of the somatic form of DNMT1, the 
maintenance methyltransferase, during the preimplantation stages of development would 
likely impede the genome wide drop in methylation that occurs, resulting in an inability 
of the nucleus to properly remodel itself to direct embryonic development.   
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Embryos produced by somatic cell nuclear transfer present a unique opportunity 
to investigate the intricacies of early epigenetic programming.  It is clear that embryos 
produced by cloning exhibit a state of hypermethylation and this phenomenon has been 
found in both cattle and mice (Kang et al. 2001a, Dean et al. 2001, Bourc’his et al. 
2001b).  Owing to the fact that the donor nucleus comes from a somatic cell, it is likely 
the misexpression due to improper reprogramming or improper regulation of DNA 
methyltransferase function is responsible for the abnormal patterns of genomic 
methylation and the inability of cloned embryos to properly recapitulate embryonic 
transcription.  Perhaps the persistence of the somatic form of DNMT1 is responsible for 
the observed state of hypermethylation as it continues to function, maintaining the 
patterns of methylation through DNA replication, during a time period when these 
methyl groups should be diminishing.  Improper expression of the de novo 
methyltransferases DNMT3a and 3b may also be to blame for this over methylation, 
perhaps due to an as yet unexplained inability of a reconstructed embryo to properly 
regulate these proteins.  Whatever the case, studies of nuclear transfer provide an 
opportunity to study epigenetic function in preimplantation development without the 
need for a traditional functional mutation. 
Somatic cell cloning is not the only reported cause of abnormal methylation as 
superovulation, alcohol exposure, and in vitro culture also result in abnormal 
methylation patterns in mouse embryos (Shi & Haaf 2002).  Environmental conditions 
involving in vitro culture can lead to abnormal gene expression in preimplantation 
embryos (Wrenzycki et al. 2001; Doherty et al. 2000; Natale et al. 2001) and abnormal 
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methylation induced by these environmental conditions during early development could 
well be the cause of this.  In addition, stem cells appear to also be epigenetically 
unstable.  Whether this instability is imposed on them by culture techniques or is in fact 
a property inherent to stem cells in general should be addressed before they are 
employed in a therapeutic setting.   
In order for the full benefits of animal cloning to be realized and made 
economically viable, the efficiency of the nuclear transfer procedure must be 
significantly improved upon.  Genomic hypermethylation is almost certainly the root of 
the abnormal gene expression patterns observed in cloned bovine embryos and is thus 
the underlying cause to the abnormal physiology and developmental failure.  Here, we 
begin to test whether abnormalities in DNMT expression and regulation result in 
improper epigenetic reprogramming and decreased developmental capacity of NT 
embryos.   
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CHAPTER II 
ANALYSIS OF DNA (CYTOSINE 5) METHYLTRANSFERASE mRNA 
SEQUENCE AND EXPRESSION IN BOVINE PREIMPLANTATION 
EMBRYOS, FETAL AND ADULT TISSUES* 
 
Analysis of the Bovine DNA Methyltransferase mRNA Sequence 
Bovine DNA methyltransferase mRNA sequences were cloned by RT-PCR using 
mRNA obtained from adult testis and the sequences reported to Genbank (Dnmt1 
AY244709; Dnmt2 AY244708; Dnmt3a AY271298; Dnmt3b AY244710).  Bovine 
Dnmt cDNA sequences display strong homology to those reported for mouse and 
human, as would be expected for developmentally essential proteins of this nature 
(Appendix A). Carboxy-terminal domains share the largest degree of sequence 
similarity, likely due to the enzymatic activity residing in this region (Bestor 2000).  
Amino-terminal sequences are less consistent but show conservation of several domain 
structures including the cysteine rich zinc finger, BAH, PWWP, and ATRX domains, as 
well as other regions of as yet unknown function (Figure 4). 
 
 
 
 
_____________ 
* Reprinted with permission from “Analysis of DNA (cytosine 5) Methyltransferase 
mRNA Sequence and Expression in Bovine Preimplantation Embryos, Fetal and Adult 
Tissues.” by Michael C. Golding and Mark E. Westhusin, 2003.  Gene Expression 
Patterns, 3/5 pages 551-558.  Copyright 2003 by Elsevier Science Ireland Ltd. 
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Figure 4  Domain structures of the bovine DNA Methyltransferase family.  Sequence 
analysis finds conserved domain architecture among the bovine Dnmts.  All four of the 
identified methyltransferases possess a C-terminal catalytic methyltransferase domain, 
which are of similar size and sequence to those of mouse and human. N-terminal 
domains of Dnmt3a and 3b are distinct from those of Dnmt1 and the proteins share no 
detectable homology other then in the C-terminal catalytic domain. Dnmt2 appears to 
lack any N-terminal regulatory domains. 
 
 
 
Splice Variant Characterization 
 
During the course of sequencing the bovine Dnmt family, several alternatively 
spliced isoforms of Dnmt3a and 3b were identified in adult testis (Figures 5 and Figure 
6).  The Dnmt3b isoforms (Figure 6) (Dnmt3b1 AY244710; Dnmt3b3 AY244711;  
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To ourbDnmt3a  CTCCAGAGCTGTAGAAAATGGCTGCTGCACCCCCAAGGATGGCCGGGGAGCCCCTGCAGA 434
bDnmt3a4 CTCCAGAGCTGTAGAAAATGGCTGCTGCACCCCCAAGGA----------GCCCCTGCAGA 424
hDnmt3a  CTCAAGAGCAGTGGAAAATGGCTGCTGCACCCCCAAGGAGGGCCGAGGAGCCCCTGCAGA 660
         *** ***** ** **************************          ***********
bDnmt3a  AGAGGGCAAAGAACAGAAGGAGACCAACATCGAATCCATGAAAATGGAGGGCTCCCGGGG 494
bDnmt3a4 AGA--------------------------------------------------------- 427
hDnmt3a  AGCGGGCAAAGAACAGAAGGAGACCAACATCGAATCCATGAAAATGGAGGGCTCCCGGGG 720
         **
bDnmt3a  CCGGCTGCGGGGTGGCCTGGGCTGGGAGTCCAGCCTCCGCCAGCGGCCCATGCCGCGGCT 554
bDnmt3a4 ------------------------------------------------------------
hDnmt3a  CCGGCTGCGGGGTGGCTTGGGCTGGGAGTCCAGCCTCCGTCAGCGGCCCATGCCGAGGCT 780
bDnmt3a  CACCTTCCAGGCGGGGGACCCCTACTACATCAGCAAGCGCAAGCGGGACGAGTGGTTGGC 614
bDnmt3a4 ------------------------------------------------------------
hDnmt3a  CACCTTCCAGGCGGGGGACCCCTACTACATCAGCAAGCGCAAGCGGGACGAGTGGCTGGC 840
bDnmt3a  ACGCTGGAAAAGGGAGGCTGAGAAGAAAGCCAAGGTGATTGCAGTAATGAATGCTGTTGA 674
bDnmt3a4 --------------AGGCTGAGAAGAAAGCCAAGGTGATTGCAGTAATGAATGCTGTTGA 473
hDnmt3a  ACGCTGGAAAAGGGAGGCTGAGAAGAAAGCCAAGGTCATTGCAGGAATGAATGCTGTGGA 900
********************** ******* ************ ** 5  Isoform analysis of bovine Dnmt3a.   (A).  A 2% ethidium bromide stained gel 
g the migration of both Dnmt3a transcripts, amplified from bovine testis by RT-
Sequence analysis of each of the bands revealed a novel transcript missing 201 
airs from the central coding region.  (B) A sequence alignment of the alternatively 
 regions of bovine Dnmt3a.  Exon arrangements for the alternatively spliced 
s of Dnmt3a4, as compared to the full-length Dnmt3a sequences of bovine (top) 
man (bottom) can be seen here.  No other reported splice variants of Dnmt3a 
 alternative splicing of exons within the central coding region.  Matches are 
ated by a star and missing bases by a dash. 
b4 AY244712; Dnmt3b5 AY244713) match perfectly those previously reported 
an tissues (Figure 6B), however, the isoform identified for Dnmt3a (Figure 5) is 
.  This novel splice variant, which we have termed Dnmt3a4 (AY271299), is 
g 201 base pairs (67 amino acids) from the central coding region (Figure 5B).  All 
eported isoforms for this gene appear to incorporate alternate exons onto the 5’ 
 the use of alternative promoters (Chen et al. 2002; Weisenberger et al. 2002).  
 knowledge, this is the first reported case of an isofom of Dnmt3a with alternative  
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 DNMT3b5 AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAGGCC 2220
DNMT3b3 AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAG--- 2217
DNMT3b1 AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAGGCC 2220
DNMT3b4 AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAG--- 2217
********************************************************* 
 
DNMT3b5 TGTGATAGCATCCAAGAATGATAAGCTCGAGCTGCAGGACTGCCTGGAGTTCAAT----- 2275
DNMT3b3 ------------------------------------------------------------ 
DNMT3b1 TGTGATAGCATCCAAGAATGATAAGCTCGAGCTGCAGGACTGCCTGGAGTTCAATAGGAC 2280
DNMT3b4 ------------------------------------------------------------ 
 
DNMT3b5 ------------------------------------------------------------ 2259
DNMT3b3 ------------------------------------------------------------ 2218
DNMT3b1 AGCAAAGTTAAAGAAAGTACAGACAATAACCACCAAGTCGAACTCGATCAGACAGGGGAA 2340
DNMT3b4 -------TTAAAGAAAGTACAGACAATAACCACCAAGTCGAACTCGATCAGACAGGGGAA 2270
 
DNMT3b5 --------------------------------------------------------AGGA 2279
DNMT3b3 ------------------------------------------------------------ 
DNMT3b1 AAACCAACTTTTCCCTGTTGTCATGAATGGCAAAGAAGATGTTTTGTGGTGCACTGAGCT 2400
DNMT3b4 AAACCAACTTTTCCCTGTTGTCATGAATGGCAAAGAAGATGTTTTGTGGTGCACTGAGCT 2330
 
DNMT3b5 CAGCAGGATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2339
DNMT3b3 ------GATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2271
DNMT3b1 AGAAAGGATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2460
DNMT3b4 AGAAAGGATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2390
******************************************************
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6  Isoform analysis of bovine Dnmt3b.   (A).  A 2% ethidium bromide stained gel 
showing the migration of each of the four Dnmt3b transcripts, amplified from bovine 
testis by RT-PCR.  Sequence analysis of each of the bands demonstrated an exon 
arrangement remarkably similar to those reported for human Dnmt3b1, 4, 3 and 5 
(results not shown).  (B) A sequence alignment of the alternatively spliced regions of 
bovine Dnmt3b.  Exon arrangements for each of the alternatively spliced regions of 
Dnmt3b are compared.  Matches are designated by a star and missing bases by a dash. 
 
 
 
exon arrangements within the central coding region. BLAST analysis of this 
alternatively spliced segment indicates that it shares weak homology with bacterial Rec 
G helicase.  Further characterization of this splice variant is needed to determine if any 
functional differences are imparted by the alternative splicing. 
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Dnmt mRNA Expression in Preimplantation Bovine Embryos 
 
During bovine preimplantation development, the genomic methylation pattern is 
erased during the fist few cleavage divisions and then reasserted during the 8cell to 16-
cell transition (Dean et al. 2001).  The specific methyltransferase enzymes responsible 
for this increase in methylation are currently unknown but work in the mouse would 
suggest an alternatively spliced isoform of Dnmt1, similar to the murine oocyte/early 
embryo specific Dnmt1o, might be involved.  To identify the alternative transcripts of 
Dnmt1 present during bovine embryogenesis, rapid amplification of cDNA ends 
(RACE) was conducted using RNA isolated from bovine oocytes and early in vitro 
produced (IVP) embryos. Early studies of Dnmt1 levels in the mouse suggest that it is 
3000 times more abundant in oocytes and embryos than in somatic cells and should thus  
be readily detectable (Carlson et al. 1992).  Repeated attempts using a variety of 
RACE techniques (see methods) readily detected RNA coding for the ubiquitous somatic 
form (Dnmt1), and yet failed to detect any Dnmt1o transcripts. Sequence analysis of 
exon four of bovine Dnmt1 mRNA, obtained from somatic tissue clearly identified the 
reading frame necessary to produce the Dnmt1o protein (Appendix A), however we were 
unable to identify the 5’ oocyte specific exon necessary to move translation to the 
DNMT1o specific start site.   
In order to further investigate the embryonic expression of the somatic isoform of 
Dnmt1, RNA from IVF derived 8-cell to 16-cell embryos was separated into ribosomal 
and subribosomal subcellular fractions via a ribonucleoprotein fractionation procedure 
previously described by DeSousa et al. (1993).  This technique allows the segregation of 
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RNA that is actively being translated from RNA sequestered in the cytoplasm.  Upon 
separation of the fractions, the RNA was isolated and reverse transcribed into cDNA.  
Primers designed to amplify regions contained in exons four to five, which are common 
to all the reported isoforms of Dnmt1 were used to verify its expression.  Separate 
primers that specifically amplify the 5’ exon 1 unique to the somatic isoform of Dnmt1, 
along with exons two through five were used to detect the presence of the Dnmt1 
somatic splice variant (Figure 7A). Results from these experiments along with 
sequencing data of the isolated cDNA amplicons, indicate that unlike the mouse, the cow 
employs the somatic form of Dnmt1 during the early developmental stages when 
genomic methylation first begins to rise. Further, Dnmt3a (Figure 7B) and Dnmt3b 
(Figure 7C) are present on the ribosome at the critical 8 to 16- cell transition. 
No specific study has yet addressed the expression of Dnmt2 within the 
preimplantation mammalian embryo.  In order to further investigate the expression of 
this gene and to determine how early the other Dnmts are expressed during bovine 
development, RNA from IVF derived four-cell stage embryos was separated into 
ribosomal and subribosomal subcellular fractions via a ribonucleoprotein fractionation 
procedure described.  RNA was again converted into cDNA and used in a PCR reaction 
using primers specific to the somatic form of Dnmt1, Dnmt2, Dnmt3a and Dnmt3b.  
Results of these experiments, along with the sequence data of the isolated PCR 
amplicons demonstrates that expression of all the bovine Dnmts can be detected as early 
as the four cell stage of IVF development (Figure 8).
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Figure 7. RT-PCR analysis demonstrating the recruitment of the Dnmt1, Dnmt3a and 
Dnmt3b mRNAs onto the polysome during the 8-cell to 16-cell transition. A 2%, 
ethidium bromide stained agarose gel showing the migration of the various Dnmt cDNA 
amplicons. Reactions were conducted on total RNA isolated from 75 8 to 16-cell-stage 
embryos, fractionated into a subribosomal supernatant (“S”) and polyribosomal pellet 
(“P”).  Expression of Dnmt1 (A) was conducted using two primer sets, one to detect 
exons common to all known splice variants (exons 4-5) and another set to specifically 
detect the somatic isoform (exons 1-5).  β-Actin transcripts were amplified as a positive 
control.  Expression of Dnmt3a (B) and Dnmt3b (C) were also analyzed in both 
fractions.  Bovine brain mRNA was isolated, reverse transcribed into cDNA and then 
used as a positive control.  A small volume of the phosphate buffered saline used in the 
final embryo wash was passed though the RNA isolation procedure and used as a 
negative control.  This wash sample was reverse transcribed and used as template in a 
PCR reaction to ensure no contaminating RNA was introduced (standard RT control).  
Background bands can be seen in some lanes and are the result of excess cDNA 
template. 
 
 
 
Given this apparent divergence from the murine model, a transcriptional profile 
of the Dnmt family throughout preimplantation development was conducted.  RNA was 
collected from pools of ten embryos for each of the 2-cell, 4-cell, 8-cell, 16-cell, morula 
and blastocyst stages and reverse transcribed into cDNA. The mRNA for all four  
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Figure 8  RT-PCR analysis demonstrating the recruitment of the Dnmt1, Dnmt2 Dnmt3a 
and Dnmt3b mRNAs onto the polysome during the 4-cell stage of bovine 
preimplantation development. A 2%, ethidium bromide stained agarose gel showing the 
migration of the various Dnmt cDNA amplicons. Reactions were conducted on total 
RNA isolated from 4-cell-stage embryos, fractionated into a subribosomal supernatant 
(“S”) and polyribosomal pellet (“P”).  Expression of Dnmt1 was conducted using the 
primer set specifically designed to detect the somatic isoform (exons 1-5), expression of 
Dnmt2, Dnmt3a and Dnmt3b were also analyzed in both the subribosomal (“S”) and 
Polyribosomal (“P”) fractions.  Bovine testis mRNA was isolated, reverse transcribed 
into cDNA and then used as a positive control.  A small volume of the phosphate 
buffered saline used in the final embryo wash was passed though the RNA isolation 
procedure and used as a negative control.  This wash sample was reverse transcribed and 
used as template in a PCR reaction to ensure no contaminating RNA was introduced 
(standard RT control).   
 
 
 
reported Dnmts is present during each stage of bovine preimplantation development 
(Figure 9).  
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Figure 9.  RT-PCR analysis of the four known Dnmt gene transcripts during all stages of 
bovine IVF preimplantation development.  Transcripts of Dnmt1, Dnmt2, Dnmt3a and 
Dnmt3b were amplified by RT-PCR and run on an ethidium bromide stained 2% agrose 
gel. PCR amplicons of the alternate transcripts for Dnmt2 and Dnmt3b are seen here as 
multiple bands migrating different distances.  Testis cDNA was used as a positive 
control and again a portion of the last embryo wash served as template for a negative 
control. 
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Similar to the testis, the preimplantation embryo contains an abundance of 
alternatively spliced products, including a novel isoform of Dnmt2 (present as a double 
band in figure 9), which has been designated Dnmt2-gamma (Dnmt2γ, AY244714).  The 
coding region of Dnmt2γ contains a premature stop codon resulting in the production of 
a 63 amino acid protein with no identifiable domains and is therefore unlikely to produce 
a functional protein (Figure 10). Recently, similar non-functional isoforms have been 
identified for Dnmt3a and 3b and have been implicated in a possible translational 
regulatory mechanism (Saito et al. 2002; Weisenberger et al. 2002).  Because the amino-
termini of each of these proteins contain unique domains that may function 
independently of the carboxy-terminal cataylitic methyltransferase domain, further 
investigation of the splice variants of each of the Dnmts is necessary to establish this 
hypothesis.   
Dnmt Real Time Quantification During Bovine Fetal Development 
 
No previous study has yet examined tissue specific Dnmt expression profiles in 
early bovine fetal development.  To expand our knowledge base on the developmental 
expression of this gene family during bovine fetal development, real time quantitation of 
all four of the known Dnmt transcripts was performed.  Primers and probes were 
designed based on the sequence information reported above.  Care was taken to ensure 
that measurements of a specific Dnmt reflected all the identified splice variants.  Total 
RNA was isolated from fetal (16 week 25-27cm crown rump length - Winters et al. 
1942) and adult tissues using Trizol reagent.  β-actin transcripts were measured as an 
internal control.   
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hDNMT2          AAGACGATTGAAGGCATTACACTCGAAGAGTTTGACAGATTATCTTTTGATATGATTTTA 229 
hDNMT2d         AAGACGATTGAAG----------------------------------------------- 121 
bDNMT2          AAGACAATTGAAGGCATTACACTAGAAGAGTTTGACAGATTATCTTTCAATATGATTTTA 240 
bDNMT2g         AAGACAATTGAA------------------------------------------------ 192 
                ***** ******                                                 
 
hDNMT2          ATGAGCCCTCCCTGCCAGCCATTCACAAGGATTGGCCGGCAGGGTGATATGACTGATTCA 289 
hDNMT2d         ------------------------------ATTGGCCGGCAGGGTGATATGACTGATTCA 151 
bDNMT2          ATGAGCCCACCCTGTCAGCCCTTCACAAGAATTGGCCTGCAAGGTGATGTGACTGATCCA 300 
bDNMT2g         -----------------------------AATTGGCCTGCAAGGTGATGTGACTGATCCA 223 
                                              ******* *** ****** ******** ** 
 
hDNMT2          AGGACGAATAGCTTCTTACATATTCTAGATATTCTCCCAAGATTACAAAAATTACCAAAG 349 
hDNMT2d         AGGACGAATAGCTTCTTACATATTCTAGATATTCTCCCAAGA------------------ 193 
bDNMT2          AGGACAAATAGCTTCTTACATATTCTAGACATTCTCCCAAGATTACAAAAATTACCGAAG 360 
bDNMT2g         AGGACAAATAGCTTCTTACATATTCTAGACATTCTCCCAAGATTACAAAAATTACCGAAG 283 
                ***** *********************** ************                   
 
hDNMT2          TATATTCTTTTGGAAAATGTTAAAGGTTTTGAAGTATCTTCTACAAGAGACCTCTTGATA 409 
hDNMT2d         ------------------------------------------------GACCTCTTGATA 205 
bDNMT2          TATATTCTTTTAGAAAACGTTAAAGGTTTTGAAATGTCTTCTACAAGAGATCTGTTAATA 420 
bDNMT2g         TATATTCTTTTAGAAAACGTTAAAGGTTTTGAAATGTCTTCTACAAGAGATCTGTTAATA 343 
                                                                ** ** ** *** 
MEPLRALELYSGIGGMHQALRESCIPAQVVAAVDVNTVANEVYKYNFPHT 
QLLAKTIENWPAR* STOP 
 
Figure 10 Bovine Dnmt2γ A) A sequence alignment of the alternatively spliced regions 
of bovine Dnmt2γ.  Exon arrangements for each of the alternatively spliced regions of 
Dnmt2γ are compared.  Matches are designated by a star and missing bases by a dash. 
This novel isoform of bovine Dnmt2 is missing an 83 base pair section near the 5’ end.  
B) Translation of Dnmt2γ results in a protein containing a premature stop codon and the 
production of a 63 AA truncated protein with no identifiable domains.   
 
 
 
Significant differences in Dnmt mRNA expression levels were found among 
different tissue types as well as between fetal and adult stages; (Figure 11) supported by 
the students T-test.  On the whole, fetal expression levels are higher then those observed 
in adult tissues, specifically fetal brain, heart, rumen (stomach) and lung display the 
highest expression levels of all tissues examined (Figure 11).  During bovine fetal 
development, the brain and heart form first and continue to steadily grow throughout 
development where as other tissue types appear to concentrate their growth during 
specific phases (Salisbury and VanDemark 1961; Winters et al. 1942).  It is possible that  
 64
Fetal Tissue                          Adult Tissue 
 
Brain 
 
 
 
 
 
Heart 
 
 
 
 
 
Kidney 
 
 
 
 
Liver 
 
 
 
 
 
Lung 
 
 
 
 
 
Ovary 
 
  
Figure 11 Real time PCR analysis of bovine DNA methyltransferase expression in fetal 
and adult tissues.  Dnmt transcripts were quantified in samples of total RNA isolated 
from 16 week fetal (left column) and adult tissues (right column). The Dnmt  family 
appears to have a tissue specific and developmentally regulated pattern of expression. 
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Figure 11 Continued. 
 
 
 
during the developmental period examined, rumen and lung tissues are in such a growth 
phase. 
High expression of the Dnmts during fetal development is somewhat expected given 
the coordinated role of these enzymes in DNA replication and tissue specific gene 
silencing.  However, examination of adult tissues found that the highest expression 
levels were found in brain, kidney, and testis tissue (Figure 11). Brain and kidney tissues 
do not have high cellular turnover rates and were expected to have lower expression 
levels.  Additionally stomach tissues that are usually associated with high cellular 
turnover contained lower levels of Dnmt expression.  These observations suggest that 
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perhaps these enzymes play additional roles in cellular physiology besides mediating 
DNA methylation. 
Discussion 
 Bovine Dnmt1 mRNA contains the coding sequence necessary to produce the 
Dnmt1o splice variant but does not appear to specifically utilize this isoform during 
preimplantation development.  It is surprising that something thought to be this 
fundamental to the early epigenetic events of mammalian development would be so 
different between the murine and bovine models.  Recently, Dnmt1o has been cloned 
from human oocytes as well as from a South American opossum (Hayward et al. 2003 
and Ding et al. 2003) although involvement of the Dnmt1o protein in the epigenetic 
events of the early development of these organisms has yet to be demonstrated.  Given 
the high conservation of this gene and the exact spacing of the reading frames encoding 
the two isoforms, it is likely that bovine Dnmt1o exists but is in fact utilized during a 
different developmental time then its murine homologue.  It is possible that bovine 
Dnmt1o is transcribed and translated during the earliest stages of oocyte development 
and utilized during this time to carry out the allele specific imprints observed in the 
mouse.  Whatever role this isoform plays in the embryogenesis of the bovine, it does not 
appear to be involved in preimplantation development specifically and is thus not likely 
to be a contributing factor to the epigenetic and developmental abnormalities observed in 
cloned cattle.  
Dnmt2 appears to contain all the catalytic domains necessary to carry out DNA 
methylation but has only recently been demonstrated to possess any observable 
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methylating ability (Okano et al. 1998a; Herman et al. 2003; Tang et al. 2003 and 
Kunert et al. 2003).  The present study of Dnmt expression between tissues and through 
development indicate that bovine Dnmt2 mRNA is expressed at significant levels in all 
tissues and is, in fact, the most abundant methyltansferase found in adult testis and 
ovary.  This in addition to the high level of sequence conservation between species and 
the multitude of reported splice variants identified for this enzyme would suggest that it 
might possess some as yet unidentified critical cellular function. 
Dnmt3a and Dnmt3b while absent from murine preimplantation development are 
present during the initial stages of bovine development.  This observation correlates with 
the results presented by Dean et al. (2001), which showed that in the bovine, genomic 
methylation levels begin to rise during the eight to sixteen cell transition.  A similar rise 
in genomic methylation is not seen in mice until after implantation, which also correlates 
with the expression of murine Dnmt3a and Dnmt3b.  Thus it would seem that while the 
specific enzymes involved in establishing the genomic methylation levels are the same, 
the timing of the events between the two species is drastically different.  The difference 
in the timing of this increase in genomic methylation and the corresponding expression 
of the de novo methyltransferases may have arisen given the large differences in the 
timing of implantation.  The bovine conceptus does not implant until around day 30, 
whereas the mouse embryo implants shortly after hatching from the zona pelucida (day 
6).  Whether the differences in implantation strategies form the basis for the different 
timing of epigenetic events, or whether it is some as yet undefined embryological 
process remains to be determined.  Additional comparative studies as well as 
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examination of the Dnmts in embryos produced by nuclear transfer may provide further 
insight into their function and relevance to disease and development.   
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CHAPTER III 
ANALYSIS OF DNA (CYTOSINE 5) METHYLTRANSFERASE mRNA 
EXPRESSION IN BOVINE PREIMPLANTATION EMBRYOS PRODUCED 
FROM IN VITRO FERTILIZATION, SOMATIC CELL NUCLEAR TRANSFER 
AND PARTHENOGENETIC ACTIVATION 
 
 Abnormal patterns of gene expression are the hallmark of cloned embryos and 
the recent studies in cloned cattle and mice that demonstrate genomic hypermethylation 
have begun to provide some explanation to these transcriptional abnormalities (Kang et 
al. 2001a, Dean et al. 2001, Bourc’his et al. 2001b, Xue et al. 2002).  The key 
modulators of DNA methylation are the DNMTs and misexpression of these proteins 
could potentially lead to the observed hypermethylation and the aberrant patterns of X-
chromosome inactivation frequently seen in animals produced by nuclear transfer.  
Examination of the Dnmts and their involvement in controlling epigenetic 
reprogramming during the early development of reconstructed embryos may provide a 
clue as to the cause of this hypermethylation phenomenon while at the same time 
revealing more about the basic biochemical roles of these important enzymes. 
Investigation of Dnmt expression during bovine IVF preimplantation 
development revealed an expression profile divergent from the one previously reported 
for murine development.  Specifically, analysis revealed the presence of mRNA 
encoding the maintenance methyltransferase Dnmt1, as well as the enigmatic Dnmt2 
along with the de novo methyltransferases Dnmt3a and Dnmt3b.  Given that RNA 
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encoding all the Dnmts is present during normal IVF development, examination of the 
entire Dnmt family and expression of their respective isoforms in cloned embryos, was 
undertaken.  RNA was again collected from pools of ten embryos for each of the 2-cell, 
4-cell, 8-cell, 16-cell, morula and blastocyst stages and reverse transcribed into cDNA. 
While transcripts encoding all of the four reported bovine Dnmts are present during each 
stage of NT preimplantation development, expression of Dnmt1 and Dnmt2 was more 
difficult to detect than during the initial studies using in vitro produced embryos.  During 
analysis of Dnmt1 and 2, as much as three times the amount of cDNA had to be seeded 
into the PCR amplification before the product could be consistently detected.  In 
addition, while mRNA encoding both Dnmt3a and Dnmt3b could be detected using 
similar amounts of template, the isoform banding pattern observed for Dnmt3b was 
much different than the one observed during the analysis of IVF embryos (Figure 12).  
Whether these abnormalities are an artifact of PCR or are in fact, due to differential 
expression of the Dnmts during early clone development is unknown. 
Real Time Analysis of Bovine Preimplantation Embryos Produced by in vitro 
Fertilization, Nuclear Transfer and Parthenogenetic Activation 
In order to more accurately assess Dnmt expression levels during the 
preimplantation development of cloned embryos, real-time PCR analysis was 
undertaken.  In these experiments, comparisons were made between embryos produced 
by IVF, somatic cell nuclear transfer and by parthenogenetic activation.  Embryos 
activated parthenogenetically contain two female compliments of the genome, can 
develop as far as the second trimester of pregnancy but lack the ability to produce live 
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Figure 12 RT-PCR analysis of the four known Dnmt gene transcripts during all stages of 
preimplantation development in embryos reconstructed by somatic cell nuclear transfer.  
Transcripts of Dnmt1, Dnmt2, Dnmt3a and Dnmt3b were amplified by RT-PCR and run 
on an ethidium bromide stained 2% agrose gel. PCR amplicons of the alternate 
transcripts for Dnmt3b are seen here as multiple bands migrating different distances.  
Testis cDNA was used as a positive control and again a portion of the last embryo wash 
served as template for a negative control.  RT-PCR amplification of the Dnmts was 
conducted on mRNA isolated from the fibroblast donor cell line for comparison. 
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offspring due to abnormal expression of imprinted genes (McGrath and Solter 1984a, 
McGrath and Solter 1984b).  Thus examination of the Dnmt expression profiles in 
embryos produced using these diverse methods may reveal specific differences imparted 
either by solely containing a female genome, or by containing a nucleus derived from a 
somatic cell.   
As in the analysis of bovine tissue, β-Actin served as the control.  RNA isolated 
from pools of 10 two-cell stage, 20 eight-cell stage and 10 blastocyst stage embryos, 
corresponding to approximately 50 ng of total RNA for each pool (Dr. A. Watson 
personal communication), was seeded into two independent reactions measuring β-Actin 
expression levels as well as an individual methyltransferase.  Examination of smaller 
pools individually may more accurately reveal minor differences between the 
experimental groups.   
 Upon obtaining the CT” values for each of the Dnmts at each of the examined 
developmental stages, the numbers were converted to the appropriate scale (a difference 
of 3.6 CT units is equal to a 10 fold difference in expression) and the reciprocals applied 
to an expression scale of 100 (Figure 13).     
Overall, results of real time quantitation of the bovine Dnmts revealed significant 
differences in the expression of Dnmt1 and Dnmt2 between IVF embryos and NT but 
surprisingly found that transcript levels for Dnmt3a and Dnmt3b were generally the 
same.  Similar differences exist between parthenote embryos and NT embryos but 
interestingly, differences in the transcript levels of Dnmt3b can be found between 
parthenote and IVF embryos.  During the two-cell stage, no statistical differences in  
 73
 
2-Cell Stage
0
10
20
30
40
50
60
70
80
90
100
Dnmt1 Dnmt2 Dnmt3a Dnmt3b
Methyltransferase
Ex
pr
es
si
on
 L
ev
el
8-Cell Stage
0
10
20
30
40
50
60
70
80
90
100
Dnmt1 Dnmt2 Dnmt3a Dnmt3b
Methyltransferase
Ex
pr
es
si
on
 L
ev
el
 
 
Blastocyst Stage
0
10
20
30
40
50
60
70
80
90
100
Dnmt1 Dnmt2 Dnmt3a Dnmt3b
Methyltransferase
Ex
pr
es
si
on
 L
ev
el
 
IVF 
 
NT 
 
Parth 
Figure 13 Real time PCR analysis of DNA methyltransferase expression during the 
preimplantation development of IVF, NT and Parthenote bovine embryos.  RNA isolated 
from pools of 10 two-cell, 25 eight-cell and 10 blastocyst stage IVF, NT and Parthenote 
embryos was used in a TaqMan one step RT-PCR real time reaction.  Measurements for 
each methyltransferase were normalized to β-Actin expression and compared to each 
other.  A difference of 3.6 CT units represents a ten-fold difference in expression.  
Measurements were applied to a scale of 100.  A minimum of three independent 
repetitions was carried out for each gene, during each developmental stage.  Testis RNA 
was run as a positive control for each independent experiment (results not shown). 
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Dnmt expression can be discerned although; this may be due to the rather large standard 
deviations of the samples.  Of note is the difference in the expression of Dnmt3b in NT 
embryos as compared to IVF, which is close to being statistically different (p-value 
0.0867).  However, no clear statistical differences exist at this stage.   
During the eight-cell stage, a statistically significant difference in the expression of 
Dnmt1 between NT and IVF embryos was observed (p-value 0.0361).  A similar 
difference in the expression of Dnmt1 between parthenotes and NT embryos may also 
exist but at the 95% confidence level the values are not significantly different (p-value 
0.079).   Interestingly, a large difference in the expression of Dnmt2 between 
parthenotes, as compared to both IVF and NT embryos exists (p-value 0.0116 and 
0.0006, respectively).  The expression of Dnmt3a is not statistically different during the 
eight-cell stage while the expression of Dnmt3b is slightly higher in parthenotes than 
IVF, although not enough to be statistically significant at the 95% confidence interval 
(p-value 0.0513).   
 In embryos reconstructed using somatic cell nuclear transfer, both Dnmt1 and 
Dnmt2 appear to be differentially expressed during the blastocyst stage.  Transcript 
levels of Dnmt1 in NT embryos as compared to both IVF and parthenote development 
were significantly lower (p-value 0.0231 and 0.028, respectively) and similarly, Dnmt2 
transcripts were much lower in NT embryos as compared to measurements of IVF and 
parthenote embryos (p- values 0.0525 and 0.0324 respectively).  Expression of Dnmt3a 
and Dnmt3b for all experimental groups measured at the blastocyst stage was not 
significantly different. 
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To gain a better appreciation for the differences in Dnmt transcript levels, CT 
values were graphed over developmental time for each experimental group (Figure  14).   
Overall, the expression profiles of the Dnmts look very similar between the different 
experimental groups.  Dnmt2, the least abundantly expressed methyltransferase has the 
most varied expression profile of all the methyltransferases.  The expression of this gene 
during IVF development is typical for genes during preimplantation development; a 
decline from fertilization on to activation of the embryonic genome at the eight-cell 
stage, followed by a resurgence in expression up to the blastocyst stage.  Dnmt2 levels in 
clones appear to decrease steadily over development and fail to rise again while Dnmt2 
levels in parthenotes seem to remain has the most varied expression profile of all the 
methyltransferases.  The expression of this gene during IVF development is typical for 
genes during preimplantation development; a decline from fertilization on to activation 
of the embryonic genome at the eight-cell stage, followed by a resurgence in expression 
up to the blastocyst stage.  Dnmt2 levels in clones appear to decrease steadily over 
development and fail to rise again while Dnmt2 levels in parthenotes seem to remain 
high.   
Of particular interest is the expression profile for Dnmt1. The patterns observed 
in IVF and parthenote development are remarkably similar, however the values recorded 
in NT embryos are much different.  It appears that Dnmt1 levels of cloned embryos 
begin at a relatively similar level at the two-cell stage, decrease during the eight-cell 
stage and then rapidly decline at the blastocyst stage.  This pattern is in contrast to the 
slow decline observed in both IVF and parthenote embryos. 
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Figure 14 Comparison of DNA methyltransferase expression over IVF, NT and 
Parthenote preimplantation development.  Expression levels of each of Dnmt1, Dnmt2, 
Dnmt3a and Dnmt3b are tracked over development from the 2-cell stage, through the 8-
cell to the blastocyst stage.  Differing DNA methyltransferase expression profiles can be 
noted here. 
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Real Time Analysis of Cultured Donor Fibroblast Cells 
Recently, DNA methylation has been postulated as a mechanism for monitoring 
cellular ageing (Lopatina et al. 2002 and Young and Smith 2001).  A correlation 
between the levels of genomic DNA methylation and cellular age may have a significant 
impact upon the choice of donor cell line used in studies of nuclear transfer.  Further, if 
this rise in DNA methylation coincides with a concurrent increase in DNA 
methyltransferase expression, the ability of the oocyte to properly reprogram the 
reconstructed embryo may be affected by the cellular age of the donor cell line.  This 
differential status of methylation and the potential differences in Dnmt expression may 
be a significant factor in the observed discrepancies of the ability to clone embryos using 
fetal and adult cells.  In order to further investigate the possibility that Dnmt expression 
levels are modulated with cellular age, the fibroblast donor cell line used in the 
experiments herein were cultured as far as the cells would pass before senescence.  At 
several key passages, RNA was isolated from a subset of cells and the remainder stained 
to examine morphology.   
Cells exhibited a gross change in morphology and a decline in gene expression as 
would be expected for cells entering senescence.  As the cells passaged, their 
morphology shifted from the defined spindle shape typical of fibroblast cells to a more 
oblong spread out cell body.  This change in morphology was accompanied by a steady 
decline in Dnmt expression (Figure15).  However, between passage 7 and 10, a 
resurgence in Dnmt expression was observed followed by a rapid decline in 
methyltransferase expression in all subsequent passages (Figure 15).  Of further note is  
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Passage 3 5X Passage 3 10X
 
Passage 10 5X Passage 10 10X 
Passage 13 5X Passage 13 10X 
 
Figure 15  Real time PCR analysis of bovine DNA methyltransferase expression in the 
donor cell fibroblasts, cultured for an extended period of time.  A) Light microscopy of 
cells cultured for varying time periods.  B) (next page)  Dnmt transcripts were quantified 
in samples of total RNA isolated from cultures of the donor fibroblast line taken at 
various passages seen in the panels of part A.  The Dnmt family appears to be briefly 
upregulated during passages seven and ten, followed by a rapid decline in expression in 
all subsequent passages. 
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Figure 15 Continued. 
 
 
 
the fact that Dnmt2 appears to maintain a steady state of expression while the remaining 
three methyltransferases show a more pronounced decline.  The significance of the spike 
in Dnmt expression observed during passages 7 and 10 is unknown, but it is conceivable 
that these enzymes are actively methylating the genome, directing the genome to a 
transcriptionally silent state, in preparation for cellular senescence.  The significance of 
maintaining Dnmt2 expression levels is unknown. 
Discussion 
 Real time quantitation of bovine Dnmt transcripts during IVF, NT and parthenote 
development has revealed Dnmt1 and Dnmt2 as the only consistently abnormally 
expressed methyltransferases.  However, given the lack of de novo methylating ability 
reported for these two enzymes (Bestor 2000 and Tang et al. 2003) and the fact that the 
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expression of these two genes is reduced in NT embryos, it is unlikely that alone, their 
misexpression results in the observed hypermethylation.  It is probable that Dnmt 
transcription on the whole is properly reprogrammed after transfer of the somatic 
nucleus into the oocyte but that inappropriate translational and regulatory control of 
these proteins maintains the genomic methylation levels during a stage when they should 
be receding.  Inappropriate or premature translation of the Dnmts due to the loss or 
disruption of some as yet unidentified translational control mechanism could indeed 
account for the proposed abnormalities in DNMT function and the rapid decline in 
transcript levels for Dnmt1 and Dnmt2.  However, why Dnmt3a and Dnmt3b levels are 
maintained is unknown. 
Conversely, it is also conceivable that the drop in transcript levels for these two 
genes in cloned embryos is the result of their down-regulation due to the embryo  
repressing their transcription during the eight-cell and blastocyst stages in order to 
compensate for the state of genomic hypermethylation.  Repression of these two genes 
could occur via the methylation of their promoters in a similar mechanism as outlined in 
chapter two.  Given the hypothesized role of Dnmt3a and Dnmt3b in laying down allele 
specific imprints and methylating the viral sequences of the genome, expression of these 
genes may be required at high levels to achieve their developmental function and thus 
their expression is maintained (Chen et al. 2003).  Examination of Dnmt expression 
levels in donor cells during successive increasing passage numbers points to a threshold 
cellular age, which may be relevant to selection of donor cells in studies of nuclear 
 81
transfer.    What affect, if any the Dnmt spike observed during passages seven and ten 
has on an oocytes capacity to reprogram a donor nucleus remains to be examined. 
Recent studies of nuclear breakdown and the dynamics of murine Dnmt1o in 
reconstructed embryos is beginning to allude to inappropriate translation and trafficking 
of key cellular proteins during the initial cleavage divisions of reconstructed embryos 
(Gonda et al. 2003; and Chung et al. 2003).  In addition, it has been noted that removal 
of the female pronucleus from the oocyte precludes any ability of the zygote to 
demethylate the donor genome as well as removing key modulators of murine Dnmt1o 
trafficking (Chung et al. 2003; Kang et al. 2001b and Oswald et al. 2000).  Taken with 
the data reported above it is likely that the abnormal methylation seen in cloned embryos 
is the result of a translational or protein regulatory abnormality rather then a 
transcriptional one. 
To date, the vast majority of anomalies reported in clones have been attributed to 
the inappropriate transcription of several well defined genes.  Given the data presented 
here in conjunction with the recent evidence of broad scale translational / regulatory 
abnormalities, it can be hypothesized that the large scale disturbances seen in clones are 
not due to any single transcriptional phenomenon but rather to a loss of translational and 
protein regulatory control caused by disruption of the embryonic nuclear architecture.   
As biologists, we have a tendency to view the nucleus as a static structure 
housing the genome when in fact; the nucleus is a dynamic structure intimately 
connecting transcription and translation.  Very little is known of mammalian nuclear 
architecture for any given cell type let alone the organization and intricacies of the 
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embryonic nucleus.  Studies of the nuclear organization in somatic cells have revealed a 
close association of nuclear structural proteins with elements of transcriptional, post-
transcriptional and translational control (Gonda et al. 2003).  On a large scale, the 
nuclear genome can be thought of as a dynamically organized superstructure with 
elements accessible to exact regulatory factors and other areas that are specifically 
shielded.  The process of nuclear transfer is a violent one and likely causes a massive 
disruption of the nuclear organization of the zygote, ultimately replacing the intricately 
organized female pronucleus with a somatic one.  Removal of the embryonic nuclear 
matrix very likely pulls key regulatory factors out with it and conversely, replacement of 
an embryonic nuclear organization with a somatic one may permit the access of some 
inappropriate factors while restricting access of other factors needed during this time.   
Kang et al. (2001a) reported that removal of the female pronucleus drastically 
reduces the ability of the zygote to demethylate the embryonic genome.  It is very likely 
that structural elements present in the male and female genomes specifically facilitate 
this process and thus it can further be hypothesized that similar structural elements aid in 
the regulation of the Dnmts along with several other key regulatory proteins important to 
the early epigenetic patterning of the mammalian embryo.  Thus, the abnormal gene 
expression thought to be due to the genomic hypermethylation seen in clones is not 
likely a down stream event of any single given transcriptional disruption per se but 
rather the end result of inappropriate biochemical events due to the loss of basic 
regulatory elements present in the nuclear matrix.   
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  The above hypothesis would suggest that the structural and biochemical 
disruptions that cause the epigenetic and transcriptional abnormalities consistent in 
cloned embryos are imparted during the initial reconstruction procedure and possibly 
during the first few cleavage divisions.  Further investigation of the nuclear structure of 
the oocyte and its role in directing the enzymatic events of “epigenesis” during early 
mammalian development will likely reveal a great deal about the patterning of the 
epigenetic foundation that is so fundamental to directing gene expression during the 
remainder of the growth and development of the organism. 
Materials and Methods 
Tissue Collection and RNA Isolation 
Fetal and adult tissues were collected from slaughterhouse materials and snap 
frozen in liquid nitrogen.  A Dounce homogenizer (Kontes, Vineland, NJ) was used for 
tissue disruption, and the Trizol (Gibco Carlsbad, CA) reagent was used to extract total 
RNA.  
Embryo Production and RNA Isolation 
Mature bovine ova and preimplantation stage embryos were obtained using 
standard procedures utilized in our laboratory for in vitro embryo production (Winger et 
al. 2000).  Briefly, bovine ovaries collected from a local abattoir were aspirated and 
oocytes placed into maturation medium (composed of TCM 199 supplemented with 10% 
fetal calf serum (FCS), 5 µg/ml FSH, 5 µg/ml LH, .05 µg/ml EGF and 1% 
penicillin/streptomycin (100 units of penicillin and 100 µg of streptomycin per ml)) at 39oC 
in an atmosphere of 5% CO2 and air for 20-22 hours.  Mature oocytes were then placed in 
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culture wells containing 0.425 ml fertilization medium and semen used to inseminate at a 
concentration of 1 X 106 cells per ml. After 18-20 hours, the presumptive zygotes were 
removed from fertilization wells, washed in TL Hepes, and placed into 20 µl drops of 
culture medium under oil in a humidified atmosphere of 5% CO2 / 7% O2 / 88% N2.  
Embryos were washed twice though phosphate buffered saline and RNA purified 
from pools of ten bovine MII oocytes or embryos (2,4,8,16-cell, morula and blastocyst 
stage) using RNA isolation spin columns commercially available from Quiagen 
(Valencia, CA), according to the manufactures recommendations. 
Ribonucleoprotein Fractionation 
In order to separate RNA into the subribosomal (less than 80S) and 
polyribosomal (80S and greater) subcellular fractions, a modified protocol based on 
methods previously reported by De Sousa et al (1999) was used.  Briefly, embryos were 
collected and washed once in Ca+ Mg++ free PBS and then placed into 300 ul of a 
detergent lysis buffer (1% NP-40, 0.4% sodium deoxycholate, 500 units RNase Out 
(Gibco Carlsbad, CA), 10ug/ml cycloheximide, and 20ug yeast tRNA (Ambion Austin, 
TX) in a TSM/EGTA buffer (Kidder & Conlon 1985)). Embryos were homogenized in a 
mini-Dounce homogenizer on ice and the lysate centrifuged for 3 minutes at 24000g at 
4º C.  The postmitochondrial supernatant was then layered onto 50ul of 40% sucrose in 
TSM/EGTA and centrifuged for 40 minutes at 100,000g, at 4º C.  The RNA was then 
isolated from the subribosomal supernatant and polyribosomal pellet using the Quiagen 
RNA isolation spin columns described above. 
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Nuclear Transfer 
Methods used to produce NT embryos were taken from Hill et al (2001)  Briefly, 
a cloned fetus was produced by NT using fibroblast cells from an adult bull. The fetus 
was surgically removed from the uterus and the fetal tissue sliced into 2–5 mm pieces. 
Tissue pieces were transferred to 25 mm2 flasks containing Dulbecco's modified Eagles 
medium (DMEM-F12, Gibco Laboratories Inc., Grand Island, NY)+10% FBS (FBS, 
Summit, Fort Collins, CO)+1% penicillin/streptomycin (Gibco) and cultured in 5% CO2 
in air.  
Recipient oocytes were slaughterhouse derived from predominantly Brahman 
cross cattle, and matured for 17 h in Medium 199 (Gibco Laboratories Inc., NY) 
supplemented with 10% (v/v) fetal calf serum (FCS, Gibco) FSH 0.1 units/ml(Sioux 
Biochem, Sioux City, IA) LH 0.1 units/ml(Sioux Biochem), estradiol 1 g/ml (Sigma, St 
Louis, MO), pyruvate 28 g/ml (Sigma), EGF 0.05 g/ml (Sigma) and 1% penicillin–
streptomycin. The cumulus-oocyte complexes were vortexed 17 h post-maturation for 1–
2 min, washed, placed in 0.05% (w/v) pronase E (Sigma) for 3 min, then held in 
M199+10% FCS.  
Oocytes were enucleated at 19 h post-maturation. Prior to enucleation, oocytes 
were placed for 15 min in Hepes-buffered M199 containing Hanks salts (H-M199, 
Gibco) with 4 mg/ml fatty acid free BSA (Sigma) that contained 7.5 g/ml cytochalasin 
B (Sigma) and 5 g/ml Hoechst 33342 (Sigma). At this time, oocytes were selected for 
the presence of a polar body and homogeneous cytoplasm. Suitable oocytes were 
enucleated in H-M199 with 7.5 g/ml cytochalasin B using a beveled 25 m outside 
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diameter glass pipette. Only oocytes in which the removal of both the polar body and 
metaphase nucleus was confirmed by observation under UV light were included in the 
experiment. Oocytes were then randomly allocated to be combined with either early or 
late passage fetal fibroblasts.  
Fibroblasts were combined with enucleated oocytes in 7.5 g/ml cytochalasin B 
in H-M199 using a 30 m outside diameter glass pipette, then returned to M199+10% 
FCS. The oocyte-fibroblast couplets were manually aligned and fused in a 3.2 mm 
fusion chamber that contained Zimmerman cell fusion medium using 2×20 s 1.6 kV/cm 
dc fusion pulses delivered by a BTX Electrocell manipulator 200 (BTX, San Diego, 
CA). Oocyte activation was performed 3–5 h after fusion at 27 h post-maturation, by a 4-
min incubation in 5 M ionomycin (Calbiochem, San Diego, CA) followed by 4 min in 
3% BSA in H-M199.   
Reverse Transcriptase Polymerase Chain Reaction  
Given the highly conserved nature of this gene family, PCR primers were 
designed against regions of high homology between the mouse and human sequences 
and then used to amplify the larger portions of the coding regions. The Gibco Super-
Script II and Platinum Taq Polymerase system (Carlsbad, CA) was used to amplify the 
targeted regions.  The cDNA amplicons were then isolated and gel purified using a PCR 
Wizard Prep (Sigma, St Louis, MO) and sequenced using an ABI 3100 Genetic Analyzer 
(Applied Biosystems Inc, Foster City, CA).  Obtained sequences were next used to probe  
a bovine cDNA library to yield the sequences of the 3’ untranslated regions.  Sequence 
analysis was conducted using BLAST software programs.   
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Expression analysis in preimplantation embryos was conducted using RT-PCR as 
above and were repeated on a minimum of three independent samples.  cDNA amplicons 
were again isolated and sequenced to verify expression of the gene of interest.  
Sequences for PCR primers are listed in the table 1.  Two independent sets of primers 
were used to validate the expression of each Dnmt. 
 
Primer Name Sequence 
Dnmt1 Exons 4-5 Fwd - GATGCCTGCCCGAACCG 
Rev -  CCCGTGGGAAATGAGATGTGAT 
Dnmt1 Exons 1-5 Fwd - GAGGAGGGCTACCTGGCTAAA 
Rev -  CCCGTGGGAAATGAGATGTGAT  
Dnmt2 Set 1 Fwd - CCACCCTGTCAGCCCTTCAC 
Rev -  GGGGATGTTCAGATTCAGTTTTGG 
Dnmt2 Set 2 * Fwd - GCTCTCAGAGAAAGCTGTAT 
Rev -  GGGGCTTGAAAGGGTAATGG 
Dnmt3a Set1 Fwd - GCCCCGAAAGAGCACAACG 
Rev -  GCCCAAGTCCTTCAGCACCAG 
Dnmt3a Set2 
 
Fwd - CTGGTGCTGAAGGACTTGGGC 
Rev -  CAGAAGAAGGGGCGGTCATC 
Dnmt3b Set1 Fwd - GTGTCCTTCCACCCTCTCTTT 
Rev -  GCTTGTCGCCAACCTTCAT 
Dnmt3b Set2 Fwd - GCACGAGGGCAACATCAAA 
Rev -  CTCCAGGACCTTCCCAGCA 
Table 1 RT-PCR Primer Sequences 
* Primers used to detect Dnmt2 isoforms based on primers designed by Franchina et al. 
2001. 
 
 
 
5’ Rapid Amplification of cDNA Ends 
Rapid Amplification of Complementary DNA Ends (RACE) techniques were 
employed to sequence the 5’ regions. RNA isolated from adult testis, mature MII 
oocytes and IVF 8-cell stage embryos was used with the Clontech SMART RACE (Pal 
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Alto, CA) and Gibco (Carlsbad, CA) RACE kits according to the manufacturer’s 
recommendations.  Additionally a modified protocol adapted from Mertineit et al (2000) 
was also employed.  Briefly, Superscipt 2 reverse transcriptase was used with a gene 
specific primer to produce cDNA, which was precipitated in ethanol.  An anchor primer 
blocked at the 3’end and phosphorylated at the 5’end (Sigma-Genosys Woodlands, TX) 
was annealed to the cDNA using T4 RNA Ligase (New England Biolabs Beverly, MA).  
A primer specific to Dnmt1 exon five was then used with RACE primer 1 in the first 
PCR reaction using Gibco Taq polymerase.  A portion of the first PCR reaction was then 
seeded into a second PCR reaction with a primer complimentary to Dnmt1 exon 4 and a 
second RACE primer. 
Real Time PCR 
TaqMan® TAMRA™ Real Time probes (Applied Biosystems Inc, Foster City, 
CA) were designed based on the bovine nucleotide sequences obtained for the Dnmts.  A 
TaqMan® One-Step RT-PCR kit was used to measure gene expression on a GeneAmp 
5700 Sequence Detector (Applied Biosystems).  β-actin mRNA expression was used as 
an internal control and analysis of variance (ANOVA) employed to compare expression 
levels between tissue types. Experiments involved a minimum of 3 repetitions for each 
tissue. 
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CHAPTER IV 
SMALL HAIRPIN RNA MEDIATED KNOCKDOWN OF BOVINE DNA 
METHYLTRANSFERASE 1: ESTABLISHMENT OF SHRNA MEDIATED 
FUNCTIONAL GENOMICS IN THE BOVINE MODEL 
 
 In order to further dissect the role bovine Dnmt1 plays in the genomic 
hypermethylation observed in cloned embryos, a transient disruption of Dnmt1 
expression during the initial stages of preimplantation development will be conducted 
using RNA interference.  However, before an RNAi based suppression of gene 
expression could be attempted it was necessary to determine if an RNAi response could 
be elicited in bovine cells.  Further, reliable methods to design and diagnose the efficacy 
of individual interfering RNA constructs was needed before attempting a gene knock 
down in the embryo.  To this end, several preliminary experiments and the 
implementation of protocols to allow easy design and testing of shRNAs were carried 
out.   
RNA Interference in Bovine Cells 
Sequencing of Bovine Dicer Argonaute 2 and Argonaute3 (Ago 2 & 3) 
The process of RNA interference (RNAi) begins with recognition of double 
stranded RNA (dsRNA) by the RNAse III family nuclease Dicer.  This enzyme cleaves 
dsRNA into small interfering RNAs (siRNA) 21 – 29 nucleotides in length.  The siRNAs 
are then incorporated into the multicomponent nuclease complex, RNA-induced 
silencing complex (RISC), which targets specific mRNAs for destruction based on their 
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homology to the siRNA.  Two of the major proteins identified in the RISC complex are 
Argonaute 2 and Argonaute 3 (Ago 2 and 3) (Carmell 2002).   
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Figure 16 RT-PCR amplification of the full-length coding sequence for bovine Dicer.  A 
0.5%, ethiduim bromide stained agarose gel showing the migration of bovine Dicer 
amplified from fetal testis cDNA. 
 
 
 
To determine if these major components of the RNAi biochemical machinery are 
present in the bovine model, PCR amplification and sequencing of the bovine Dicer, 
Ago2 and Ago3 mRNAs was undertaken.  Primers designed against homologous regions 
between the mouse and human cDNA sequences were used in an RT-PCR utilizing 
bovine testis mRNA (Figure 16).  The complete coding sequence for the bovine 
homologue of Dicer (AY386968) displayed 92% homology on the level of nucleotide 
sequence and 88% identity on the level of amino acid composition, when compared to 
the human sequence.  Similarly, bovine Ago2 and Ago3 (AY436348) displayed 92% and 
94% nucleotide homology and 95% and 99% amino acid similarity, suggesting that these 
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evolutionarily conserved proteins are present in bovine cells and that the capacity exists 
to trigger an RNAi based suppression of gene expression.  
RNAi Knockdown of GFP in Bovine Embryos 
In order to determine if short hairpin mediated RNA interference will effectively 
suppress gene expression in the bovine model, preliminary trials were conducted using 
an injection system to deliver a plasmid encoding GFP into 1-cell bovine zygotes in 
addition to a vector producing an shRNA targeting the GFP mRNA.  Both the control 
and experimental embryos were injected with a plasmid expressing DS Red as a 
normalization control.  In two independent trials, embryos injected with vector carrying 
GFP alone exhibited the expected green fluorescence, while those injected with vectors 
carrying both the GFP and shRNAs targeting GFP displayed drastically reduced 
florescence (Figure 17).  Results of these experiments strongly suggest that RNAi can be 
employed in cattle to effectively knock down gene expression using targeted shRNAs.   
These experiments also demonstrate that the mouse U6 snRNA promoter can 
effectively drive the expression of a transgene in bovine cells.  Of further interest is the 
fact that GFP florescence was detected as early as the one cell stage.  This is significant 
as transcriptional activity is thought to begin at the eight-cell stage in the bovine 
(Camous et al. 1986; Frei et al. 1989; Kopecny et al. 1989) although several studies 
have suggested transcriptional activity as early as the two cell stage (Plante et al. 1994; 
Viuff et al. 1996).  However, observation of transcription (and translation) of a gene 
under the control of a snRNA promoter during the one cell stage would suggest that the 
machinery necessary to achieve transcription is present and active at the one cell stage.   
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Figure 17 RNAi based suppression of GFP expression in bovine embryos.  (A) Bovine 1 
and 2-cell stage embryos injected with the Fug-W plasmid expressing GFP under the 
control of the Mouse U6 promoter.  (B) Bovine 1 and 2-cell stage embryos injected with 
Fug-W and a vector expressing an shRNA homologous GFP under the mouse U6 
promoter.  A plasmid expressing DS-Red was injected into both experimental groups as 
a normalization control.   
 
 
 
Further, suppression of GFP expression in embryos injected with the shRNA-expressing 
vector suggests that the mouse H1 promoter is also active during this early stage.   
Endogenous H1 RNA forms the RNA component of nuclear RNase P and is 
transcribed by RNA polymerase III (Pol III) (Myslinski et al 2001).  The U6 snRNA 
gene is also transcribed by Pol III (Domitrovich and Kunkel 2003), which suggests that 
at least this enzyme is transcriptionally active during this stage.  Whether Pol II, the 
enzyme responsible for the transcription of protein encoding genes is also 
transcriptionally active will be subject to future investigations.   
As development proceeded, GFP florescence was eliminated, sometimes as early 
as the four-cell stage.  Whether this is an epigenetic phenomenon or a factor of plasmid 
degradation remains to be examined.  
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shRNA Mediated Knockdown of the Prion Protein (PrP) – Methods for RNAi 
Mediated Gene Silencing in an Agricultural Model 
 Introduction of shRNAs targeting GFP appeared to effectively suppress the 
expression of the reporter construct but whether this technique can effectively be used to 
suppress expression of an endogenous gene remains to be determined.  In order to 
accurately study RNAi based suppression in an agriculturally relevant model, it was 
desirable to select a target gene that has been well studied, sequenced, is ubiquitously 
expressed, easily diagnosed on both the level of mRNA and protein and is not essential 
to cell survival.  Based on these criteria, and given the biosecurity issues of working in 
the bovine, the caprine prion protein was selected due to our experience working with 
this animal model. 
Prion diseases such as mad cow disease, scrapie or Creutzfeldt-Jakob disease are 
all fatal and are of major agricultural and medical significance.  In these diseases the 
normal cellular prion protein is transformed into an infectious self-propagating disease 
agent (White et al. 2003).  The exact nature of this transformation and the natural role of 
the prion protein have yet to be determined.  Recently, studies of prion protein knockout 
mice revealed that elimination of prion expression conferred disease resistance, and that 
the animals were phenotypically normal (Sailer et al. 1994).  Prion proteins (PrP) are 
expressed in most major cell types and have been extensively studied in numerous model 
organisms, including the cow and goat.  The goat PrP gene has been sequenced and 
commercial antibodies exist for detection of the protein product.  Thus, the PrP gene 
represents and excellent candidate with which to pioneer studies of RNAi based gene 
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suppression in an agriculturally relevant model.  In addition, creation of a PrP 
knockdown cell line and animal will likely be of significant research interest. 
RNA interference is fast becoming a standard laboratory technique for studies of 
functional genomics.  Using this technique, many genes can be suppressed 
independently, or in large groups and the biological consequences analyzed.  In addition, 
genes can be suppressed to varying degrees in independent experiments creating 
epimorphic alleles, which allow simultaneous examination of the biological effects of a 
partial suppression versus a complete knock down (Hemann et al. 2003).  Experiments 
like these may be more informative then simple knockouts based on homologous 
recombination.  Due to the power and versatility of this technique, it is desirable to 
establish reliable, reproducible methods with which to conduct RNAi based studies of 
gene expression on multiple genes in a high throughput fashion.  To this end, the PrP 
gene was used to study and establish an RNAi based system in the caprine model that 
could easily be adapted to study genes of biological interest in other agriculturally 
relevant species, including cattle.  This system allows rapid design and screening of 
candidate shRNAs, large scale screening of the hairpins utilizing an in vitro luciferase 
reporter assay, in vitro suppression of a tagged fusion protein to validate the RNAi 
molecule and ultimately creation of a transgenic cell line and testing for in vivo knock 
down of gene expression. 
Large-Scale Design and Synthesis of shRNAs   
Small hairpin RNAs can be designed using a computer program on the Cold 
Spring Harbor website (http://www.cshl.edu/public/SCIENCE/hannon.html) which 
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searches for sequences that are amenable to forming the hairpin loop structure (Figure 
18).  The output from this program will contain some base pair changes from the original 
sequence owing to the fact that it is necessary to change the sequence given that design 
and propagation of a vector containing an inverted repeat is difficult.  Due to the fact that 
the RNA base uracil will pair with guanine, as stated by the wobble hypothesis, 
substitutions can be made without altering the functionality of the hairpin.  The output 
from this computer program was taken and modified to include a directional cloning site 
on the 5’end, Pac1 restriction sites flanking the entire sequence and a homologous region 
to the mouse H1 promoter.  The modified sequence was then used as a PCR primer to 
create a short hairpin expressing sequence, under the control of the mouse H1 promoter.  
Following the initial PCR reaction, sequences were cut from the gel, purified and 
directionally cloned into the gateway vector pENTR-D.  The Pac1 sites allowed for easy 
diagnosis of positive clones, which were then sequenced to verify the shRNA and 
promoter sequence.  Positive clones were used in a clonase reaction, transferring the 
shRNA and promoter sequence to the modified destination vector Fug-W.  Fug-W is a 
lenti-viral vector containing GFP under the U6 promoter and Attl sites allowing 
recombinatorial insertion of gene sequences via recombination.  At the end of this 
cloning procedure a vector expressing GFP and a shRNA targeted to our gene of interest 
was produced.  All of the above procedures can be done in 96 well format and is thus 
viable for high throughput studies. 
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In vitro Luciferase Assay – Ligation Independent Cloning of a Reporter Construct 
 In order to rapidly assess that capacity of a large number of shRNAs to suppress 
the expression of our genes of interest, a method was needed to create a reporter 
construct that would easily allow introduction of coding sequences in a high throughput 
way.  To this end, ligation independent cloning was used to insert the coding sequence 
for the PrP and Dnmt1 gene into a vector expressing firefly luciferase.  The coding 
sequences were inserted into the 3’ untranslated region of the luciferase transcript, such 
that RNAi mediated suppression of our targeted gene sequence would lead to a 
concurrent suppression of luciferase activity as well.  This strategy of utilizing a 
luciferase fusion transcript to diagnose siRNA activity has been effectively used to 
identify RNA sequences that elicit maximal response (Yu et al. 2003).  
 Ligation independent cloning utilizes a DNA (or RNA) overhang to join two 
separate DNA molecules together via homologous base pairing between the “sense” and 
“antisense” overhangs (Coljee at al, 2000).  Here, DNA overhangs were introduced onto 
the 3’end of luciferase and the 5’ end of PrP, our gene of interest.  This was 
accomplished by the introduction of a 2’-O- methyl RNA base in the primer sequence, 
proximal to the overhang sequence.  This modified RNA base is refractory to RNase H 
digestion, and causes DNA polymerase to terminate polymerization leaving a single 
stranded DNA overhang.  When incorporated into the final plasmid, the bacterial DNA 
repair machinery can replace the modified RNA base with a normal DNA base and thus 
allow normal DNA replication to proceed.  Two linker overhang sequences were tested 
here, one allowing the formation of a luciferase–PrP fusion protein and another that  
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 Using the primers discussed above, PCR reactions were conducted on the pGL3 
plasmid (Promega) and goat testis cDNA.  The amplified Luciferase and PrP sequences, 
containing the modified DNA overhangs were gel purified and mixed in equal molar 
ratios (Figure 19 B and C).  DNA was incubated at 94°C for 5 minutes and then allowed 
to cool to room temperature over the course of two hours.  The annealed DNA was then 
used in a Topo cloning reaction and placed in the gateway vector pENTR-D.  Positive 
clones were selected and sequenced and overall, the cloning reaction had a background 
of approximately 25% non-positive colonies.  From here, the luciferase-PrP fusion was 
moved to a vector containing the CMV promoter and grown in sufficient quantities for 
use in the in vitro reporter assay (Figure 19 D).   
In Vitro Knockdown of the Luciferase-PrP Reporter 
Using the strategies discussed above, shRNAs targeting the bovine PrP mRNA 
and a luciferase-PrP reporter construct were created.  In order to test whether fusion of 
the PrP protein sequence to luciferase affected luminescence, two plasmids were 
constructed, one containing the luciferase-PrP fusion protein coding sequence and 
another that has been termed a “fusion transcript” containing a stop codon between the 
two reading frames.  Both plasmids were transfected into LynxA cells and luciferase 
activity read on a luminomiter.  Renilla luciferase activity was measured and served as a 
normalization control.  Both plasmids displayed luciferase activity however; the 
luminescence of the fusion protein was greatly reduced when compared to the transcript 
containing the stop codon.  This reduction of luminescence by fusion of the two coding 
sequences together may affect experimental measurements, thus all further experiments 
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were conducted using the “fusion transcript” plasmid containing the stop codon between 
the two coding sequences.   
 A total of 42 shRNAs were designed against the PrP mRNA and randomly 
pooled into 6 groups of 7.  Co-transfection of the reporter and with a single pool of the 
shRNA expressing plasmids into Lynx A cells using calcium phosphate, allowed 
diagnosis of and selection of the pool containing the hairpin eliciting maximal gene 
suppression.  A Small hairpin RNA designed against bovine Dnmt1 served as a control.  
Luciferase activity as compared to the control was reduced in all pools examined, 
however, pools 6 and 7 displayed the maximal reduction (Figure 20).  Pool 7 exhibited a 
greater then 5 fold reduction in luciferase activity and was thus selected for expansion 
into its eight individual plasmids.  These individual plasmids were then used in a similar 
assay to identify the individual shRNA sequence that was most effective in suppressing 
reporter gene expression.   
The shRNA producing maximal reporter gene suppression was then used to 
knock down a T7 tagged fusion protein.  A tagged protein was used to prevent 
endogenous PrP from interfering with the reporter assay.  Co-transfection of the T7 
tagged caprine PrP with the vector expressing GFP and the shRNA targeting bovine PrP 
enabled diagnosis of shRNA effect upon PrP protein translation.  Western blot analysis 
was conducted using a V5 antibody to measure the recombinant PrP protein and an 
antibody to GFP used to normalize the data allowing for differing transfection 
efficiencies experiment to experiment. 
 
 100
 
A 
 
Topo                                                                                                                                                                  
Topo 
 
 
 
 
 
 
 
 
 
A
CACC 
Luciferase Prion Protein 
pENTR
Figure19  LIC Procedure.  (A)  Schematic d
construct the Luciferase-PrP fusion reporter
directional cloning site upstream of the fire
red) followed by a linker overhang inserted
compliment to the overhang followed by an
the PrP coding sequence.  (B) PCR amplific
sequences using the LIC primers.  (C) LIC 
the DNA marker, lane 2 the assembled repo
backbone alone.  (D) (next page) Plasmid m
 
 
 
 CTCCAGGTGGGAGGTCCACCT-D Bia
 c
fly
 d
 R
a
cl
rt
aC 
 
gram of the LIC procedure used to 
onstruct.  PCR was used to insert a 
 luciferase start site and an RNA base (in 
ownstream of the luciferase stop site.  The 
NA base (in red) was inserted in front of 
tion of the Luciferase and PrP coding 
oning of Luciferase-PrP reporter.  Lane 1 is 
er construct and lane 3 the pENTR-D 
p of the Luciferase-PrP reporter construct. 
 101
 
TOPO sitepENTR-D
Figure 19 Cont
 
 
 
Lenti-viral Me
 Identific
animal that will
Previous work 
creating founde
vectors carrying
and then transfe
with 76% of the
addition, the tra
approach has be
embryos that taDprp
5019 bp
linkerprp
luciferase
 
inued. 
diated Transgenesis  
ation of a PrP suppressing shRNA enables the creation of a transgenic 
 effectively knock down the PrP protein using an RNAi based approach.  
using recombinant lentiviral vectors has demonstrated the efficacy of 
r animals carrying a transgene in one generation.  In these studies, viral 
 GFP were injected into the perivitelline space of 1-cell mouse embryos 
rred into recipient females.  This approach proved to be very efficient 
 resulting pups exhibiting GFP fluorescence (Lois et al. 2002).  In 
nsgene was transmitted to progeny of the founder animals. A similar 
en used to effectively deliver shRNAs into mouse preimplantation 
rget (knock down) the expression of a specific gene (Rubinson et al. 
 102
 
 
0
1
2
3
4
5
6
7
8
9
10
PrP (Dnmt)
Control
PrP Pool 2 PrP Pool 3 PrP Pool 4 PrP Pool 5 PrP Pool 6 PrP Pool 7
Lu
m
in
es
ce
nc
e
 
Figure 20  Inhibition of Luciferase activity using shRNAs targeting a Luciferase-PrP 
transcript.  Luciferase activity was assayed 3 days post-transfection using a luminomiter.  
Control cells were transfected with an shRNA molecule targeting bovine Dnmt1.  
Experimental cells were transfected with pools of shRNAs targeting various regions of 
the PrP coding sequence.  Experiments consisted of three independent trials and six 
luminescence readings per sample.  Cells transfected with Pools 6 and 7 elicited the 
greatest amount of reporter suppression and were thus selected for further 
experimentation. 
 
 
 
2003).  This strategy is currently being employed to create transgenic shRNA expressing 
animals that suppress some of the genes discussed herein but is not the subject of this 
dissertation. 
Discussion 
 The development of reliable methods to accurately diagnose shRNA function is a 
critical element to establishing this technology for use in functional genomics.  Study of 
shRNA mediated suppression of the goat PrP has revealed that large-scale synthesis and 
testing of shRNAs targeting a gene of interest is possible utilizing common laboratory 
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procedures.  This greatly extends the scope of molecular studies, which can be utilized in 
the caprine and other agriculturally relevant species and opens the door for use of RNAi 
in the creation of disease resistant livestock.  Further, it provides a secure platform from 
which to launch RNAi based studies of bovine Dnmt1. 
shRNA Mediated Knockdown of Dnmt1 
 In order to determine what role, if any the inappropriate expression of Dnmt1 
reported above has on the genomic hypermethylation observed in cloned bovine 
embryos, methods using RNA interference to transiently disrupt Dnmt1 expression were 
developed.  To this end shRNAs homologous to regions of the bovine mRNA sequence 
were constructed using methods described above.  Current literature supports the 
hypothesis that siRNA sequences designed using sequences near the 5’ end of a gene 
work the best.  Four shRNA molecules targeting this region were selected, cloned into 
Fug-W and tested using the luciferase reporter assay described above.  Of these four 
shRNAs, the first two, targeting bases 5-34 and 623-652 produced a marginal 
knockdown while shRNA three and four targeting bases 1082-1111 and 1789-1818 
produced a much more pronounced effect (data not shown).  Subsequently, shRNA3 and 
shRNA4 were selected for further testing (Figure 21).   
In order to determine what affect shRNA3 and shRNA4 have upon translation of 
the bovine DNMT1protein, the coding sequence for the first two thirds of the gene was 
cloned into the pcDNA3 backbone, with a T7 tag appended to the 5’end, just upstream 
of the natural Dnmt1 start site.  Design of this vector specifically containing an 
incomplete Dnmt1 protein prevents any of the toxic effects associated with 
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Figure 21  Inhibition of Luciferase activity using shRNAs targeting a Luciferase-Dnmt1 
target transcript.  Luciferase activity was assayed 3 days post-transfection using a 
luminomiter.  Control cells were transfected with an shRNA molecule targeting the 
5’UTR of the FMD virus.  Experimental cells were transfected with shRNAs targeting 
various regions of the Dnmt1 coding sequence.  Experiments consisted of three 
independent trials and six luminescence readings per sample.  It is likely that the 
inability of the shRNAs to completely eliminate reporter luminescence is simply due to 
the difference in the strengths of the CMV and H1 promoters driving reporter and 
shRNA expression. 
 
 
 
overexpression of the full-length protein (Biniszkiewicz et al. 2002).  This construct was 
transfected into LynxA cells as above, protein extract collected after 3 days and probed 
with antibodies recognizing the T7 tag and GFP.  Probing the blot with a GFP antibody 
serves to normalize the data for differing transfection efficiencies between experimental  
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Discussion 
These experiments show that several of the key biochemical elements necessary 
to elicit an RNAi based suppression are present in the bovine and caprine models and 
further that shRNAs can be used to effectively knock down a targeted gene in vitro.  The 
next phase of this project will be to test the capacity of these interfering RNAs to 
modulate the hypermethylation frequently seen in cloned cattle.  Given that Dnmt1 is 
thought to be the predominant methyltransferase and that its inappropriate regulation 
during the initial stages of clone development could prevent the demethylation necessary 
to reset the genome, targeting this gene for a transient disruption is a logical choice.  
Further, given the divergent expression profile for Dnmt expression in the 
preimplantation bovine embryo, it will be interesting to see if permanent disruption of 
Dnmt1 elicits the same effect in cattle as it does in the mouse. 
Materials and Methods 
Design and Cloning of Small Hairpin RNAs  
 Gene sequences were run through a computer algorithm on the world wide web 
(http://www.cshl.edu/public/SCIENCE/hannon.html) and the output modified in the 
following:  the compliment to the mouse H1 promoter was added to the 3’ end of the 
sequence, a directional cloning site and Pac1 restriction site added to the 5’ end and the 
sequence for the U6 promoter removed.  These primer sequences were synthesized by 
Sigma-Genesis (Woodlands TX) and used as the reverse primer in a reaction amplifying 
the mouse H1 promoter.  The sense primer contains a Pac1 restriction site followed by 
the forward H1 promoter sequence.  Reactions were set up using the NEB ThermoPol 
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reaction buffer (10 mM KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl pH 8.8, 2 mM 
MgSO4, 0.1% Triton X-100), 10 mM dNTP, 4% DMSO, 50pmols of each primer and 2 
units of Taq polymerase.  Thirty cycles of 94° C for 30sec, an annealing temperature of 
55° C and a 30 second 72° C extension were used to amplify the PCR product.  Samples 
were run on a 2.5% agarose gel, cut and purified using a Quiagen Quiax II gel extraction 
kit, according to the manufactures recommendations.  Purified product (3ul) was then 
seeded into a Topo cloning reaction and placed into the pENTR-D Gateway vector using 
the manufactures protocol.  Plasmid DNA was used to transform Top10 bacteria, which 
were grown on kanamycin selective medium.  Colonies were selected, grown and 
plasmid purified using the Quiagen mini-prep system, according to the manufactures 
recommendations.  Samples were digested with the Pac1 restriction endonuclease and 
the 180 base pair H1 promoter-shRNA construct separated from the vector backbone on 
a 2% gel. 
 Positive clones were sequenced at the Texas A&M Gene Technology Lab on an 
Applied Biosystems 3100 Gene Analyzer (Applied Biosystems).  Sequenced clones were 
then used in a Clonase reaction (Invitrogen) transferring the H1 Promoter-shRNA 
construct to a modified Fug-W plasmid (Lois et al. 2002) containing the Gateway 
Recombinase Attl sites, according to the manufactures protocol.  Stbl2 bacteria 
(Invitrogen) were transformed with recombinant Fug-W and grown under ampicillin 
selection.  Colonies were selected, grown and diagnosed as above.  Positive clones were 
pooled or used individually in in vitro reporter assays described below.  Fug-W 
expresses the Green florescent protein (GFP) under the control of the U6 promoter and 
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the shRNA targeting the gene of interest under the H1 promoter.  GFP florescence was 
used to assay transfection efficiency using standard microscopy.  
Ligation Independent Cloning of Reporter Constructs 
 Primers homologous to the 3’end of Luciferase and the 5’ end of bovine PrP 
were synthesized with a modified 2’-O-Methyl RNA residue preceding a linker sequence 
(Sigma-Genesis, Woodlands TX).  Sequences given in Table 2.  Two linker sequences 
were tested here; one, which creates a fusion protein between Luciferase and PrP, and 
another that, contains a stop site and produces the normal luciferase protein.  The 
primers listed below were used to amplify the LIC ready Luciferase and PrP templates 
using Taq polymerase (New England Biosciences).  The pGL3 plasmid (Promega) and 
bovine testis cDNA were used as reaction template for Luciferase and PrP, respectively. 
 
 
Gene Primer Sequence 
Luciferase 5’  CACCATGGAAGACGCCAAAA 
Luciferase 3’ 
Fusion 
AGGTGGACCTCCCGGAGGCACGGCGATCTTTCCGCCCTT 
Luciferase 3’ Stop AGGTGGACCTCCCGGAGGTTACACGGCGATCTTTCCGCC 
PrP 5’ CCTCCGGGAGGTCCACCTATGGTGAAAAGCCACATAGG 
PrP 3’ ACTATCCTACTATGAGAAAAATGAGG 
Table 2 Sequences of Primers Used for Ligation Independent Cloning.  Base in Red is 
the modified 2’-O-Methyl RNA base.  Underlined sequence in Luciferase 5’ primer is 
the directional cloning sequence necessary for directional insertion into pENTR-D. 
 
 
 
 Equimolar amounts of amplified Luciferase and PrP were combined in 50ul of 
ligation buffer (132 mM Tris-HCl, 20 mM MgCl2 2 mM dithiothreitol, 2 mM ATP, 15% 
Polyethylene glycol pH 7.6) New England BioSciences), heated to 94 degrees for 5 
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minutes and allowed to cool down to room temperature over the course of two hours.  A 
small aliquot (3-5ul) was used in a Topo-cloning reaction placing the construct into the 
pENTR-D Gateway vector, per the manufactures recommendations (Invitrogen).  Top10 
bacteria were transformed, and grown on kanamycin plates.  Colonies were selected, 
grown, and plasmid isolated using the Quiagen mini-prep plasmid isolation system, per 
the manufactures recommendation.  An EcoR1 restriction digest was used to identify 
positive clones, which were selected and used in a Clonase reaction, moving the reporter 
gene into the pcDNA 3.1 backbone.  Bacteria were grown on ampicillin media and 
colonies screened as above.  A single positive clone was selected for each of the two 
plasmid designs (fusion protein and fusion transcript) grown and plasmid DNA isolated 
to a yield of sufficient quantity for in vitro testing of the reporters.   
Cloning of Tagged Proteins 
The coding sequence of bovine PrP was amplified using PCR primers containing 
the directional cloning sequence listed above.  PCR product was isolated and used in a 
directional Topo reaction placing the PrP sequence into the Gateway vector pENTR-D.  
Positive clones were used in a Clonase reaction transferring the coding sequence to the 
pCDNA 3.1 – V5 Destination vector.  The vector adds an amino terminal V5 fusion tag. 
Dnmt1 was amplified in three pieces from an RT-PCR using bovine testis cDNA.  
An EcoR1 site and T7 Tag were added to the 5’ end of the Dnmt1 coding sequence.  A 
Not1 site was added to the 3’ terminus and endogenous BamH1 and HindIII restriction 
sites in the central coding sequence used to assemble the full length Dnmt1 into pcDNA 
3.0 (Invitrogen). 
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Cell Culture and Transfection 
 LynX A viral packaging cell lines (Hannon Lab) were grown in DMEM – 5% 
BSA.  Cells were split prior to transfection using a Calcium Phosphate transfection 
protocol.  Briefly, for a 10cm dish, 30ug of total DNA were mixed into 900 ul of H2O, 
100 ul of 0.25M Calcium Chloride in Hepes and 1 ml of BBS (50 mm BES, pH 6.95, 
280 mm NaCl, 1.5 mm Na2HPO4).  Mixed transfection reagent was added drop-wise to 
the plates and allowed to equilibrate at room temperature for 5 minutes.  Cells were 
grown overnight, then washed with PBS and allowed to grow for two more days before 
cells were harvested. 
 For the Luciferase Reporter Assay, 15ug of salmon sperm DNA were transfected 
with 7.5ug of the shRNA containing Fug-W, 0.75ug Renilla expressing pRL SV40 
(Promega) and 6.75ug of the Firefly Luciferase reporter construct (9:1 ratio of Firefly to 
Renilla).  For fusion-protein analysis, 15ug of salmon sperm DNA was transfected with 
7.5ug of the shRNA containing Fug-W and 7.5ug of the vector containing the fusion 
protein.   
Western Blotting 
 Cells were collected using a standard lysis buffer (50mM Tris pH 7.8, 150 mM 
NaCl, 1% Nonidet P-40 and 1ml Protease Inhibitor (Calbiochem) per 100 ml of buffer) 
and protein extracted by centrifugation.  Samples were loaded onto a 4-15% 
polyarylamide gel and separated prior to transfer to PVDF paper (BioRad).  Protein blots 
were blocked in 10% goat serum, 3% milk and washed in TTBS.   
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 T7 tag, (Novagen) V5 tag (Invitrogen) and GFP (AbCam) antibodies were used 
to probe the blots to examine protein quantities and results analyzed using the 
SuperSignal Chemiluminescent assay (Pierce). 
Luciferase Reporter Assay 
The Promega Dual-Luciferase Reporter Assay System was used to quantify 
shRNA mediated reporter gene knock down.  Briefly, a passive protein lysis buffer was 
used to collect protein from the transfected cells.  A small aliquot (1-5ul) of the cell 
lysate was added to 100 ul of Luciferase Assay Reagent II and mixed by pipetting.  A 
reading was then recorded from the luminomiter.  After the initial reading, 100 ul of 
Stop and Glo Reagent was added and the sample vortexed.  The second reading was then 
recorded.  The Firefly luminescence was then divided by the Ranilla luminescence and a 
ratio used to compare samples.  A minimum of 4 independent readings were taken for 
each sample and students T-test used to affirm significance. 
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CHAPTER V 
SUMMARY 
 
 
The results reported herin demonstrate that the DNA methyltransferase 
expression profile of the early bovine preimplantation embryo is divergent from the 
paradigm reported in the mouse.  In addition, real time quantitative analysis of the 
Dnmts in cloned embryos suggests that misexpression of these enzymes is not solely 
responsible for the hypermethylation consistently seen in cloned embryos.   
These experiments demonstrate that several of the key biochemical elements 
necessary to elicit an RNAi based suppression are present in the bovine model and that 
shRNAs can be used to effectively knock down a targeted gene in vitro.  The next phase 
of this project will be to test the capacity of these interfering RNAs to modulate the 
hypermethylation frequently seen in cloned cattle.  Given that Dnmt1 is thought to be the 
predominant methyltransferase and that its inappropriate regulation during the initial 
stages of clone development could prevent the demethylation necessary to reset the 
genome, targeting this gene for a transient disruption is a logical choice.  Further, given 
the divergent expression profile for Dnmt expression in the preimplantation bovine 
embryo, it will be interesting to see if permanent disruption of Dnmt1 elicits the same 
effect in cattle as it does in the mouse. 
 113
REFERENCES 
Akker, S., Smith P., Chew S.  (2001)  Nuclear post-transcriptional control of gene 
expression.  J Mol Endocrinol. 27:123-31. 
 
Bachman, K., Rountree, M., Baylin, S.  (2001)  Dnmt3a and Dnmt3b are transcriptional 
repressors that exhibit unique localization properties to heterochromatin.  J Biol 
Chem. 276:32282-7. 
 
Baguisi, A., Behboodi, E., Melican, D., Pollock, J., Destrempes, M., Cammuso, C., 
Williams, J., Nims, S., Porter, C., Midura, P., Palacios, M., Ayres, S., Denniston, 
R., Hayes, M., Ziomek, C., Meade, H., Godke, R., Gavin, W., Overstrom, E., 
Echelard, Y.  (1999)  Production of goats by somatic cell nuclear transfer.  Nat 
Biotechnol. 17:456-61. 
 
Barker, D.  (1990)  The fetal and infant origins of adult disease.  BMJ  301:1111. 
 
Beckett, D.  (2001)  Regulated assembly of transcription factors and control of 
transcription initiation.  J Mol Biol. 314:335-52. 
 
Bernstein, E., Denli, A., Hannon, G.  (2001)  The rest is silence.  RNA 7:1509-21. 
 
Bestor, T.  (1992)  Activation of mammalian DNA methyltransferase by cleavage of a 
Zn binding regulatory domain.  EMBO J. 11:2611-7.     
 
Bestor, T.  (2000)  The DNA methyltransferases of mammals.  Hum Mol Genet  9:2395-
402. 
 
Bestor, T. and Verdine, G. (1994)  DNA methyltransferases.  Curr Opin Cell Biol. 
6:380-9. 
 
Bigey, P., Ramchandani, S., Theberge, J., Araujo, F., Szyf, M.  (2000)  Transcriptional 
regulation of the human DNA methyltransferase (dnmt1) gene.  Gene. 242:407-18. 
 
Biniszkiewicz, D., Gribnau, J., Ramsahoye, B., Gaudet, F., Eggan, K., Humpherys, D., 
Mastrangelo, M., Jun, Z., Walter, J., Jaenisch, R.  (2002)  Dnmt1 overexpression 
causes genomic hypermethylation, loss of imprinting, and embryonic lethality.  
Mol Cell Biol 22:2124-35. 
 
Bird, A. & Wolffe A. (1999)  Methylation-induced repression--belts, braces, and 
chromatin.  Cell 99:451-4. 
 
Bourc'his, D., Xu, G., Lin, C., Bollman, B., Bestor, T.  (2001a)  Dnmt3L and the 
establishment of maternal genomic imprints.  Science 294:2536-9. 
 114
 
Bourc'his, D., Le Bourhis, D., Patin, D., Niveleau, A., Comizzoli, P., Renard, J., Viegas- 
Pequignot, E.  (2001b)  Delayed and incomplete reprogramming of chromosome 
methylation patterns in bovine cloned embryos.  Curr Biol 11:1542-6. 
 
Brown, R. & Strathdee, G.  (2002)  Epigenomics and epigenetic therapy of cancer.  
Trends Mol Med 8(4 Suppl):S43-8. 
 
Caceres, J. & Kornblihtt, A. (2002)  Alternative splicing: multiple control mechanisms 
and involvement in human disease.  Trends Genet. 18:186-93. 
 
Camous, S., Kopecny, V., Flechon, J.  (1986)  Autoradiographic detection of the earliest 
stage of [3H]-uridine incorporation into the cow embryo.  Biol Cell 58:195-200. 
 
Carlson, L., Page, A., Bestor, T., 1992.  Properties and localization of DNA 
methyltransferases in preimplantation ouse embryos: implications for genomic 
imprinting.  Genes & Development 6:2536-2541. 
 
Chen, T., Ueda, Y., Xie, S., Li, E.  (2002)  A novel dnmt3a isoform produced from an 
alternative promoter localizes to euchromatin and its expression correlates with 
active de novo methylation.  J Biol Chem 277:38746-54. 
 
Chen, T., Ueda, Y., Dodge, J., Wang, Z., Li, E.  (2003)  Establishment and maintenance 
of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and 
Dnmt3b.  Mol Cell Biol. 23:5594-605. 
 
Chuang, L., Ng, H., Chia, J., Li, B.  (1996)  Characterisation of independent DNA and 
multiple Zn-binding domains at the N terminus of human DNA-(cytosine-5) 
methyltransferase: modulating the property of a DNA-binding domain by 
contiguous Zn-binding motifs.  J Mol Biol. 257:935-48. 
 
Chung, Y., Ratnam, S., Chaillet, J., Latham, K.  (2003)  Abnormal regulation of DNA 
methyltransferase expression in cloned mouse embryos.  Biol Reprod. 69:146-53. 
 
Cibelli, J., Stice, S., Golueke, P., Kane, J., Jerry, J., Blackwell, C., Ponce de Leon, F., 
Robl, J.  (1998)  Cloned transgenic calves produced from nonquiescent fetal 
fibroblasts.  Science. 280:1256-8. 
 
Coljee, V., Murray, H., Donahue, W., Jarrell, K.  (2000)  Seamless gene engineering 
using RNA- and DNA-overhang cloning.  Nat Biotechnol. 18:789-91. 
 
Comfort, N. (1999)  "The real point is control": the reception of Barbara McClintock's 
controlling elements.  J Hist Biol. 32:133-62. 
 
 115
Daniels, R., Hall, V., French, A., Korfiatis, N., Trounson, A.  (2001)  Comparison of 
gene transcription in cloned bovine embryos produced by different nuclear transfer 
techniques.  Mol Reprod Dev 60:281-8. 
 
Datta, J., Ghoshal, K., Sharma, S., Tajima, S., Jacob, S.  (2003)  Biochemical 
fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 
and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1.  J Cell 
Biochem. 88:855-64.  
 
Dean, W., Santos, F., Stojkovic, M., Zakhartchenko, V., Walter, J., Wolf, E., Reik, W.  
(2001)  Conservation of methylation reprogramming in mammalian development: 
aberrant reprogramming in cloned embryos. Proc Natl Acad Sci USA 98:13734-8. 
 
Denli, A. & Hannon, G. (2003)  RNAi: an ever-growing puzzle.  Trends Biochem Sci. 
28:196-201.  
 
De Sousa, P., Valdimarsson, G., Nicholson, B., Kidder, G., 1993.  Connexin trafficking 
and the control of gap junction assembly in mouse preimplantation embryos. 
Development 117:1355-1367. 
 
De Sousa, P., Winger, Q., Hill, J., Jones, K., Watson, A., Westhusin, M.  (1999)  
Reprogramming of fibroblast mRNA expression following nuclear transfer in 
bovine embryos.  Cloning 1:63-69. 
 
Ding, F. & Chaillet, J.  (2002)  In vivo stabilization of the Dnmt1 (cytosine-5)- 
methyltransferase protein.  Proc Natl Acad Sci U S A 99:14861-6. 
 
Ding, F., Patel, C., Ratnam, S., McCarrey, J., Chaillet, J.  (2003)  Conservation of 
Dnmt1o cytosine methyltransferase in the marsupial Monodelphis domestica.  
Genesis. 36:209-13. 
 
Doherty, A., Mann, M., Tremblay, K., Bartolomei, M., Schultz, R.  (2000) Differential 
effects of culture on imprinted H19 expression in the preimplantation mouse 
embryo.  Biol Reprod 62:1526-35. 
 
Domitrovich, A. & Kunkel, G.  (2003)  Multiple, dispersed human U6 small nuclear 
RNA genes with varied transcriptional efficiencies.  Nucleic Acids Res. 31:2344-
52. 
Donovan, D., Powell, A., Talbot, N., Persel, V., Graninger, P., FosterFrey, J., Becker, 
K., Dawson, H., Wall, R.  (2003) cDNA Microarray Analysis is Not Predictive of 
Donor Cell Clonability in Bovine Somatic Cell Cloning.  Transgenic Animal 
Research Conference IV, University of California Davis, August 10th – 14th. 
 
 116
Dvir, A., Conaway, J., Conaway, R.  (2001)  Mechanism of transcription initiation and 
promoter escape by RNA polymerase II.  Curr Opin Genet Dev. 11:209-14. 
 
Elbashir S., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. (2001)  
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured 
mammalian cells, Nature 411: 494-498. 
 
Elbashir, S., Harborth, J., Weber, K., Tuschl, T.  (2002)  Analysis of gene function in 
somatic mammalian cells using small interfering RNAs.  Methods 26:199-213. 
 
Fatemi, M., Hermann, A., Pradhan, S., Jeltsch, A.  (2001)  The activity of the murine 
DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain 
with the N-terminal part of the enzyme leading to an allosteric activation of the 
enzyme after binding to methylated DNA.  J Mol Biol. 309:1189-99. 
 
Fire, A., Xu, S., Montgomery, M., Kostas, S., Driver, S., Mello, C. (1998) Potent and 
specific genetic interference by double-stranded RNA in Caenorhabditis elegans.  
Nature 391: 806-811. 
Frei, R., Schultz, G., Church, R.  (1989)  Qualitative and quantitative changes in protein 
synthesis occur at the 8-16-cell stage of embryogenesis in the cow.  J Reprod Fertil 
86:637-41.   
Fuks, F., Burgers, W., Godin, N., Kasai, M., Kouzarides, T.  (2001)  Dnmt3a binds 
deacetylases and is recruited by a sequence-specific repressor to silence 
transcription. EMBO J 20:2536-44. 
 
Garry, F., Adams, R., Cattell, M., Dinsmore, R.  (1996)  Comparison of passive 
immunoglobulin transfer to dairy calves fed colostrum or commercially available 
colostral-supplement products.  J Am Vet Med Assoc. 208:107-10. 
 
Gibbons, R., Picketts, D., Villard, L., Higgs, D. (1995) Mutations in a putative global 
transcriptional regulator cause X-linked mental retardation with alpha-thalassemia 
(ATR-X syndrome).  Cell 80:837-45. 
 
Gitlin, L., Karelsky, S., Andino, R. (2002)  Short interfering RNA confers intracellular 
antiviral immunity in human cells, Nature 418: 430-434 
Gonda, K., Fowler, J., Katoku-Kikyo, N., Haroldson, J., Wudel, J., Kikyo, N.  (2003)  
Reversible disassembly of somatic nucleoli by the germ cell proteins FRGY2a and 
FRGY2b.  Nat Cell Biol. 5:205-10. 
 117
Hanamura, A., Caceres, J., Mayeda, A., Franza, B., Krainer, A.  (2002)  Regulated 
tissue-specific expression of antagonistic pre-mRNA splicing factors.  RNA 4:430-
44. 
 
Hannon, G. (2002), RNA Interference, Nature 418:244-251. 
 
Hata, K., Okano, M., Lei, H., Li, E.  (2002)  Dnmt3L cooperates with the Dnmt3 family 
of de novo DNA methyltransferases to establish maternal imprints in mice.  
Development 129:1983-93. 
 
Hausheer, F., Rao, S., Gamcsik, M., Kollman, P., Colvin, O., Saxe, J., Nelkin, B., 
McLennan, I., Barnett, G., Baylin, S.  (1989) Computational analysis of structural 
and energetic consequences of DNA methylation.  Carcinogenesis 10:1131-1137. 
 
Hayward, B., De Vos, M., Judson, H., Hodge, D., Huntriss, J., Picton, H., Sheridan, E., 
Bonthron, D.  (2003)  Lack of involvement of known DNA methyltransferases in 
familial hydatidiform mole implies the involvement of other factors in 
establishment of imprinting in the human female germline.  BMC Genet. 20:2. 
 
Hemann, M., Fridman, J., Zilfou, J., Hernando, E., Paddison, P., Cordon-Cardo, C., 
Hannon, G., Lowe, S.  (2003)  An epi-allelic series of p53 hypomorphs created by 
stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet. 33:396-400. 
 
Hermann, A., Schmitt, S., Jeltsch, A.  (2003)  The human Dnmt2 has residual DNA-
(cytosine-C5) methyltransferase activity.  J Biol Chem. 278:31717-21. 
 
Hill, J., Burghardt, R., Jones, K., Long, C., Looney, C., Shin, T., Spencer, T., Thompson, 
J., Winger, Q., Westhusin, M.  (2000a)  Evidence for placental abnormality as the 
major cause of mortality in first-trimester somatic cell cloned bovine fetuses.  Biol 
Reprod  63:1787-94. 
 
Hill, J., Winger, Q., Long, C., Looney, C., Thompson, J., Westhusin, M.  (2000b)  
Development rates of male bovine nuclear transfer embryos derived from adult and 
fetal cells.  Biol Reprod 62:1135-40. 
 
Hill, J., Winger, Q., Burghardt, R., Westhusin, M.  (2001)  Bovine nuclear transfer 
embryo development using cells derived from a cloned fetus.  Anim Reprod Sci. 
67:17-26. 
 
Howell, C., Bestor, T., Ding, F., Latham, K., Mertineit, C., Trasler, J., Chaillet, J.  
(2001)  Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 
gene.  Cell. 23:829-38. 
 
 118
Humpherys, D., Eggan, K., Akutsu, H., Hochedlinger, K., Rideout, W., Biniszkiewicz, 
D., Yanagimachi, R., Jaenisch, R.  (2001)  Epigenetic instability in ES cells and 
cloned mice.  Science. 293:95-7. 
 
Humpherys, D., Eggan, K., Akutsu, H., Friedman, A., Hochedlinger, K., Yanagimachi, 
R., Lander, E., Golub, T., Jaenisch, R.  (2002)  Abnormal gene expression in 
cloned mice derived from embryonic stem cell and cumulus cell nuclei.  Proc Natl 
Acad Sci U S A 99:12889-94. 
 
Inoue, K., Kohda, T., Lee, J., Ogonuki, N., Mochida, K., Noguchi, Y., Tanemura, K., 
Kaneko-Ishino, T., Ishino, F., Ogura, A.  (2002)  Faithful expression of imprinted 
genes in cloned mice.  Science. 295:297. 
 
International Human Genome Sequencing Consortium (2001)  Initial sequencing and 
analysis of the human genome.  Nature. 409:860-921. 
 
Jenuwein, T. & Allis, C.  (2001)  Translating the histone code.  Science 293:1074-80. 
 
Jones, P., Veenstra, G., Wade, P., Vermaak, D., Kass, S., Landsberger, N., Strouboulis, 
J., Wolffe, A.  (1998)  Methylated DNA and MeCP2 recruit histone deacetylase to 
repress transcription.  Nat Genet 19:187-91. 
 
Judson, H., Hayward, B., Sheridan, E., Bonthron, D.  (2002)  A global disorder of 
imprinting in the human female germ line.  Nature 416:539-42. 
 
Kang, Y., Koo, D., Park, J., Choi, Y., Chung, A., Lee, K., Han, Y. (2001a)  Aberrant 
methylation of donor genome in cloned bovine embryos. Nat Genet 28:173-7. 
 
Kang, Y., Koo, D., Park, J., Choi, Y., Lee, K., Han, Y.  (2001b)  Influence of oocyte 
nuclei on demethylation of donor genome in cloned bovine embryos.  FEBS Lett. 
499:55-8. 
 
Kato, Y., Tani, T., Sotomaru, Y., Kurokawa, K., Kato, J., Doguchi, H., Yasue, H., 
Tsunoda, Y.  (1998)  Eight calves cloned from somatic cells of a single adult.  
Science. 282:2095-8. 
 
Kidder, G., & Conlon, R.  (1985)  Utilization of cytoplasmic poly(A)+RNA for protein 
synthesis in preimplantation mouse embryos.  J Embryol Exp Morphol. 89:223-34. 
 
Klimasauskas, S., Kumar, S., Roberts, R., Cheng, X.  (1994)  HhaI methyltransferase 
flips its target base out of the DNA helix.  Cell 76:357-69. 
 
 119
Kopecny, V., Flechon, J., Camous, S., Fulka, J.  (1989)  Nucleologenesis and the onset 
of transcription in the eight-cell bovine embryo: fine-structural autoradiographic 
study.  Mol Reprod Dev 1:79-90. 
 
Kumar, S., Cheng, X., Klimasauskas, S., Mi, S., Posfai, J., Roberts, R., Wilson, G.  
(1994)  The DNA (cytosine-5) methyltransferases.  Nucleic Acids Res. 22:1-10. 
 
Kunert, N., Marhold, J., Stanke, J., Stach, D., Lyko, F.  (2003)  A Dnmt2-like protein 
mediates DNA methylation in Drosophila.  Development 130:5083-90.  
 
Lebedeva, L. & Tillib, S. (2003) Trithorax protein, a global factor for maintenance of 
tissue specific gene activation in Drosophila melanogaster, is associated with the 
nuclear matrix Genetika 39:250-8. 
 
Leonhardt, H., Page, A., Weier, H., Bestor, T.  (1992)  A targeting sequence directs 
DNA methyltransferase to sites of DNA replication in mammalian nuclei.  Cell 
71:865-873. 
 
Levine, M. & Tjian, R.  (2003)  Transcription regulation and animal diversity.  Nature 
424:147-51. 
 
Li, E., Bestor, T., Jaenisch, R.  (1992).  Targeted mutation of the DNA methyltransferase 
gene results in embryonic lethality.  Cell 69:915-926. 
 
Liu, Z. & Foote R.  (1997)  Effects of amino acids and alpha-amanitin on bovine embryo 
development in a simple protein-free medium.  Mol Reprod Dev 46:278-85. 
 
Lois, C., Hong, E., Pease, S., Brown, E., Baltimore, D.  (2002)  Germline transmission 
and tissue-specific expression of transgenes delivered by lentiviral vectors.  
Science. 295:868-72. 
 
Lopatina, N., Haskell, J., Andrews, L., Poole, J., Saldanha, S., Tollefsbol, T.  (2002) 
Differential maintenance and de novo methylating activity by three DNA 
methyltransferases in aging and immortalized fibroblasts. Journal of Cellular 
Biochemistry 84:324-34. 
 
Lopez, A.  (1998)  Alternative splicing of pre-mRNA: developmental consequences and 
mechanisms of regulation.  Annu Rev Genet. 32:279-305. 
 
Margot, J., Ehrenhofer-Murray, A., Leonhardt, H.  (2003)  Interactions within the 
mammalian DNA methyltransferase family.  BMC Mol Biol. 4:7. 
 
McCance, R.  (1962)  Food, growth and time.  Lancet ii;271-2. 
 
 120
McGrath, J. & Solter, D.  (1984a) Completion of mouse embryogenesis requires both the 
maternal and paternal genomes.  Cell 37:179-83. 
 
McGrath, J. & Solter, D.  (1984b)  Maternal Thp lethality in the mouse is a nuclear, not 
cytoplasmic, defect.  Nature 308:550-1. 
 
Mertineit, C., Yoder, J., Taketo, T., Laird, D., Trasler, J., Bestor, T. (1998).  Sex-specific 
exons control DNA methyltransferase in mammalian germ cells.  Development 
125:889-897. 
 
Monk, M., Adams, R., Rinaldi, A.  (1991) Decrease in DNA methylase activity during 
preimplantation development in the mouse.  Development 112:189-92. 
 
Mott, G., Lewis, D., McGill, H.  (1991)  Programming of cholesterol metabolism by 
breast or formula feeding.  Ciba Found Symp 156:56-66. 
 
Myslinski, E., Ame, J., Krol, A., Carbon, P. 2001 An unusually compact external 
promoter for RNA polymerase III transcription of the human H1RNA gene.  
Nucleic Acids Res. 29:2502-9. 
 
Natale, D., De Sousa, P., Westhusin, M., Watson, A.  (2001)  Sensitivity of bovine 
blastocyst gene expression patterns to culture environments assessed by differential 
display RT-PCR.  Reproduction 122:687-93. 
 
Ogbourne, S. & Antalis, T.  (1998)  Transcriptional control and the role of silencers in 
transcriptional regulation in eukaryotes.  Biochem J. 331:1-14. 
 
Ogonuki, N., Inoue, K., Yamamoto, Y., Noguchi, Y., Tanemura, K., Suzuki, O., 
Nakayama, H., Doi, K., Ohtomo, Y., Satoh, M., Nishida, A., Ogura, A.  (2002)  
Early death of mice cloned from somatic cells.  Nat Genet 30:253-4 
 
Okano, M., Xie, S., Li, E.  (1998a).  Cloning and characterization of a family of novel 
mammalian DNA (cytosine-5) methyltransferases.  Nature Genetics 19:219-20. 
 
Okano, M., Xie, S., Li, E.  (1998b).  Dnmt2 is not required for de novo and maintenance 
methylation of viral DNA in embryonic stem cells. Nucleic Acids Res 26:2536-40. 
 
Okano, M., Bell, D., Haber, D., Li, E.  (1999)  DNA methyltransferases Dnmt3a and 
Dnmt3b are essential for de novo methylation and mammalian development. Cell 
99:247-57. 
 
Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., Dean, W., Reik, 
W., Walter, J.  (2000)  Active demethylation of the paternal genome in the mouse 
zygote.  Curr Biol. 10:475-8. 
 121
 
Pace, M., Augenstein, M., Betthauser, J., Childs, L., Eilertsen, K., Enos, J., Forsberg, E., 
Golueke, P., Graber, D., Kemper, J., Koppang, R., Lange, G., Lesmeister, T., 
Mallon, K., Mell, G., Misica, P., Pfister-Genskow, M., Strelchenko, N., Voelker, 
G., Watt, S., Bishop, M.  (2002)  Ontogeny of cloned cattle to lactation.  Biol 
Reprod 67:334-9. 
 
Pascual, J., Martinez-Yamout, M., Dyson, H., Wright, P.  (2000)  Structure of the PHD 
zinc finger from human Williams-Beuren syndrome transcription factor.  J Mol 
Biol. 304:723-9.  
 
Picketts, D., Tastan, A., Higgs, D., Gibbons, R.  (1998)  Comparison of the human and 
murine ATRX gene identifies highly conserved, functionally important domains.  
Mamm Genome. 9:400-3.  
 
Plante, L., Plante, C., Shepherd, D., King, W.  (1994)  Cleavage and 3H-uridine 
incorporation in bovine embryos of high in vitro developmental potential.  Mol 
Reprod Dev. 39:375-83. 
 
Prather, R.  (1996)  Progress in cloning embryos from domesticated livestock.  Proc Soc 
Exp Biol 212:38-43. 
 
Prather, R., Tao, T., Machaty, Z.  (1999)  Development of the techniques for nuclear 
transfer in pigs.  Theriogenology. 51:487-98. 
 
Qiu, C., Sawada, K., Zhang, X., Cheng, X.  (2002) The PWWP domain of mammalian 
DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds.  Nat 
Struct Biol. 9:217-24. 
 
Ratnam, S., Mertineit, C., Ding, F., Howell, C., Clarke, H., Bestor, T., Chaillet, J., 
Trasler, J.  (2002)  Dynamics of Dnmt1 methyltransferase expression and 
intracellular localization during oogenesis and preimplantation development.  Dev 
Biol 245:304-14. 
 
Renard, J., Chastant, S., Chesne, P., Richard, C., Marchal, J., Cordonnier, N., Chavatte, 
P., Vignon, X.  (1999)  Lymphoid hypoplasia and somatic cloning.  Lancet. 
353:1489-91. 
 
Robertson, K., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F., Jones, P.  
(1999).  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate 
mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids 
Research 27:2291-8. 
 
 122
Rubinson. D., Dillon, C., Kwiatkowski, A., Sievers, C., Yang, L., Kopinja, J., Rooney, 
D., Ihrig, M., McManus, M., Gertler, F., Scott, M., Van Parijs, L.  (2003)  A 
lentivirus-based system to functionally silence genes in primary mammalian cells, 
stem cells and transgenic mice by RNA interference.  Nat Genet. 33:401-6. 
 
Rush, L. & Plass, C.  (2002)  Restriction landmark genomic scanning for DNA 
methylation in cancer: past, present, and future applications.  Anal Biochem. 
307:191-201. 
 
Sailer, A., Bueler, H., Fischer, M., Aguzzi, A., Weissmann, C. (1994) No propagation of 
prions in mice devoid of PrP.  Cell 77:967-8. 
 
Saito, Y., Kanai, Y., Sakamoto, M., Saito, H., Ishii, H., Hirohashi, S.  (2002) 
Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, 
associated with DNA hypomethylation on pericentromeric satellite regions during 
human hepatocarcinogenesis.  Proc Natl Acad Sci USA  23:10060-5. 
 
Salisbury S. & VanDemark, G. 1961.  Physiology of Reproduction and Artificial 
Insemination of Cattle, San Francisco, Freeman & Co. 
 
Santi, D., Norment, A., Garrett, C. (1984) Covalent bond formation between a DNA-
cytosine methyltransferase and DNA containing 5-azacytosine.  Proc Natl Acad 
Sci U S A. 81:6993-7.  
 
Schultz, G., Harvey, M., Watson, A., Arcellana-Panlilio, M., Jones, K., Westhusin, M.  
(1996)  Regulation of early embryonic development by growth factors: growth 
factor gene expression in cloned bovine embryos.  J Anim Sci 74(Suppl 3):50-57. 
 
Shi, W. & Haaf, T. (2002)  Aberrant methylation patterns at the two-cell stage as an 
indicator of early developmental failure.  Mol Reprod Dev 63:329-34. 
 
Shin, T., Kraemer, D., Pryor, J., Liu, L., Rugila, J., Howe, L., Buck, S., Murphy, K., 
Lyons, L., Westhusin, M.  (2002)  A cat cloned by nuclear transplantation.  Nature. 
415:859. 
 
Shilatifard A.  (1998)  Factors regulating the transcriptional elongation activity of RNA 
polymerase II.  FASEB J. 12:1437-46. 
 
Shiota, K., Kogo, Y., Ohgane, J., Imamura, T., Urano, A., Nishino, K., Tanaka, S., 
Hattori, N.  (2002)  Epigenetic marks by DNA methylation specific to stem, germ 
and somatic cells in mice.  Genes Cells 7:961-9. 
 
 123
Sinclair, K., Young, L., Wilmut, I., McEvoy, T.  (2000)  In-utero overgrowth in 
ruminants following embryo culture: lessons from mice and a warning to men.  
Hum Reprod 15:68-86. 
 
Smart, J.  (1990)  Vulnerability of developing brain to undernutrition.  Ups J Med Sci 
Suppl 48:21-41. 
 
Staley, J. & Guthrie, C.  (1998)  Mechanical devices of the spliceosome: motors, clocks, 
springs, and things.  Cell  92:315-26. 
 
Stec, I., Nagl, S., van Ommen, G., den Dunnen, J.  (2000) The PWWP domain: a 
potential protein-protein interaction domain in nuclear proteins influencing 
differentiation?  FEBS Lett. 473:1-5. 
 
Suetake, I., Miyazaki, J., Murakami, C., Takeshima, H., Tajima, S.  (2003)  Distinct 
enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and 
Dnmt3b.  J Biochem. 133:737-44. 
 
Svoboda, P., Stein, P., Hayashi, H., Schultz, R.  (2000)  Selective reduction of dormant 
maternal mRNAs in mouse oocytes by RNA interference.  Development 127:4147-
56. 
 
Tamashiro, K., Wakayama, T., Akutsu, H., Yamazaki, Y., Lachey, J., Wortman, M., 
Seeley, R., D'Alessio, D., Woods, S., Yanagimachi, R., Sakai, R.  (2002)  Cloned 
mice have an obese phenotype not transmitted to their offspring.  Nat Med 8:262-7. 
 
Tang, L., Reddy, M., Rasheva, V., Lee, T., Lin, M., Hung, M., Shen, C.  (2003)  The 
eukaryotic DNMT2 genes encode a new class of cytosine-5 DNA 
methyltransferases.  J Biol Chem. 278:33613-6. 
 
Telford, N., Watson, A., Schultz, G.  (1990) Transition from maternal to embryonic 
control in early mammalian development: a comparison of several species.  Mol 
Reprod Dev. 26:90-100. 
 
Tucker, K., Talbot, D., Lee, M., Leonhardt, H., Jaenisch, R. (1996) Complementation of 
methylation deficiency in embryonic stem cells by a DNA methyltransferase 
minigene.  Proc Natl Acad Sci U S A. 12:12920-5. 
 
Vignon, X., Chesne, P., Le Bourhis, D., Flechon, J., Heyman, Y., Renard, J.  (1998)  
Developmental potential of bovine embryos reconstructed from enucleated 
matured oocytes fused with cultured somatic cells.  C R Acad Sci III. 321:735-45. 
 
Viuff, D., Avery, B., Greve, T., King, W., Hyttel, P.  (1996) Transcriptional activity in in 
vitro produced bovine two- and four-cell embryos.  Mol Reprod Dev. 43:171-9. 
 124
 
Weisenberger, D., Velicescu, M., Preciado-Lopez, M., Gonzales, F., Tsai, Y., Liang, G., 
Jones, P.  (2002)  Identification and characterization of alternatively spliced 
variants of DNA methyltransferase 3a in mammalian cells.  Gene. 298:91-9. 
 
White, A., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., 
Collinge, J., Hawke, S.  (2003) Monoclonal antibodies inhibit prion replication and 
delay the development of prion disease. Nature 422:80-3. 
 
Winger, Q., Hill, J., Watson, A., Westhusin, M.  (2000)  Characterization of a bovine 
cDNA encoding citrate synthase, and presence of citrate synthase mRNA during 
bovine pre-attachment development.  Mol Reprod Dev. 55:14-9. 
 
Wilmut, I., Schnieke, A., McWhir, J., Kind, A., Campbell, K.  (1997)  Viable offspring 
derived from fetal and adult mammalian cells.  Nature. 385:810-3. 
 
Wilson, D. & Wyatt, D.  (1995)  Patterns of lectin binding during mammalian 
neurogenesis.  J Anat. 186:209-16. 
 
Winters, L., Green, W., Comstock, R., 1942.  The prenatal development of the Bovine.  
Agricultural Experiment Station, University of Minnesota, St. Paul. Technical 
Bulletin 151. 
 
Wrenzycki, C., Wells, D., Herrmann, D., Miller, A., Oliver, J., Tervit, R., Niemann, H.  
(2001)  Nuclear transfer protocol affects messenger RNA expression patterns in 
cloned bovine blastocysts.  Biol Reprod. 65:309-17. 
 
Xue, F., Tian, X., Du, F., Kubota, C., Taneja, M., Dinnyes, A., Dai, Y., Levine, H., 
Pereira, L., Yang, X.  (2002)  Aberrant patterns of X chromosome inactivation in 
bovine clones.  Nat Genet. 31:216-20.  
 
Yanagisawa, Y., Ito, E., Yuasa, Y., Maruyama, K.  (2002)  The human DNA 
methyltransferases DNMT3A and DNMT3B have two types of promoters with 
different CpG contents.  Biochim Biophys Acta. 1577:457-65. 
 
Young, L., Sinclair, K., Wilmut, I.  (1998)  Large offspring syndrome in cattle and 
sheep.  Rev Reprod 3:155-63. 
 
Young, J. & Smith, J. (2001).  DNA methyltransferase inhibition in normal human 
fibroblasts induces a p21-dependant cell cycle withdrawal.  J Biol Chem. 
276:19610-19616. 
 
 125
Yong, Z. & Yuqiang, L.  (1998)  Nuclear-cytoplasmic interaction and development of 
goat embryos reconstructed by nuclear transplantation: production of goats by 
serially cloning embryos.  Biol Reprod. 58:266-9. 
 
Zhao, J., Hyman, L., Moore, C.  (1999)  Formation of mRNA 3' ends in eukaryotes: 
mechanism, regulation, and interrelationships with other steps in mRNA synthesis.  
Microbiol Mol Biol Rev. 63:405-45. 
 
Zimmermann, C., Guhl, E., Graessmann, A. (1997)  Mouse DNA methyltransferase 
(MTase) deletion mutants that retain the catalytic domain display neither de novo 
nor maintenance methylation activity in vivo. Biol Chem. 378:393-405. 
 126
APPENDIX A 
BOVINE DNMT mRNA SEQUENCES AND SEQUENCE  ALLIGNMENTS 
 
Bovine Dnmt1 Complete CDS 
Green Start Site = Somatic Start 
Blue Start Site = Putative Embryonic Start 
AAGATGCCTGCCCGAACCGCCCCGGCGCGGGTGCCTGCGCTGGCCTCCCGG
GCCTTCTCACTGCCTGACGATGTCCGCAGGCGGCTCAAAGATTTGGAAAGAG
ATAGTTTGACAGAAAAGGAATGTGTGAAGGAGAAACTGAATCTCTTGCACG
AATTTCTGCGGACAGAAATAAAGAATCAGTTATGTGATTTGGAAACCAAATT
GCATAAAGAAGAATTATCTGAGGAGGGCTACCTGGCTAAAGTCAAATCCCTT
TTAAATAAAGATTTGTCCTTGGAGAACGGAGCTCATGCTTTCAGTCGGGAAG
CGAATGGATGTCTAGAGAACGGGAGCCAGACAAGTGGTGAGGATTGCAGAG
TGGTAATGGCAGAGAAAGGCAAGCCCCCCAAACCTGTCTCCAGACTTTACA
CGCCCAGGAGAAGCAAGTCTGATGGAGAAACAAAGTCTGAAGTCTCTTCTA
GCCCCAGGATTACAAGGAAGACTACCAGGCAGACCACCATCACATCTCATTT
CCCACGGGGCCCTGCCAAACGAAAACCTGAGGAAGAACCTGAAAAAGTGAA
GTCAGACGATTCTGTTGATGAAGAAAAAGACCAGGAGGAAAAGAGACGTCG
AGTTACATCCAGAGAACGAGTTGCTGGGCTGCTCCCTGCAGAAGAACCAGG
AAGAGTAAGACCAGGAACACACATGGAAGAAGAAGGAAGAGATGATAAAG
AAGAAAAGAGACTCAGAAGTCAAACCAAAGAACCGACACCTAAACACAAA
GCTAAGGAGGAGCCAGACAGAGATGTGAGGCCTGGAGGAGCTCAGGCTGAA
ATGAATGAAGGAGAAGACAAAGATGAAAAGAGGCACAGAAGTCAACCCAA
AGATCTAGCTAGCAAACGGAGACCAGAAGAAAAAGAACCTGAAAGAGTAA
AGCCACAAGTTTCTGATGAGAAAGATGAAGATGAAAAGGAGGAGAAGAGA
CGCAGAACTACATACAGAGAACTAACCGAGAAGAAAATGACTCGAACCAAA
ATAGCCGTAGTGTCCAAGACCAATCCTCCGAAGTGCACCGAGTGCTTGCAGT
ACCTGGACGACCCTGAGCTGAGATACGAGCAGCACCCCCCCGATGCGGTGG
AAGAGATACAGATACTGACCAACGAGAGGTTGTCCATCTTTGATGCCAACG
AATCTGGCTTTGAGAGTTACGAGGATTTGCCTCAGCACAAACTAACCTGCTT
CAGCGTGTACTGTAAACGCGGTCACCTTTGCCCGATCGACACCGGCCTCATT
GAGAAGGATGTCGAGCTCCTCTTTTCTGGTTCAGCAAAGCCGATATATGAGG
ATGACCCATCTCCCGAAGGTGGTATTAATGGCAAAAATTTTGGCCCCATAAA
CGAATGGTGGATTGCTGGTTTTGATGGAGGTGAAAAGGCTCTTCTTGGCTTT
AGCACCTCATTTGCCGAGTATATCTTGATGGATCCCAGCCCAGAGTACGCAC
CACTATTCAGCGTGATGCAGGAGAAGATCTATATAAGTAAGATAGTGGTTGA
GTTCCTGCAGAGCAACCCTGACTCCACCTACGAAGACCTGATCAATAAGATT
GAGACCACCGTTCCTCCTTGTATGCTCAACTTGAATCGATTCACAGAGGATT
CTCTCCTGCGGCATGCCCAGTTCGTGGTGGAGCAAGTAGAGAGTTATGATCG
GGCTGGGGACAGTGACGAGCAGCCCATCTTCCTGAGCCCCTGCATGAGAGA
CCTCATCAAGCTGGCCGGGGTCACCCTGGGAAAAAGGCGAGCCGAGAGGCG
GCAGACCATCCGGCAACCCGCCAAAGAGAAGGACAAGGGCCCCACCAAGGC
CACCACCACCAAGCTGGTCTACCAGATCTTTGACACTTTCTTTGCGGAGCAA
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ATTGAAAAAGATGACAAGGAAGACAAGGAGAATGCCTTCAAGCGCCGGCGC
TGTGGCGTCTGTGAGATTTGTCAACAGCCCGAGTGTGGAAAGTGTAAGGCCT
GTAAGGATATGGTTAAATTTGGTGGTAGCGGACGGAGCAAGCAGGCTTGCC
AAAAGAGGAGGTGTCCCAACATGGCCATGAAGGAGGCAGACGATGACGAG
GAAGTGGATGACAATATTCCAGAGATGCCATCACCCAAAAAGATGCATCAG
GGGAAGAAAAAGAAGCAGAATAAGAATCGGATCTCTTGGGTTGGCGATGCC
GTCAAGACTGACGGGAAGAAGAGTTACTACAAGAAGGTATGCATCGACTCG
GAAACCCTGGAAGTGGGGGACTGTGTTTCTGTAATTCCAGACGACTCTTCAA
AACCACTGTATCTAGCAAGGGTCACGGCGCTGTGGGAGGACAGCAGCAATG
GGCAGATGTTCCATGCCCACTGGTTCTGTGCTGGGACGGACACGGTCCTCGG
GGCCACATCGGACCCCCTGGAGCTGTTCCTGGTTGACGAGTGTGAGGACATG
CAGCTCTCGTACATCCACAGCAAGGTGCAGGTCATTTATAAGGCGCCCTCAG
AGAACTGGGCCATGGAGGGAGGCGTGGACCCCGAGGCCCTGATGTCAGAGG
ACGACGGGAAGACCTACTTCTACCAGCTGTGGTACGACCAAGACTACGCGA
GATTTGAGTCCCCTCCGAAAACTCAGCCGACGGAGGACAACAAGTACAAGT
TCTGCGCAAGCTGTGCACGTCTGGCCGAAATGAGGCAGAAGGAAATCCCCA
GGGTCGTGGAGCAGCTCCAGGACCTGGAAGGCCGCGTCCTCTACAGCCTCGC
CACCAAGAACGGCGTCCAGTACCGGGTGGGCGATGGCGTGTACCTCCCTCCC
GAGGCCTTCACCTTCAACATCAAGCTGTCCAGTCCTGTGAAACGCCCCCGGA
AGGAGCCTGTGGACGAAGCTCTGTATCCAGAACACTACCGGAAGTACTCTG
ACTACATCAAGGGCAGCAACCTGGATGCCCCTGAGCCCTACCGTATTGGCCG
CATAAAGGAGATCTTCTGCAGCAAGAAGAGCAACGGCCGGCCCAATGAGAC
AGACATCAAGATCAGGGTCAACAAGTTCTACAGGCCGGAGAACACACACAA
GTCTACCCCAGCCAGTTACCACGCAGACATCAACCTGCTTTACTGGAGCGAT
GAGGAGGCCGTGGTGGACTTCAAGGCCGTGCAGGGCCGCTGCACCGTGGAG
TACGGAGAGGACCTGCCTCAGTGCCTCCAGGACTTCTCCGCTGGTGGCCCCG
ATCGCTTCTATTTTCTCGAGGCCTATAACGCCAAGAGCAAAAGCTTTGAAGA
TCCTCCGAACCACGCCCGGAGCACCGGAAATAAAGGGAAAGGGAAGGGGA
AAGGAAAAAACAGGACGAAATCTCAGACGTGTGAGCCGAGTGAACTGGAG
ACAGAAATCAAACTGCCGAAGCTGCGGACCCTGGACGTGTTTTCCGGCTGTG
GGGGATTGTCGGAAGGCTTCCACCAAGCAGGCATCTCGGAAACACTTTGGG
CCATCGAGATGTGGGACCCTGCGGCCCAGGCGTTCCGGTTCAACAACCCTGG
GTCCACGGTGTTCACAAAGGACTGCAACGTCCTGGTGAAGCTGGTCATGGCC
GGGGAGGTGACCAACTCCCGCGGCCAGAAGCTGCTTCAAAAGGGAGATGTG
GAGATGTTGTGCGGCGGGCCGCCCTGCCAGGGCTTTAGCGGCATGAACCGCT
TCAACTCTCGAACCTACTCCAAATTCAAGAACTCCCTGGTGGTCTCTTTCCTC
AGCTACTGTGACTACTACCGGCCCCGCTACTTCCTCTTGGAGAACGTTCGGA
ACTTCGTCTCCTTCAAGCGCTCCATGGTCCTGAAGCTGACGCTGCGCTGCCTG
GTCCGCAGGGGGTACCAGTGCACCTTTGGCGTGCTGCAGGCTGGTCAGTACG
GCGTGGCCCAGACTCGGAGGCGAGCCATCATCCTGGCTGCAGCCCCTGGGG
AGCCACTCCCGCTGTTCCCGGAGCCGTTGCATGTGTTCGCACCCCGGGCCTG
CCAGCTGAGCGTCGTAGTGGACGACAAGAAGTTTGTCAGCAACATCACCAG
GTTGAGCTCGGGTCCCTTCCGAACCATCACCGTGCGGGACACCATGTCTGAC
CTCCCTGAGATCCGGAACGGGGCCTCGGCACTGGAGATTTCATACAACCGGG
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AGCCCCAGTCCTGGTTCCAGAGGCAGCTCCGGGGCTCGCAGTACCAGCCCAT
CCTCAGGGATCATATTTGCAAGGACATGAGCGCCTTGGTGGCTGCCCGCATG
CGGCACATCCCCCTGGCCCCGGGCTCGGACTGGCGTGACCTGCCCAACATTG
AGGTGCGGCTCTCTGACGGCACCCTGGCCCGGAAGCTGCGGTACAACTACCA
CGACAAGAAGAACGGCTGCAGCAGCAGCGGCGCCCTCCGTGGGGTCTGCTC
CTGTGTGGAAGGCAAGCCCTGTGAGCCTGCGGCCCGACAGTTTAACACCCTT
ATCCCCTGGTGCCTGCCCCACACTGGGAACAGGCACAACCACTGGGCCGGCC
TCTACGGGCGTCTCGAGTGGGACGGCTTCTTCAGCACAACTGTCACCAACCC
CGAGCCCATGGGCAAGCAGGGCCGCGTGCTCCACCCCGAGCAGCACCGAGT
GGTGAGCGTCCGGGAGTGCGCCCGCTCCCAGGGCTTCCCCGACACCTATCGG
CTGTTCGGCAACATCCTAGACAAGCACCGGCAGGTGGGTAATGCTGTGCCGC
CGCCACTGGCCAAAGCCATCGGCTTGGAGATCAAGCGCTGCATGTTGGCCAA
AGCGCGCGAGAGCGCCTCAGCTAAAATCAAGGAGGAGGCTGCCAAGGACTA
GTTCTCTCCTCCTATCACCCATGTTTCTGCCACCAGAGATCCCCAACGTGCAC
TGATATTGGTGTATTTTTCACATGTCAATCAGTCAATTCAGATGTGTCGTATG
CGGTGTTTGTGGCCTTGGCTGACATGAAACTCTTCAGTGAGATTTGCCTATCG
GCTAATTTGGACTTANTGATCAAACTGTGCAGTACTTTGTCCATTCTGGATTT
TAAAAGTTTTTTTTTACGCATTATATNAAATTTACCACTGTTTGAGTGGNAAT
TAAGACTTTATGTAGNTTTTATATGTTGNAATATTTCTTCAAAAAATCTCTTC
TTAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
 
 129
Bovine DNMT1 Protein Sequence 
 
MPARTAPARVPALASRAFSLPDDVRRRLKDLERDSLTEKECVKEKLNLLHEFLR
TEIKNQLCDLETKLHKEELSEEGYLAKVKSLLNKDLSLENGAHAFSREANGCLE
NGSQTSGEDCRVVMAEKGKPPKPVSRLYTPRRSKSDGETKSEVSSSPRITRKTTR
QTTITSHFPRGPAKRKPEEEPEKVKSDDSVDEEKDQEEKRRRVTSRERVAGLLPA
EEPGRVRPGTHMEEEGRDDKEEKRLRSQTKEPTPKHKAKEEPDRDVRPGGAQA
EMNEGEDKDEKRHRSQPKDLASKRRPEEKEPERVKPQVSDEKDEDEKEEKRRR
TTYRELTEKKMTRTKIAVVSKTNPPKCTECLQYLDDPELRYEQHPPDAVEEIQIL
TNERLSIFDANESGFESYEDLPQHKLTCFSVYCKRGHLCPIDTGLIEKDVELLFSG
SAKPIYEDDPSPEGGINGKNFGPINEWWIAGFDGGEKALLGFSTSFAEYILMDPSP
EYAPLFSVMQEKIYISKIVVEFLQSNPDSTYEDLINKIETTVPPCMLNLNRFTEDSL
LRHAQFVVEQVESYDRAGDSDEQPIFLSPCMRDLIKLAGVTLGKRRAERRQTIR
QPAKEKDKGPTKATTTKLVYQIFDTFFAEQIEKDDKEDKENAFKRRRCGVCEIC
QQPECGKCKACKDMVKFGGSGRSKQACQKRRCPNMAMKEADDDEEVDDNIPE
MPSPKKMHQGKKKKQNKNRISWVGDAVKTDGKKSYYKKVCIDSETLEVGDCV
SVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLV
DECEDMQLSYIHSKVQVIYKAPSENWAMEGGVDPEALMSEDDGKTYFYQLWY
DQDYARFESPPKTQPTEDNKYKFCASCARLAEMRQKEIPRVVEQLQDLEGRVL
YSLATKNGVQYRVGDGVYLPPEAFTFNIKLSSPVKRPRKEPVDEALYPEHYRKY
SDYIKGSNLDAPEPYRIGRIKEIFCSKKSNGRPNETDIKIRVNKFYRPENTHKSTPA
SYHADINLLYWSDEEAVVDFKAVQGRCTVEYGEDLPQCLQDFSAGGPDRFYFL
EAYNAKSKSFEDPPNHARSTGNKGKGKGKGKNRTKSQTCEPSELETEIKLPKLR
TLDVFSGCGGLSEGFHQAGISETLWAIEMWDPAAQAFRFNNPGSTVFTKDC
NVLVKLVMAGEVTNSRGQKLLQKGDVEMLCGGPPCQGFSGMNRFNSRTYSK
FKNSLVVSFLSYCDYYRPRYFLLENVRNFVSFKRSMVLKLTLRCLVRRGYQC
TFGVLQAGQYGVAQTRRRAIILAAAPGEPLPLFPEPLHVFAPRACQLSVVVDD
KKFVSNITRLSSGPFRTITVRDTMSDLPEIRNGASALEISYNREPQSWFQRQLRGS
QYQPILRDHICKDMSALVAARMRHIPLAPGSDWRDLPNIEVRLSDGTLARKLRY
NYHDKKNGCSSSGALRGVCSCVEGKPCEPAARQFNTLIPWCLPHTGNRHNHWA
GLYGRLEWDGFFSTTVTNPEPMGKQGRVLHPEQHRVVSVRECARSQGFPDTY
RLFGNILDKHRQVGNAVPPPLAKAIGLEIKRCMLAKARESASAKIKEEAAKD* 
Bold sequence = Methyltransferase Domains I, II, IV, VI, VII, VIII, IX, X respectively. 
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Sequence Alignment 
 
Bovine          ----------------------------------------------------------AA 2 
Human           CCGCGCG---AAAAGCCGGGGCGCCTGCGCTGCCGCCGCCGCGTCTGCTGAAGCCTCCGA 236 
Mouse           CCGCGCGCGCGAAAAAGCCGGGGTCTCGTTCAGAGCTGTTCTGTCGTCTGCAACCTGCAA 191 
                                                                           * 
 
Bovine          GATGCCTGCCCGAACCGCCCCGGCGCGGGTGCCTGCGCTGGCCTCCCGGGCCTTCTCACT 62 
Human           GATGCCGGCGCGTACCGCCCCAGCCCGGGTGCCCACACTGGCCGTCCCGGCCATCTCGCT 296 
Mouse           GATGCCAGCGCGAACAGCTCCAGCCCGAGTGCCTGCGCTTGCCTCCCCGGCAGGCTCGCT 251 
                ****** ** ** ** ** ** ** ** *****  * ** ***  ** ***   *** ** 
 
Bovine          GCCTGACGATGTCCGCAGGCGGCTCAAAGATTTGGAAAGAGATAGTTTGACAGAAAAGGA 122 
Human           GCCCGACGATGTCCGCAGGCGGCTCAAAGATTTGGAAAGAGACAGCTTAACAGAAAAGGA 356 
Mouse           CCCGGACCATGTCCGCAGGCGGCTCAAAGACTTGGAAAGAGATGGCTTAACAGAAAAGGA 311 
                 ** *** ********************** ***********  * ** *********** 
 
Bovine          ATGTGTGAAGGAGAAACTGAATCTCTTGCACGAATTTCTGCGGACAGAAATAAAGAATCA 182 
Human           ATGTGTGAAGGAGAAATTGAATCTCTTGCACGAATTTCTGCAAACAGAAATAAAGAATCA 416 
Mouse           GTGTGTGAGGGAGAAATTAAACTTACTGCATGAATTCCTGCAAACAGAAATAAAAAGCCA 371 
                 ******* ******* * **  *  **** ***** ****  *********** *  ** 
 
Bovine          GTTATGTGATTTGGAAACCAAATTGCATAAAGAAGAATTATCTGAGGAGGGCTACCTGGC 242 
Human           GTTATGTGACTTGGAAACCAAATTACGTAAAGAAGAATTATCCGAGGAGGGCTACCTGGC 476 
Mouse           GTTGTGTGACTTGGAAACCAAATTACATAAAGAGGAATTATCTGAGGAAGGCTACCTGGC 431 
                *** ***** ************** * ****** ******** ***** *********** 
 
Bovine          TAAAGTCAAATCCCTTTTAAATAAAGATTTGTCCTTGGAGAACGGAGCTCATGCTTTCAG 302 
Human           TAAAGTCAAATCCCTTTTAAATAAAGATTTGTCCTTGGAGAACGGTGCTCATGCTTACAA 536 
Mouse           TAAAGTCAAGTCCCTCTTAAATAAGGATTTGTCCTTGGAGAACGGAACACACACTCTCAC 491 
                ********* ***** ******** ********************  * **  **  **  
 
Bovine          TCGGGAAGCGAATGGATGTCTAGAGAACGGGAGCCAGACAAGTGGTGAGGATTGCAGAGT 362 
Human           CCGGGAAGTGAATGGACGTCTAGAAAACGGGAACCAAGCAAGAAGTGAAGCCCGTAGAGT 596 
Mouse           TCAAAAAGCCAACGGTTGTCCCGCCAACGGGAGCCGGCCAA---------CCTGGAGAGC 542 
                 *   ***  ** **  ***  *  ******* **   ***            * ****  
 
Bovine          GGTAATGGCAGAGAAAGGCAAGCCCCCCAAACCTGTCTCCAGACTTTACACGCCCAGGAG 422 
Human           GGGAATGGCAGATGCCAACAGCCCCCCCAAACCCCTTTCCAAACCTCGCACGCCCAGGAG 656 
Mouse           AGAAATGGCAGACTCAAATAGATCCCCAAGATCCAGGCCCAAGCCTCGGGGACCCAGGAG 602 
                 * *********       *   **** * * *     ***  * *      ******** 
 
Bovine          AAGCAAGTCTGATGGAGAAACAAAGTC---TGAAGTCTCTTCTAGCCCCAGGATTACAAG 479 
Human           GAGCAAGTCCGATGGAGAGGCTAAGCC---TGAACCTTCACCTAGCCCCAGGATTACAAG 713 
Mouse           AAGCAAGTCGGACAGTGACACCCTTTCAGTTGAAACTTCACCTAGTTCCGTGGCTACGAG 662 
                 ******** **  * **  *     *   ****   **  ****  **  *  *** ** 
 
Bovine          GAAGACTACCAGGCAGACCACCATCACATCTCATTTCCCACGGGGCCCTGCCAAACGAAA 539 
Human           GAAAAGCACCAGGCAAACCACCATCACATCTCATTTTGCAAAGGGCCCTGCCAAACGGAA 773 
Mouse           GAGAACCACCAGGCAGACCACCATCACGGCTCACTTCACGAAGGGCCCCACTAAACGGAA 722 
                **  *  ******** ***********  **** **  *   ******  * ***** ** 
 
Bovine          ACCTGAGGAAGAACCTGAAAAAGTGAAGTCAGACGATTCTGTTGATGAAGAA---AAAGA 596 
Human           ACCTCAGGAAGAGTCTGAAAGAGCCAAATCGGATGAGTCCATCAAGGAAGAAGACAAAGA 833 
Mouse           ACCCAAGGAAGAGTCGGAAGAGGGGAACTCGGCTGAGTCGGCTGCAGAGGAG---AGAGA 779 
                ***  *******  * ***   *  ** ** *  ** **       ** **    * *** 
 
Bovine          CCAGGAGGAAAAGAGACGTCGAGTTACATCCAGAGAACGAGTTGCTGGGCTGCTCCCTGC 656 
Human           CCAGGATGAGAAGAGACGTAGAGTTACATCCAGAGAACGAGTTGCTAGACCGCTTCCTGC 893 
Mouse           CCAGGAT---AAGAAACGCAGAGTTGTAGACACAGAGAGTGGTGCT--GCAGCTGC-TGT 833 
                ******    **** ***  *****  *  ** ***  * * ****   * *** * **  
 
Bovine          AGAAGAACCAGGAAGAGTAAGACCAGGAACACACATGGAA---GAAGAAGGAAGAGATGA 713 
Human           AGAAGAACCTGAAAGAGCAAAATCAGGAACGCGCACTGAAAAGGAAGAAGAAAGAGATGA 953 
Mouse           GGAGAAACTGGAAGAGGTAACAGCGGGAACCCAGCTGGGTCCGGAAGAGCCATGTGAACA 893 
                 **  ***  * *   * ** * * ***** *     *     *****   * * **  * 
 
Bovine          TAAAGAAGAAAA---GAGACTCAGAAGTCAAACCAAAGAACCGACACCTAAACACAAAGC 770 
Human           AAAAGAAGAAAA---GAGACTCCGAAGTCAAACCAAAGAACCAACACCCAAACAGAAACT 1010 
Mouse           GGAAGATGACAACAGGAGTCTTCGACGTCACACCAGAGAGCTATCATTGAGGCGGAAATC 953 
                  **** ** **   *** **  ** **** **** *** *   **   *  *  ***   
 
Bovine          TAAGGAGGAGCCAGACAGAGATGTGAGGCCTGGAGGAGCTCAGGCTGAAATGAATGAAGG 830 
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Human           GAAGGAGGAGCCGGACAGAGAAGCCAGGGC---AGGCGTGCAGGCTGACGAGGACGAAGA 1067 
Mouse           AAAGGAGGATCCAGACAGAGAAGCAAGACC---GGAAACTCACTTGGACGAGGACGAGGA 1010 
                 ******** ** ******** *  **  *    *     **    **   * * ** *  
 
Bovine          AGAAGAC---AAAGATGAAAAGAG------GCACAGAAGTCAACCCAAAGATCTAGCTAG 881 
Human           TGGAGACGAGAAAGATGAGAAGAA------GCACAGAAGTCAACCCAAAGATCTAGCTGC 1121 
Mouse           CGGAAAA---AAGGATAAAAGAAGTTCCAGACCCAGGAGCCAGCCCAGAGATCCAGCTGC 1067 
                 * * *    ** *** * *  *        * *** ** ** **** ***** ****   
 
Bovine          CAAACGGAGACCAGAAGAAAAAGAACCTGAAAGAGTAAAGCCACAAGTTTCTGATGAGAA 941 
Human           CAAACGGAGGCCCGAAGAAAAAGAACCTGAAAAAGTAAATCCACAGATTTCTGATGAAAA 1181 
Mouse           CAAACGGAGACCCAAGGAAGCAGAGCCAGAGCAGGTAGCTCCAGAGACTCCCGAGGACAG 1127 
                ********* **  * ***  *** ** **    ***   *** *   * * ** ** *  
 
Bovine          AGATGAAGATGAAAAGGAGGAGAAGAGACGCAGAACTACATACAGAGAACTAA------- 994 
Human           AGACGAGGATGAAAAGGAGGAGAAGAGACGCAAAACGACCCCCAAAGAACCAA------- 1234 
Mouse           AGACGAGGATGAGAGGGAGGAGAAGAGACGAAAAACGACACGTAAAAAACTGGAGTCACA 1187 
                *** ** ***** * *************** * *** **    * * ***           
 
Bovine          -----------------------CCGAGAAGAAAATGACTCGAACCAAAATAGCCGTAGT 1031 
Human           -----------------------CGGAGAAAAAAATGGCTCGCGCCAAAACAGTCATGAA 1271 
Mouse           CACCGTTCCCGTTCAGAGCAGATCGGAGAGAAAAGCCGCTCAAAGCAAAAG---TGTGAT 1244 
                                       * ****  ***    ***    *****      *    
 
Bovine          GTCCAAGACCAATCCTCCGAAGTGCACCGAGTGCTTGCAGTACCTGGACGACCCTGAGCT 1091 
Human           CTCCAAGACCCACCCTCCCAAGTGCATTCAGTGCGGGCAGTACCTGGACGACCCTGACCT 1331 
Mouse           CCCGAAGATCAACTCACCAAAGTGCCCCGAGTGTGGCCAGCACCTAGACGACCCTAACCT 1304 
                  * **** * *  * ** ******    ****    *** **** ********* * ** 
 
Bovine          GAGATACGAGCAGCACCCCCCCGATGCGGTGGAAGAGATACAGATACTGACCAACGAGAG 1151 
Human           CAAATATGGGCAGCACCCACCAGACGCGGTGGATGAGCCACAGATGCTGACAAATGAGAA 1391 
Mouse           GAAGTACCAGCAGCACCCTGAGGATGCTGTGGATGAACCCCAGATGTTGACCAGTGAGAA 1364 
                 *  **   *********    ** ** ***** **    *****  **** *  ****  
 
Bovine          GTTGTCCATCTTTGATGCCAACGAATCTGGCTTTGAGAGTTACGAGGATTTGCCTCAGCA 1211 
Human           GCTGTCCATCTTTGATGCCAACGAGTCTGGCTTTGAGAGTTATGAGGCGCTTCCCCAGCA 1451 
Mouse           ACTGTCCATCTACGACTCCACCTCGACCTGGTTTGATACTTATGAAGATTCTCCCATGCA 1424 
                  *********  **  *** *    *  * ***** * *** ** *     **   *** 
 
Bovine          CAAACTAACCTGCTTCAGCGTGTACTGTAAACGCGGTCACCTTTGCCCGATCGACACCGG 1271 
Human           CAAACTGACCTGCTTCAGTGTGTACTGTAAGCACGGTCACCTGTGTCCCATCGACACCGG 1511 
Mouse           TAGGTTCACTTCCTTCAGTGTGTACTGCAGTCGCGGGCACCTGTGTCCTGTCGACACCGG 1484 
                 *   * ** * ****** ******** *  * *** ***** ** **  ********** 
 
Bovine          CCTCATTGAGAAGGATGTCGAGCTCCTCTTTTCTGGTTCAGCAAAGCCGATATATGAGGA 1331 
Human           CCTCATCGAGAAGAATATCGAACTCTTCTTTTCTGGTTCAGCAAAACCAATCTATGATGA 1571 
Mouse           TCTCATTGAGAAGAATGTAGAGCTCTACTTTTCTGGGTGTGCCAAAGCAATTCATGACGA 1544 
                 ***** ****** ** * ** ***  ********* *  ** **  * **  **** ** 
 
Bovine          TGACCCATCTCCCGAAGGTGGTATTAATGGCAAAAATTTTGGCCCCATAAACGAATGGTG 1391 
Human           TGACCCGTCTCTTGAAGGTGGTGTTAATGGCAAAAATCTTGGCCCCATAAATGAATGGTG 1631 
Mouse           GAATCCATCTATGGAAGGTGGTATTAATGGCAAAAACCTCGGGCCAATCAATCAGTGGTG 1604 
                  * ** ***   ********* *************  * ** ** ** **  * ***** 
 
Bovine          GATTGCTGGTTTTGATGGAGGTGAAAAGGCTCTTCTTGGCTTTAGCACCTCATTTGCCGA 1451 
Human           GATCACTGGCTTTGATGGAGGTGAAAAGGCCCTCATCGGCTTCAGCACCTCATTTGCCGA 1691 
Mouse           GCTCAGTGGCTTTGATGGTGGCGAGAAGGTGCTCATTGGCTTCTCCACTGCATTTGCTGA 1664 
                * *   *** ******** ** ** ****  **  * *****   ***  ******* ** 
 
Bovine          GTATATCTTGATGGATCCCAGCCCAGAGTACGCACCACTATTCAGCGTGATGCAGGAGAA 1511 
Human           ATACATTCTGATGGATCCCAGTCCCGAGTATGCGCCCATATTTGGGCTGATGCAGGAGAA 1751 
Mouse           ATACATTTTGATGGAGCCCAGCAAAGAGTATGAGCCAATATTTGGGCTGATGCAGGAGAA 1724 
                 ** **  ******* *****    ***** *  **  ****  *  ************* 
 
Bovine          GATCTATATAAGTAAGATAGTGGTTGAGTTCCTGCAGAGCAACCCTGACTCCACCTACGA 1571 
Human           GATCTACATCAGCAAGATTGTGGTGGAGTTCCTGCAGAGCAATTCCGACTCGACCTATGA 1811 
Mouse           AATTTACATCAGCAAGATTGTTGTTGAGTTCCTGCAAAACAATCCTGATGCTGTATATGA 1784 
                 ** ** ** ** ***** ** ** *********** * ***  * **  *    ** ** 
 
Bovine          AGACCTGATCAATAAGATTGAGACCACCGTTCCTCCTTGTATGCTCAACTTGAATCGATT 1631 
Human           GGACCTGATCAACAAGATCGAGACCACGGTTCCTCCTTCTGGCCTCAACTTGAACCGCTT 1871 
Mouse           AGACCTGATCAATAAGATTGAGACCACTGTTCCTCCTTCTACCATTAATGTGAACCGGTT 1844 
                 *********** ***** ******** ********** *    * **  **** ** ** 
 
Bovine          CACAGAGGATTCTCTCCTGCGGCATGCCCAGTTCGTGGTGGAGCAAGTAGAGAGTTATGA 1691 
Human           CACAGAGGACTCCCTCCTGCGACACGCGCAGTTTGTGGTGGAGCAGGTGGAGAGTTATGA 1931 
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Mouse           CACAGAGGACTCCCTCTTACGCCACGCCCAGTTTGTAGTGAGCCAGGTAGAGAGTTACGA 1904 
                ********* ** *** * ** ** ** ***** ** ***   ** ** ******** ** 
 
Bovine          TCGGGCTGGGGACAGTGACGAGCAGCCCATCTTCCTGAGCCCCTGCATGAGAGACCTCAT 1751 
Human           CGAGGCCGGGGACAGTGATGAGCAGCCCATCTTCCTGACGCCCTGCATGCGGGACCTGAT 1991 
Mouse           CGAAGCCAAGGACGATGATGAGACCCCCATCTTCTTGTCTCCCTGTATGAGAGCCCTGAT 1964 
                    **   ****  *** ***   ********* **   ***** *** * * *** ** 
 
Bovine          CAAGCTGGCCGGGGTCACCCTGGGAAAAAGGCGAGCCGAG---AGGCGGCAGACCATCCG 1808 
Human           CAAGCTGGCTGGGGTCACGCTGGGACAGAGGCGAGCCCAGGCGAGGCGGCAGACCATCAG 2051 
Mouse           CCATTTGGCTGGTGTCTCCCTGGGACAGAGGCGAGCAACA---AGGCG------CGTCAT 2015 
                * *  **** ** *** * ****** * ********       *****      * **   
 
Bovine          GCAACCCGCCAAAGAGAAGGACAAGGGCCCCACCAAGGCCACCACCACCAAGCTGGTCTA 1868 
Human           GCATTCTACCAGGGAGAAGGACAGGGGACCCACGAAAGCCACCACCACCAAGCTGGTCTA 2111 
Mouse           GGGTGCTACCAAGGAGAAGGACAAAGCACCCACGAAAGCCACCACCACCAAGCTGGTCTA 2075 
                *    *  ***  **********  *  ***** ** *********************** 
 
Bovine          CCAGATCTTTGACACTTTCTTTGCGGAGCAAATTGAAAAAGATGACAAGGAAGACAAGGA 1928 
Human           CCAGATCTTCGATACTTTCTTCGCAGAGCAAATTGAAAAGGATGACAGAGAAGACAAGGA 2171 
Mouse           TCAGATCTTTGACACTTTCTTCTCAGAGCAGATTGAGAAGTATGATAAGGAGGACAAGGA 2135 
                 ******** ** ********  * ***** ***** **  **** *  ** ******** 
 
Bovine          GAATGCCTTCAAGCGCCGGCGCTGTGGCGTCTGTGAGATTTGTCAACAGCCCGAGTGTGG 1988 
Human           GAACGCCTTTAAGCGCCGGCGATGTGGCGTCTGTGAGGTGTGTCAGCAGCCTGAGTGTGG 2231 
Mouse           GAATGCCATGAAGCGCCGCCGCTGTGGTGTCTGTGAGGTCTGTCAGCAGCCTGAGTGTGG 2195 
                *** *** * ******** ** ***** ********* * ***** ***** ******** 
 
Bovine          AAAGTGTAAGGCCTGTAAGGATATGGTTAAATTTGGTGGTAGCGGACGGAGCAAGCAGGC 2048 
Human           GAAATGTAAAGCCTGCAAGGACATGGTTAAATTTGGTGGCAGTGGACGGAGCAAGCAGGC 2291 
Mouse           GAAGTGCAAGGCGTGCAAAGATATGGTGAAGTTTGGTGGCACTGGACGGAGTAAGCAGGC 2255 
                 ** ** ** ** ** ** ** ***** ** ******** *  ******** ******** 
 
Bovine          TTGCCAAAAGAGGAGGTGTCCCAACATGGCCATGAAGGAGGCAGACGATGACGAGGAAGT 2108 
Human           TTGCCAAGAGCGGAGGTGTCCCAATATGGCCATGAAGGAGGCAGATGACGATGAGGAAGT 2351 
Mouse           TTGCCTCAAGAGGAGGTGTCCTAACTTGGCGGTGAAGGAGGCAGACGACGATGAAGAGGC 2315 
                *****   ** ********** **  ****  ************* ** ** ** ** *  
 
Bovine          GGATGACAATATTCCAGAGATGCCATCACCCAAAAAGATGCATCAGGGGAAGAAAAAGAA 2168 
Human           CGATGATAACATCCCAGAGATGCCGTCACCCAAAAAAATGCACCAGGGGAAGAAGAAGAA 2411 
Mouse           TGATGATGATGTGTCAGAGATGCCATCACCCAAAAAGCTGCATCAGGGGAAGAAGAAGAA 2375 
                 *****  *  *  ********** ***********  **** *********** ***** 
 
Bovine          GCAGAATAAGAATCGGATCTCTTGGGTTGGCGATGCCGTCAAGACTGACGGGAAGAAGAG 2228 
Human           ACAGAACAAGAATCGCATCTCTTGGGTCGGAGAAGCCGTCAAGACTGATGGGAAGAAGAG 2471 
Mouse           GCAGAACAAGGACCGCATCTCCTGGCTTGGGCAGCCTATGAAGATTGAAGAGAATAGAAC 2435 
                 ***** *** * ** ***** *** * **  *  *  * **** *** * *** *  *  
 
Bovine          TTACTACAAGAAGGTATGCATCGACTCGGAAACCCTGGAAGTGGGGGACTGTGTTTCTGT 2288 
Human           TTACTATAAGAAGGTGTGCATTGATGCGGAAACCCTGGAAGTGGGGGACTGTGTCTCTGT 2531 
Mouse           TTACTATCAGAAGGTGAGCATCGATGAGGAGATGCTAGAGGTGGGCGACTGCGTCTCGGT 2495 
                ******  *******  **** **   *** *  ** ** ***** ***** ** ** ** 
 
Bovine          AATTCCAGACGACTCTTCAAAACCACTGTATCTAGCAAGGGTCACGGCGCTGTGGGAGGA 2348 
Human           TATTCCAGATGATTCCTCAAAACCGCTGTATCTAGCAAGGGTCACGGCGCTGTGGGAGGA 2591 
Mouse           CATTCCAGATGATTCCTCCAAACCACTCTATCTAGCCAGGGTCACAGCTCTGTGGGAAGA 2555 
                 ******** ** ** ** ***** ** ******** ******** ** ******** ** 
 
Bovine          CAGCAGCAATGGGCAGATGTTCCATGCCCACTGGTTCTGTGCTGGGACGGACACGGTCCT 2408 
Human           CAGCAGCAACGGGCAGATGTTTCACGCCCACTGGTTCTGCGCTGGGACAGACACAGTCCT 2651 
Mouse           CAAAAATGGTCAGATGATGTTCCATGCGCACTGGTTCTGCGCTGGGACAGACACAGTCCT 2615 
                **  *       *  ****** ** ** *********** ******** ***** ***** 
 
 
Bovine          CGGGGCCACATCGGACCCCCTGGAGCTGTTCCTGGTTGACGAGTGTGAGGACATGCAGCT 2468 
Human           CGGGGCCACGTCGGACCCTCTGGAGCTGTTCTTGGTGGATGAATGTGAGGACATGCAGCT 2711 
Mouse           GGGAGCCACCTCCGACCCCCTGGAACTGTTCCTGGTGGGCGAGTGCGAAAACATGCAGCT 2675 
                 ** ***** ** ***** ***** ****** **** *  ** ** **  ********** 
 
Bovine          CTCGTACATCCACAGCAAGGTGCAGGTCATTTATAAGGCGCCCTCAGAGAACTGGGCCAT 2528 
Human           TTCATATATCCACAGCAAAGTGAAAGTCATCTACAAAGCCCCCTCCGAAAACTGGGCCAT 2771 
Mouse           TTCCTACATCCACAGCAAGGTCAAGGTCATCTACAAAGCCCCTTCTGAAAACTGGGCCAT 2735 
                 ** ** *********** **  * ***** ** ** ** ** ** ** *********** 
 
Bovine          GGAGGGAGGCGTGGACCCCGAGGCCCTGATGTCAGAGG---ACGACGGGAAGACCTACTT 2585 
Human           GGAGGGAGGCATGGATCCCGAGTCCCTGCTGGAGGGGG---ACGACGGGAAGACCTACTT 2828 
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Mouse           GGAGGGAGGCACAGACCCTGAGACCACACTGCCTGGGGCTGAGGATGGCAAGACTTACTT 2795 
                **********   ** ** *** **    **   * **   * ** ** ***** ***** 
 
Bovine          CTACCAGCTGTGGTACGACCAAGACTACGCGAGATTTGAGTCCCCTCCGAAAACTCAGCC 2645 
Human           CTACCAGCTGTGGTATGATCAAGACTACGCGAGATTCGAGTCCCCTCCAAAAACCCAGCC 2888 
Mouse           CTTCCAGCTCTGGTACAACCAGGAGTACGCAAGGTTTGAATCCCCACCCAAGACCCAGCC 2855 
                ** ****** *****  * ** ** ***** ** ** ** ***** ** ** ** ***** 
 
Bovine          GACGGAGGACAACAAGTACAAGTTCTGCGCAAGCTGTGCACGTCTGGCCGAAATGAGGCA 2705 
Human           AACAGAGGACAACAAGTTCAAATTCTGTGTGAGCTGTGCCCGTCTGGCTGAGATGAGGCA 2948 
Mouse           GACCGAGGACAACAAGCACAAGTTCTGCCTATCTTGTATCCGGCTGGCTGAGCTGAGACA 2915 
                 ** ************  *** *****       ***   ** ***** **  **** ** 
 
Bovine          GAAGGAAATCCCCAGGGTCGTGGAGCAGCTCCAGGACCTGGAAGGCCGCGTCCTCTACAG 2765 
Human           AAAAGAAATCCCCAGGGTCCTGGAGCAGCTCGAGGACCTGGATAGCCGGGTCCTCTACTA 3008 
Mouse           AAAAGAAATGCCCAAGGTCCTGGAACAAATTGAGGAGGTGGATGGCCGGGTCTACTGCAG 2975 
                 ** ***** **** **** **** **  *  ****  ****  **** ***  ** *   
 
Bovine          CCTCGCCACCAAGAACGGCGTCCAGTACCGGGTGGGCGATGGCGTGTACCTCCCTCCCGA 2825 
Human           CTCAGCCACCAAGAACGGCATCCTGTACCGAGTTGGTGATGGTGTGTACCTGCCCCCTGA 3068 
Mouse           TTCCATCACCAAGAATGGTGTTGTCTACCGACTGGGTGACAGTGTGTACCTTCCTCCCGA 3035 
                      ********* **  *    *****  * ** **  * ******** ** ** ** 
 
Bovine          GGCCTTCACCTTCAACATCAAGCTGTCCAGTCCTGTGAAACGCCCCCGGAAGGAGCCTGT 2885 
Human           GGCCTTCACGTTCAACATCAAGCTGTCCAGTCCCGTGAAACGCCCACGGAAGGAGCCCGT 3128 
Mouse           GGCCTTTACTTTCAACATCAAAGTGGCTAGCCCCGTGAAACGCCCAAAGAAGGATCCTGT 3095 
                ****** ** ***********  ** * ** ** ***********   ****** ** ** 
 
Bovine          GGACGAAGCTCTGTATCCAGAACACTACCGGAAGTACTCTGACTACATCAAGGGCAGCAA 2945 
Human           GGATGAGGACCTGTACCCAGAGCACTACCGGAAATACTCCGACTACATCAAAGGCAGCAA 3188 
Mouse           GAACGAGACCCTGTACCCTGAGCACTACCGCAAGTATTCTGACTACATCAAGGGGAGCAA 3155 
                * * **    ***** ** ** ******** ** ** ** *********** ** ***** 
 
Bovine          CCTGGATGCCCCTGAGCCCTACCGTATTGGCCGCATAAAGGAGATCTTCTGCAGCAAGAA 3005 
Human           CCTGGATGCCCCTGAGCCCTACCGAATTGGCCGGATCAAAGAGATCTTCTGTCCCAAGAA 3248 
Mouse           CCTGGATGCTCCAGAGCCCTATCGCATCGGTCGGATAAAAGAGATCCACTGTGGCAAGAA 3215 
                ********* ** ******** ** ** ** ** ** ** ******  ***   ****** 
 
Bovine          GAGCAACGGCCGGCCCAATGAGACAGACATCAAGATCAGGGTCAACAAGTTCTACAGGCC 3065 
Human           GAGCAACGGCAGGCCCAATGAGACTGACATCAAAATCCGGGTCAACAAGTTCTACAGGCC 3308 
Mouse           GA---AAGGCAAGGTCAACGAGGCAGACATCAAGCTGAGGCTCTACAAGTTCTACAGGCC 3272 
                **   * ***  *  *** *** * ********  *  ** ** **************** 
 
Bovine          GGAGAACACACACAAGTCTACCCCAGCCAGTTACCACGCAGACATCAACCTGCTTTACTG 3125 
Human           TGAGAACACCCACAAGTCCACTCCAGCGAGCTACCACGCAGACATCAACCTGCTCTACTG 3368 
Mouse           TGAGAATACCCACAGGTCCTACAACGGATCCTATCACACTGACATCAACATGCTTTACTG 3332 
                 ***** ** **** ***       *     ** *** * ********* **** ***** 
 
Bovine          GAGCGATGAGGAGGCCGTGGTGGACTTCAAGGCCGTGCAGGGCCGCTGCACCGTGGAGTA 3185 
Human           GAGCGACGAGGAGGCCGTGGTGGACTTCAAGGCTGTGCAGGGCCGCTGCACCGTGGAGTA 3428 
Mouse           GAGCGACGAGGAAGCTGTGGTGAACTTCAGCGACGTGCAGGGCCGCTGTACCGTGGAGTA 3392 
                ****** ***** ** ****** ******  *  ************** *********** 
 
Bovine          CGGAGAGGACCTGCCTCAGTGCCTCCAGGACTTCTCCGCTGGTGGCCCCGATCGCTTCTA 3245 
Human           TGGGGAGGACCTGCCCGAGTGCGTCCAGGTGTACTCCATGGGCGGCCCCAACCGCTTCTA 3488 
Mouse           CGGGGAAGACCTACTTGAGAGCATCCAGGATTATTCACAAGGGGGCCCTGACCGCTTCTA 3452 
                 ** ** ***** *   ** ** ******  *  **    ** *****  * ******** 
 
Bovine          TTTTCTCGAGGCCTATAACGCCAAGAGCAAAAGCTTTGAAGATCCTCCGAACCACGCCCG 3305 
Human           CTTCCTCGAGGCCTATAATGCAAAGAGCAAAAGCTTTGAAGATCCTCCCAACCATGCCCG 3548 
Mouse           CTTCCTCGAGGCCTACAATTCAAAGACCAAGAACTTTGAAGACCCACCAAACCATGCCCG 3512 
                 ** *********** **  * **** *** * ********* ** ** ***** ***** 
 
Bovine          GAGCACCGGAAATAAAGGGAAAGGGAAGGGGAAAGGAAAAAACAGGACGAAATCTCAGAC 3365 
Human           TAGCCCTGGAAACAAAGGGAAGGGCAAGGGAAAAGGGAAGGGCAAGCCCAAGTCCCAAGC 3608 
Mouse           CAGCCCTGGGAACAAAGGGAAAGGGAAGGGGAAAGGGAAGGGGAAGGGGAAGCATCAGGT 3572 
                 *** * ** ** ******** ** ***** ***** **    * *   **    **    
 
Bovine          GTGTGAGCCGAGTGAACTGGAGACAGAAATCAAACTGCCGAAGCTGCGGACCCTGGACGT 3425 
Human           CTGTGAGCCGAGCGAGCCAGAGATAGAGATCAAGCTGCCCAAGCTGCGGACCCTGGATGT 3668 
Mouse           GTCAGAGCCCAAAGAGCCTGAGGCAGCCATCAAACTGCCCAAGCTCCGGACCCTGGATGT 3632 
                 *  ***** *  ** *  ***  **  ***** ***** ***** *********** ** 
 
Bovine          GTTTTCCGGCTGTGGGGGATTGTCGGAAGGCTTCCACCAAGCAGGCATCTCGGAAACACT 3485 
Human           GTTTTCTGGCTGCGGGGGGTTGTCGGAGGGATTCCACCAAGCAGGCATCTCTGACACGCT 3728 
Mouse           GTTTTCCGGCTGTGGAGGGTTATCGGAAGGATTCCACCAAGCAGGCATCTCGGAAACGCT 3692 
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                ****** ***** ** ** ** ***** ** ******************** ** ** ** 
 
Bovine          TTGGGCCATCGAGATGTGGGACCCTGCGGCCCAGGCGTTCCGGTTCAACAACCCTGGGTC 3545 
Human           GTGGGCCATCGAGATGTGGGACCCTGCGGCCCAGGCGTTCCGGCTGAACAACCCCGGCTC 3788 
Mouse           GTGGGCCATCGAGATGTGGGACCCGGCAGCCCAGGCATTTCGGCTGAACAACCCCGGCAC 3752 
                 *********************** ** ******** ** *** * ******** **  * 
 
Bovine          CACGGTGTTCACAAAGGACTGCAACGTCCTGGTGAAGCTGGTCATGGCCGGGGAGGTGAC 3605 
Human           CACAGTGTTCACAGAGGACTGCAACATCCTGCTGAAGCTGGTCATGGCTGGGGAGACCAC 3848 
Mouse           CACAGTGTTCACAGAGGACTGCAACGTGCTTCTTAAGCTGGTCATGGCTGGGGAGGTGAC 3812 
                *** ********* *********** * **  * ************** ******   ** 
 
Bovine          CAACTCCCGCGGCCAGAAGCTGCTTCAAAAGGGAGATGTGGAGATGTTGTGCGGCGGGCC 3665 
Human           CAACTCCCGCGGCCAGCGGCTGCCCCAGAAGGGAGACGTGGAGATGCTGTGCGGCGGGCC 3908 
Mouse           CAACTCTCTGGGCCAAAGGCTGCCACAGAAGGGCGATGTGGAGATGCTGTGTGGTGGGCC 3872 
                ****** *  *****   *****  ** ***** ** ********* **** ** ***** 
 
Bovine          GCCCTGCCAGGGCTTTAGCGGCATGAACCGCTTCAACTCTCGAACCTACTCCAAATTCAA 3725 
Human           GCCCTGCCAGGGCTTCAGCGGCATGAACCGCTTCAATTCGCGCACCTACTCCAAGTTCAA 3968 
Mouse           ACCCTGCCAGGGCTTCAGTGGCATGAACCGCTTCAACTCCCGCACTTACTCCAAGTTCAA 3932 
                 ************** ** ***************** ** ** ** ******** ***** 
 
Bovine          GAACTCCCTGGTGGTCTCTTTCCTCAGCTACTGTGACTACTACCGGCCCCGCTACTTCCT 3785 
Human           AAACTCTCTGGTGGTTTCCTTCCTCAGCTACTGCGACTACTACCGGCCCCGGTTCTTCCT 4028 
Mouse           AAACTCCCTAGTGGTCTCCTTCCTCAGCTACTGTGACTACTACCGGCCTCGGTTCTTCCT 3992 
                 ***** ** ***** ** ************** ************** ** * ****** 
 
Bovine          CTTGGAGAACGTTCGGAACTTCGTCTCCTTCAAGCGCTCCATGGTCCTGAAGCTGACGCT 3845 
Human           CCTGGAGAATGTCAGGAACTTTGTCTCCTTCAAGCGCTCCATGGTCCTGAAGCTCACCCT 4088 
Mouse           TCTGGAGAACGTCAGGAACTTCGTGTCCTACAGACGCTCCATGGTGCTGAAGCTCACACT 4052 
                  ******* **  ******* ** **** **  *********** ******** ** ** 
 
Bovine          GCGCTGCCTGGTCCGCAGGGGGTACCAGTGCACCTTTGGCGTGCTGCAGGCTGGTCAGTA 3905 
Human           CCGCTGCCTGGTCCGCATGGGCTATCAGTGCACCTTCGGCGTGCTGCAGGCCGGTCAGTA 4148 
Mouse           GCGCTGCCTGGTCCGCATGGGCTACCAGTGCACCTTTGGTGTGCTCCAGGCTGGACAGTA 4112 
                 **************** *** ** *********** ** ***** ***** ** ***** 
 
Bovine          CGGCGTGGCCCAGACTCGGAGGCGAGCCATCATCCTGGCTGCAGCCCCTGGGGAGCCACT 3965 
Human           CGGCGTGGCCCAGACTAGGAGGCGGGCCATCATCCTGGCCGCGGCCCCTGGAGAGAAGCT 4208 
Mouse           TGGCGTGGCCCAGACACGAAGGAGGGCCATCATCTTGGCTGCAGCCCCAGGAGAAAAGCT 4172 
                 **************  * *** * ********* **** ** ***** ** **    ** 
 
Bovine          CCCGCTGTTCCCGGAGCCGTTGCATGTGTTCGCACCCCGGGCCTGCCAGCTGAGCGTCGT 4025 
Human           CCCTCTGTTCCCGGAGCCACTGCACGTGTTTGCTCCCCGGGCCTGCCAGCTGAGCGTGGT 4268 
Mouse           GCCTCTGTTCCCAGAGCCTCTGCATGTGTTTGCGCCCCGTGCCTGCCAGCTGAGCGTTGT 4232 
                 ** ******** *****  **** ***** ** ***** ***************** ** 
 
Bovine          AGTGGACGACAAGAAGTTTGTCAGCAACATCACCAGGTTGAGCTCGGGTCCCTTCCGAAC 4085 
Human           GGTGGATGACAAGAAGTTTGTGAGCAACATAACCAGGTTGAGCTCGGGTCCTTTCCGGAC 4328 
Mouse           GGTGGATGACAAGAAGTTTGTTAGCAACATAACGAGGCTGAGCTCGGGGCCCTTCCGAAC 4292 
                 ***** ************** ******** ** *** ********** ** ***** ** 
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Bovine          CATCACCGTGCGGGACACCATGTCTGACCTCCCTGAGATCCGGAACGGGGCCTCGGCACT 4145 
Human           CATCACGGTGCGAGACACGATGTCCGACCTGCCGGAGGTGCGGAATGGAGCCTCGGCACT 4388 
Mouse           CATCACCGTGCGAGACACCATGTCTGACCTCCCCGAGATCCAGAATGGAGCCTCGAATTC 4352 
                ****** ***** ***** ***** ***** ** *** * * *** ** ******      
 
Bovine          GGAGATTTCATACAACCGGGAGCCCCAGTCCTGGTTCCAGAGGCAGCTCCGGGGCTCGCA 4205 
Human           GGAGATCTCCTACAACGGGGAGCCTCAGTCCTGGTTCCAGAGGCAGCTCCGGGGCGCACA 4448 
Mouse           TGAGATCCCCTACAATGGAGAGCCACTGTCCTGGTTCCAGAGGCAGCTGCGAGGATCACA 4412 
                 *****  * *****  * ***** * ********************* ** **  * ** 
 
Bovine          GTACCAGCCCATCCTCAGGGATCATATTTGCAAGGACATGAGCGCCTTGGTGGCTGCCCG 4265 
Human           GTACCAGCCCATCCTCAGGGACCACATCTGTAAGGACATGAGTGCATTGGTGGCTGCCCG 4508 
Mouse           CTACCAGCCCATCCTCAGGGACCATATCTGCAAGGACATGAGCCCACTGGTGGCTGCCCG 4472 
                 ******************** ** ** ** ***********  *  ************* 
 
Bovine          CATGCGGCACATCCCCCTGGCCCCGGGCTCGGACTGGCGTGACCTGCCCAACATTGAGGT 4325 
Human           CATGCGGCACATCCCCTTGGCCCCAGGGTCAGACTGGCGCGATCTGCCCAACATCGAGGT 4568 
Mouse           CATGCGGCACATCCCACTGTTCCCAGGATCAGATTGGCGTGACCTGCCCAACATACAGGT 4532 
                ***************  **  *** ** ** ** ***** ** ***********  **** 
 
Bovine          GCGGCTCTCTGACGGCACCCTGGCCCGGAAGCTGCGGTACAACTACCACGACAAGAAGAA 4385 
Human           GCGGCTCTCAGACGGCACCATGGCCAGGAAGCTGCGGTATACCCACCATGACAGGAAGAA 4628 
Mouse           GCGGCTGGGAGATGGCGTCATAGCCCATAAGCTACAGTACACCTTTCATGATGTGAAAAA 4592 
                ******    ** ***  * * ***   ***** * *** * *   ** **   *** ** 
 
Bovine          CGGCTGCAGCAGCAGCGGCGCCCTCCGTGGGGTCTGCTCCTGTGTGGAAG---GCAAGCC 4442 
Human           CGGCCGCAGCAGCTCTGGGGCCCTCCGTGGGGTCTGCTCCTGCGTGGAAGCCGGCAAAGC 4688 
Mouse           TGGCTACAGCAGCACCGGTGCCCTGCGTGGAGTCTGTTCCTGTGCAGAAG---GCAAGGC 4649 
                 ***  *******   ** ***** ***** ***** ***** *  ****   ****  * 
 
Bovine          CTGTGAGCCTGCGGCCCGACAGTTTAACACCCTTATCCCCTGGTGCCTGCCCCACACTGG 4502 
Human           CTGCGACCCCGCAGCCAGGCAGTTCAACACCCTCATCCCCTGGTGCCTGCCCCACACCGG 4748 
Mouse           CTGCGACCCTGAGTCCAGGCAATTCAGCACCCTCATCCCCTGGTGCCTGCCGCACACTGG 4709 
                *** ** ** *   ** * ** ** * ****** ***************** ***** ** 
 
Bovine          GAACAGGCACAACCACTGGGCCGGCCTCTACGGGCGTCTCGAGTGGGACGGCTTCTTCAG 4562 
Human           GAACCGGCACAACCACTGGGCTGGCCTCTATGGAAGGCTCGAGTGGGACGGCTTCTTCAG 4808 
Mouse           GAACCGGCACAACCACTGGGCTGGCCTCTACGGGCGTCTGGAGTGGGATGGCTTCTTCAG 4769 
                **** **************** ******** **  * ** ******** *********** 
 
Bovine          CACAACTGTCACCAACCCCGAGCCCATGGGCAAGCAGGGCCGCGTGCTCCACCCCGAGCA 4622 
Human           CACAACCGTCACCAACCCCGAGCCCATGGGCAAGCAGGGCCGCGTGCTCCACCCAGAGCA 4868 
Mouse           CACCACTGTCACCAACCCTGAGCCCATGGGCAAGCAGGGTCGGGTGCTCCACCCGGAGCA 4829 
                *** ** *********** ******************** ** *********** ***** 
 
Bovine          GCACCGAGTGGTGAGCGTCCGGGAGTGCGCCCGCTCCCAGGGCTTCCCCGACACCTATCG 4682 
Human           GCACCGTGTGGTGAGCGTGCGGGAGTGTGCCCGCTCCCAGGGCTTCCCTGACACCTACCG 4928 
Mouse           GCACCGGGTCGTGAGTGTTCGGGAATGTGCCCGCTCCCAGGGCTTTCCAGATAGCTACCG 4889 
                ****** ** ***** ** ***** ** ***************** ** ** * *** ** 
 
Bovine          GCTGTTCGGCAACATCCTAGACAAGCACCGGCAGGTGGGTAATGCTGTGCCGCCGCCACT 4742 
Human           GCTCTTCGGCAACATCCTGGACAAGCACCGGCAGGTGGGCAATGCCGTGCCACCGCCCCT 4988 
Mouse           GTTCTTCGGCAACATCCTGGACAGACACCGGCAGGTGGGTAATGCTGTGCCACCACCCCT 4949 
                * * ************** ****  ************** ***** ***** ** ** ** 
 
Bovine          GGCCAAAGCCATCGGCTTGGAGATCAAGCGCTGCATGTTGGCCAAAGCGCGCGAGAGCGC 4802 
Human           GGCCAAAGCCATTGGCTTGGAGATCAAGCTTTGTATGTTGGCCAAAGCCCGAGAGAGTGC 5048 
Mouse           GGCCAAAGCCATTGGCCTGGAGATTAAGCTCTGCCTGCTGTCCAGTGCTCGGGAGAGCGC 5009 
                ************ *** ******* ****  **  ** ** ***  ** ** ***** ** 
 
Bovine          CTCAGCT------AAAATCAAGGAGGAGG---CTGCCAAGGACTAGTTCTCTCCTCCTAT 4853 
Human           CTCAGCT------AAAATAAAGGAGGAGGAAGCTGCTAAGGACTAGTTCTGCCCTCCCGT 5102 
Mouse           ATCAGCTGCAGTTAAAGCAAAAGAGGAGGCTGCTACCAAGGACTAG-------------- 5055 
                 ******      ***   ** *******   ** * *********               
 
Bovine          CACCCATGTTTCTGCCACCAGAGATCCCCAACGTGCACTGATATTGGTGTATTTTTCACA 4913 
Human           CACCCCTGTTTCTGGCACCAGGAATCCCCAACATGCACTGATGTTG---TGTTTTTAACA 5159 
Mouse           ------------------------------------------------------------ 
 
Human NM_001379  Mouse NM_010066 
 
Bovine DNMT2 
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Bovine Dnmt2 Complete CDS 
 
Green = Start Site Red = Stop Codon 
 
CCGGGGGGCGGCGCGGGAATGGAGCCCTTGCGGGCCCTGGAGCTATACAGC
GGAATTGGGGGCATGCACCAGGCTCTCAGAGAAAGCTGTATACCTGCACAA
GTGGTGGCTGCTGTTGATGTAAACACTGTTGCTAATGAAGTATACAAGTATA
ATTTTCCTCACACACAGTTACTGGCCAAGACAATTGAAGGCATTACACTAGA
AGAGTTTGACAGATTATCTTTCAATATGATTTTAATGAGCCCACCCTGTCAGC
CCTTCACAAGAATTGGCCTGCAAGGTGATGTGACTGATCCAAGGACAAATA
GCTTCTTACATATTCTAGACATTCTCCCAAGATTACAAAAATTACCGAAGTA
TATTCTTTTAGAAAACGTTAAAGGTTTTGAAATGTCTTCTACAAGAGATCTGT
TAATACAAACAATAGAAAATTGTGGTTTTCAGTATCAAGAATTTCTACTGTC
TCCAACCTCTCTTGGCATTCCAAATTCAAGATTACGGTACTTCCTTATTGCAA
AGCTTCAGCCAGAGCCATTCCCTTTTCAGGCCCCTGGTCAGGTACTGATGGA
GTTCCCCAAAACTGAATCTGAACATCCCCCTAAATATGCAATAAATGCAGAA
AAGAAAACTGAAGAAAAGAAAACTGGACCAAAGATTTGCTTTGATAGCAGC
ACACAGTGTTCTGGAAAAGAGGCCATTCTTTTTAAGCTTGAAACTGCAGGAG
AAATTGACAGGAAACATCAACAGGACAGCGATCTCTCTGTGCGAATGCTAA
AAGATTTTCTTGAAGATGACATTGACAAGCATTCATTCTTTTTACCACCAAA
GTCATTACTGCGATACGCTCTTTTGTTAGACATTGTTAAACCCACTTCCAGAA
GATCCATGTGCTTTACAAAAGGTTATGGACGCTACATAGAAGGGACAGGAT
CTGTGTTACAGACAACAGAGGATGTGCAGATTGAGAATATCTACAAATCCCT
TACCAGTTTGTCACAAGAAGAAAAGATAATGAGATTGTCAATGCTTCAACTT
CGATTTTTCACTCCTAAAGAAATAGCAAATCTCCTTGGATTTCCTCCAGAGTT
TGGATTTCCTGAGATGACAACTGTCAAACAGCGTTACCGTCTACTTGGAAAT
AGTCTCAACGTGCATGTTGTAGCTAAACTAATCAAAATCCTATGTGACTAAT
TTTTTAAATAACTCTGAAAGAGGGTCACAGTTTTCTGTCATATCCATATAGTA
ACTTTGAAATTCTTTTTTGAATTAATTTTGACAAAATTTGACTAAATTATTTTT
CTCTTTAATAAGA 
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Bovine DNMT2 Protein Sequence 
 
MEPLRALELYSGIGGMHQALRESCIPAQVVAAVDVNTVANEMEPLRALELYS
GIGGMHQALRESCIPAQVVAAVDVNTVANEVYKYNFPHTQLLAKTIEGITLEEF
DRLSFNMILMSPPCQPFTRIGLQGDVTDPRTNSFLHILDILPRLQKLPKYILLE
NVKGFEMSSTRDLLIQTIENCGFQYQEFLLSPTSLGIPNSRLRYFLIAKLQPEPF
PFQAPGQVLMEFPKTESEHPPKYAINAEKKTEEKKTGPKICFDSSTQCSGKEAILF
KLETAGEIDRKHQQDSDLSVRMLKDFLEDDXDKHSFFLPPKSLLRYALLLDIVK
PTSRRSMCFTKGYGRYIEGTGSVLQTTEDVQIENIYKSLTSLSQEEKIMRLSMLQ
LRFFTPKEIANLLGFPPEFGFPEMTTVKQRYRLLGNSLNVHVVAKLIKILCD* 
 
Bold sequence = Methyltransferase Domains I, II, IV, V VI, VII, VIII, IX, X 
respectively. 
 
 
 
Sequence Allignment 
 
Bovine          -CCGGGGGGCGGCGCGGGAATGGAGCCCTTGCGGGCCCTGGAGCTATACAGCGGAATTGG 59 
Human           ------------CGCGGGGATGGAGCCCCTGCGGGTGCTGGAGCTATACAGCGGCGTGGG 48 
Mouse           CGGTCGCGGTTGCGAGAGGATGGAACCTCTGCGTGTCCTGGAGCTGTACAGTGGCATTGG 60 
                            ** * * ***** **  **** *  ******** ***** **  * ** 
 
Bovine          GGGCATGCACCAGGCTCTCAGAGAAAGCTGTATACCTGCACAAGTGGTGGCTGCTGTTGA 119 
Human           CGGCATGCACCACGCGCTGAGAGAAAGCTGTATACCTGCACAAGTGGTGGCTGCCATTGA 108 
Mouse           TGGCATGCACCACGCGCTGCGAGAAAGTCATATCCCTGCACATGTGGTGGCTGCTATTGA 120 
                 *********** ** **  *******   *** ******** ***********  **** 
 
Bovine          TGTAAACACTGTTGCTAATGAAGTATACAAGTATAATTTTCCTCACACACAGTTACTGGC 179 
Human           TGTCAACACTGTCGCTAATGAAGTATACAAGTATAATTTTCCTCACACACAGTTACTTGC 168 
Mouse           TGTGAATACTGTTGCTAATGAAGTATACAAGCATAATTTTCCTCATACTCACTTACTGTC 180 
                *** ** ***** ****************** ************* ** ** *****  * 
 
Bovine          CAAGACAATTGAAGGCATTACACTAGAAGAGTTTGACAGATTATCTTTCAATATGATTTT 239 
Human           CAAGACGATTGAAGGCATTACACTCGAAGAGTTTGACAGATTATCTTTTGATATGATTTT 228 
Mouse           AAAGACAATTGAAGGTATTTCACTGGAAGACTTTGACAAGCTATCTTTCAATATGATTTT 240 
                 ***** ******** *** **** ***** *******   *******  ********** 
 
Bovine          AATGAGCCCACCCTGTCAGCCCTTCACAAGAATTGGCCTGCAAGGTGATGTGACTGATCC 299 
Human           AATGAGCCCTCCCTGCCAGCCATTCACAAGGATTGGCCGGCAGGGTGATATGACTGATTC 288 
Mouse           AATGAGCCCTCCATGCCAGCCATTCACAAGAATTGGCCTACAGGGGGATATGACCGATCC 300 
                ********* ** ** ***** ******** *******  ** ** *** **** *** * 
 
Bovine          AAGGACAAATAGCTTCTTACATATTCTAGACATTCTCCCAAGATTACAAAAATTACCGAA 359 
Human           AAGGACGAATAGCTTCTTACATATTCTAGATATTCTCCCAAGATTACAAAAATTACCAAA 348 
Mouse           AAGGACAACTAGCTTCTTGTATATTCTAGATATTCTCCCAAGATTACAAAAATTACCCAA 360 
                ****** * *********  ********** ************************** ** 
 
Bovine          GTATATTCTTTTAGAAAACGTTAAAGGTTTTGAAATGTCTTCTACAAGAGATCTGTTAAT 419 
Human           GTATATTCTTTTGGAAAATGTTAAAGGTTTTGAAGTATCTTCTACAAGAGACCTCTTGAT 408 
Mouse           GTATATTCTCTTAGAAAATGTCAAAGGTTTTGAAGTATCTTCTACAAGAGGGCTGCTGAT 420 
                ********* ** ***** ** ************ * *************  **  * ** 
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Bovine          ACAAACAATAGAAAATTGTGGTTTTCAGTATCAAGAATTTCTACTGTCTCCAACCTCTCT 479 
Human           ACAAACAATAGAAAATTGTGGCTTTCAGTACCAAGAATTTCTATTATCTCCAACCTCTCT 468 
Mouse           ACAAACAATAGAAGCCTGTGGCTTTCAGTATCAAGAGTTTCTATTGTCTCCTTCTTCTCT 480 
                *************   ***** ******** ***** ****** * *****  * ***** 
 
Bovine          TGGCATTCCAAATTCAAGATTACGGTACTTCCTTATTGCAAAGCTTCAGCCAGAGCCATT 539 
Human           TGGCATTCCAAATTCAAGGCTACGATATTTTCTTATTGCAAAGCTTCAGTCAGAGCCATT 528 
Mouse           AGGCATTCCAAACTCGAGGCTCCGATATTTTCTCATTGCAAAGCTTCAGTCAGAGCCTTT 540 
                 *********** ** **  * ** ** ** ** *************** ******* ** 
 
Bovine          CCCTTTTCAGGCCCCTGGTCAGGTACTGATGGAGTTCCCCAAAACTGAATCTGAACATCC 599 
Human           ACCCTTTCAAGCCCCTGGTCAGGTACTGATGGAGTTCCCCAAAATTGAATCTGTACATCC 588 
Mouse           CCCCTTCCAGGCCCCTGGACAGATACTGATGGAGTTTCCTAAAATTGTAACTGTTGAGCC 600 
                 ** ** ** ******** *** ************* ** **** ** * ***   * ** 
 
Bovine          CCCTAAATATGCAATAAATGCAGAAAAGAAAACTGAAGAAAAGAAAACTGGACCAAAGAT 659 
Human           ACAAAAATATGCAATGGATGTAGAAAATAAAATTCAAGAAAAGAACGTTGAACCAAATAT 648 
Mouse           ACAAAAATATGCAGTAGTTGAAGAAAGTCAGCCAAGAGTGCAGAGAACTGGACCACGTAT 660 
                 *  ********* *   ** *****   *      **   ***    ** ****   ** 
 
Bovine          TTGCTTTGA---TAGCAGCACACAGTGTTCTGGAAAAGAGGCCATTCTTTTTAAGCTTGA 716 
Human           TAGCTTTGA---TGGCAGCATACAGTGTTCTGGAAAAGATGCCATTCTTTTTAAGCTTGA 705 
Mouse           CTGTGCTGAGAGCAGCAGCACACAGAGTTCTGGAAAAGATACCATTCTCTTTAAGCTTGA 720 
                  *   ***     ****** **** *************  ******* *********** 
 
Bovine          AACTGCAGGAGAAATTGACAGGAAACATCAACAGGACAGCGATCTCTCTGTGCGAATGCT 776 
Human           AACTGCAGAAGAAATTCACAGGAAAAATCAACAAGATAGTGATCTCTCTGTGAAAATGCT 765 
Mouse           GACTGTAGAAGAAAGGGACAGGAAACATCAACAAGACAGTGACCTCTCTGTGCAGATGCT 780 
                 **** ** *****   ******** ******* ** ** ** *********   ***** 
 
Bovine          AAAAGATTTTCTTGAAGATGACATTGACAAGCATTCATTCTTTTTACCACCAAAGTCATT 836 
Human           AAAAGATTTTCTTGAAGATGACACTGACGTGAACCAGTATCTTTTACCACCAAAGTCATT 825 
Mouse           GAAAGACTTCCTTGAAGATGGC---GACACAGATGAGTACCTTTTACCACCCAAGTTATT 837 
                 ***** ** ********** *   ***    *    *   ********** **** *** 
 
Bovine          ACTGCGATACGCTCTTTTGTTAGACATTGTTAAACCCACTTCCAGAAGATCCATGTGCTT 896 
Human           GCTGCGATATGCTCTTCTGTTAGACATTGTTCAGCCCACTTGTAGAAGGTCCGTGTGCTT 885 
Mouse           GCTGCGATACGCTCTCTTACTAGATATCGTGAAGCCCACGTCCAGAAGGTCCATGTGCTT 897 
                 ******** *****  *  **** ** **  * ***** *  ***** *** ******* 
 
Bovine          TACAAAAGGTTATGGACGCTACATAGAAGGGACAGGATCTGTGTTACAGACAACAGAGGA 956 
Human           TACCAAAGGATATGGAAGCTACATAGAAGGGACAGGGTCTGTGTTACAGACTGCAGAGGA 945 
Mouse           TACGAAAGGGTATGGGAGTTACATAGAGGGGACAGGCTCCGTGTTACAGGCTGCAGAGGA 957 
                *** ***** *****  * ******** ******** ** ********* *  ******* 
 
Bovine          TGTGCAGATTGAGAATATCTACAAATCCCTTACCAGTTTGTCACAAGAAGAAAAGATAAT 1016 
Human           TGTGCAGGTTGAGAATATCTACAAATCCCTTACCAATTTGTCACAAGAAGAACAGATAAC 1005 
Mouse           TGCGCAGATTGAGAATATCTACAAATCTCTTCCTGATTTGCCACCAGAAGAAAAGATAGC 1017 
                ** **** ******************* *** *   **** *** ******* *****   
 
Bovine          GAGATTGTCAATGCTTCAACTTCGATTTTTCACTCCTAAAGAAATAGCAAATCTCCTTGG 1076 
Human           AAAGCTGTTAATACTTAAACTGCGATATTTCACTCCTAAAGAAATAGCAAATCTCCTTGG 1065 
Mouse           TAAATTGTCAATGCTTAAACTGCGATATTTCACACCGAAAGAAATTGCAAATCTCCAGGG 1077 
                 *   *** *** *** **** **** ****** ** ******** **********  ** 
 
Bovine          ATTTCCTCCAGAGTTTGGATTTCCTGAGATGACAACTGTCAAACAGCGTTACCGTCTACT 1136 
Human           ATTTCCTCCAGAGTTCGGATTTCCTGAGAAGATAACAGTGAAACAGCGTTATCGCCTACT 1125 
Mouse           ATTTCCTCCAGAATTTGGGTTTCCTGAGAAGACAACAGTGAAACAGCGTTACCGGCTGCT 1137 
                ************ ** ** ********** ** *** ** *********** ** ** ** 
 
Bovine          TGGAAATAGTCTCAACGTGCATGTTGTAGCTAAACTAATCAAAATCCTATGTGACTAATT 1196 
Human           TGGAAATAGTCTCAACGTGCATGTAGTAGCTAAACTAATCAAAATCTTATATGAATAATT 1185 
Mouse           TGGCAATAGCCTCAACGTGCATGTGGTAGCAAAACTCCTCACAGTCCTGTGTGAAGGATT 1197 
                *** ***** ************** ***** *****  *** * ** * * ***   *** 
 
Bovine          TTTTAAATAACTCTGAAAGAGGGTCACA--GTTTTCTGTCATATCCATATAGTAACTTTG 1254 
Human           TTG-AAATAACTCTGAAAGATGGTCATATGATATTCCTTCATTTTCAGAGAGTAATTCTG 1244 
Mouse           TGG-AAATGCCTCTGAGAGCTG-TCACA--AGATGCCGCTAATTCTAGATAGTAATTCCA 1253 
                *   ****  ****** **  * *** *     * *    *  *  * * ***** *    
 
Bovine          AAATTCTTTTTTGAATTAATTTTGACAAAATTTGACTAAATTATTTT-------CTCTCT 1306 
Human           AAATTCTGTTTTGAACTAATTCTGGTGAAATTTAACTAAATTATTTTAAT----CTGTCC 1300 
Mouse           AGATTCTATCTTGAATGAATTCTTATAGAGTTCAGCTAAATTCTTTGAATAGCATTTTCC 1313 
                * ***** * *****  **** *     * **   ******* ***         * **  
 
Bovine          TTAATAAGA--------------------------------------------------- 1315 
 139
Human           TTATTAAGAAATTTGGATTTTATTAAAAAAATCCATGTGTTTCATCAAATTTATATTACT 1360 
Mouse           TGGGTAATTCAGCAGGAACTTAAATGTGTACATCCAATTGTCCCTCACATTTATGTCACT 1373 
                *   ***                                                                                    
 
Human AF012128 
Mouse AF012129 
 140
Bovine DNMT3b Protein Sequence 
 
MKGVDSLINEDKHANRREDSVITDGAVIAQCCDSKQSPSPRILQSISTLE 
IIGARGVRGRRSSSRLSKREVSSLLSYTQDLTGDGDGEGEDGDGSDTPVM 
PKLFRETRTRSESPAVRTRNNSSTSTRERHRPSLRSTQGRQARNHVDESP 
VAFSTTRSLRRRTGSSAGTPWPSPASPYLTIDLTDEDVVPQSSSTPYARL 
GQDSQQESMESSQLDADGRDADSTEYQDGKEFGIGDLVSCGGKIKGFSWW 
PAMVVSWKATSKRQAMSGMRWVQWFGDGKFSEIPADKLVALGLFSQHFNL 
ATFNKLVSYRKAMYHALEKARIRAGKMFPSSPGDSLEDQLKPMLEWAHGG 
FKPTGVEGLKPNNKQPENKTRRRTADDSATSDYCPPPKRLKTNCYNNGKD 
RGEEDQSREQMASDVASNKGNLEDSCLSCGRKNPVSFHPLFEGGLCQTCR 
DRFLELFYMYDDDGYQSYCTVCCEGRELLLCSNTSCCRCFCVECLEVLVG 
AGTAAEAKLQEPWSCYMCLPQRCHGILRRRKDWSVRLQAFFTSDPGLEYE 
APKLYPAIPANRRRPIRVLSLFDGIATGYLVLKELGIKVEKYVASEVCEE 
SIAVGTVKHEGNIKYVNDVRNITKKNIEEWGPFDLVIGGSPCNDLSNVNP 
ARKGLYEGTGRLFFEFYHLLNYTRPKEGEDRPFFWMFENVVAMKVGDKRD 
ISRFLECNPVMIDAIKVSAAHRARYFWGNLPGMNRPVIASKNDKLELQDC 
LEFNRTAKLKKVQTITTKSNSIRQGKNQLFPVVMNGKEDVLWCTELERIF 
GFPVHYTDVSNMGRVARQKLLGRSWR 
 
 
 
Bovine Dnmt3b Isoform Sequence Allignment 
 
DNMT3b5         GNNTGAAGTAAGCATGAAGGGAGTCGACAGCCTAATCAATGAAGACAAGCACGCCAACAG 60 
DNMT3b3         GNNTGAAGTAAGCATGAAGGGAGTCGACAGCCTAATCAATGAAGACAAGCACGCCAACAG 60 
DNMT3b1         GNNTGAAGTAAGCATGAAGGGAGTCGACAGCCTAATCAATGAAGACAAGCACGCCAACAG 60 
DNMT3b4         GNNTGAAGTAAGCATGAAGGGAGTCGACAGCCTAATCAATGAAGACAAGCACGCCAACAG 60 
                ************************************************************ 
 
DNMT3b5         AAGGGAAGACTCCGTCATCACCGACGGGGCCGTCATCGCCCAGTGTTGTGACTCCAAGCA 120 
DNMT3b3         AAGGGAAGACTCCGTCATCACCGACGGGGCCGTCATCGCCCAGTGTTGTGACTCCAAGCA 120 
DNMT3b1         AAGGGAAGACTCCGTCATCACCGACGGGGCCGTCATCGCCCAGTGTTGTGACTCCAAGCA 120 
DNMT3b4         AAGGGAAGACTCCGTCATCACCGACGGGGCCGTCATCGCCCAGTGTTGTGACTCCAAGCA 120 
                ************************************************************ 
 
DNMT3b5         GTCTCCTTCACCCCGGATCCTGCAGTCTATCAGCACCCTGGAGATCATAGGTGCCCGAGG 180 
DNMT3b3         GTCTCCTTCACCCCGGATCCTGCAGTCTATCAGCACCCTGGAGATCATAGGTGCCCGAGG 180 
DNMT3b1         GTCTCCTTCACCCCGGATCCTGCAGTCTATCAGCACCCTGGAGATCATAGGTGCCCGAGG 180 
DNMT3b4         GTCTCCTTCACCCCGGATCCTGCAGTCTATCAGCACCCTGGAGATCATAGGTGCCCGAGG 180 
                ************************************************************ 
 
DNMT3b5         TGTCAGAGGCCGCAGATCAAGCTCACGACTGTCCAAGAGGGAGGTCTCCAGCCTGCTAAG 240 
DNMT3b3         TGTCAGAGGCCGCAGATCAAGCTCACGACTGTCCAAGAGGGAGGTCTCCAGCCTGCTAAG 240 
DNMT3b1         TGTCAGAGGCCGCAGATCAAGCTCACGACTGTCCAAGAGGGAGGTCTCCAGCCTGCTAAG 240 
DNMT3b4         TGTCAGAGGCCGCAGATCAAGCTCACGACTGTCCAAGAGGGAGGTCTCCAGCCTGCTAAG 240 
                ************************************************************ 
 
DNMT3b5         TTATACTCAGGACCTGACGGGTGATGGAGATGGCGAGGGAGAAGACGGGGATGGCTCCGA 300 
DNMT3b3         TTATACTCAGGACCTGACGGGTGATGGAGATGGCGAGGGAGAAGACGGGGATGGCTCCGA 300 
DNMT3b1         TTATACTCAGGACCTGACGGGTGATGGAGATGGCGAGGGAGAAGACGGGGATGGCTCCGA 300 
DNMT3b4         TTATACTCAGGACCTGACGGGTGATGGAGATGGCGAGGGAGAAGACGGGGATGGCTCCGA 300 
                ************************************************************ 
 
DNMT3b5         CACTCCAGTGATGCCAAAGCTCTTCCGAGAAACCAGGACTCGGTCTGAAAGCCCAGCTGT 360 
DNMT3b3         CACTCCAGTGATGCCAAAGCTCTTCCGAGAAACCAGGACTCGGTCTGAAAGCCCAGCTGT 360 
DNMT3b1         CACTCCAGTGATGCCAAAGCTCTTCCGAGAAACCAGGACTCGGTCTGAAAGCCCAGCTGT 360 
DNMT3b4         CACTCCAGTGATGCCAAAGCTCTTCCGAGAAACCAGGACTCGGTCTGAAAGCCCAGCTGT 360 
                ************************************************************ 
 141
 
DNMT3b5         CCGAACCCGAAATAACAGCAGTACCTCCACCCGGGAGAGGCACAGGCCCTCCCTACGTTC 420 
DNMT3b3         CCGAACCCGAAATAACAGCAGTACCTCCACCCGGGAGAGGCACAGGCCCTCCCTACGTTC 420 
DNMT3b1         CCGAACCCGAAATAACAGCAGTACCTCCACCCGGGAGAGGCACAGGCCCTCCCTACGTTC 420 
DNMT3b4         CCGAACCCGAAATAACAGCAGTACCTCCACCCGGGAGAGGCACAGGCCCTCCCTACGTTC 420 
                ************************************************************ 
 
DNMT3b5         CACCCAAGGCCGGCAGGCCCGCAACCACGTGGATGAATCCCCTGTGGCGTTCTCAACTAC 480 
DNMT3b3         CACCCAAGGCCGGCAGGCCCGCAACCACGTGGATGAATCCCCTGTGGCGTTCTCAACTAC 480 
DNMT3b1         CACCCAAGGCCGGCAGGCCCGCAACCACGTGGATGAATCCCCTGTGGCGTTCTCAACTAC 480 
DNMT3b4         CACCCAAGGCCGGCAGGCCCGCAACCACGTGGATGAATCCCCTGTGGCGTTCTCAACTAC 480 
                ************************************************************ 
 
DNMT3b5         CAGGTCCCTGAGGCGAAGGACGGGATCCTCTGCAGGCACGCCATGGCCGTCCCCCGCCAG 540 
DNMT3b3         CAGGTCCCTGAGGCGAAGGACGGGATCCTCTGCAGGCACGCCATGGCCGTCCCCCGCCAG 540 
DNMT3b1         CAGGTCCCTGAGGCGAAGGACGGGATCCTCTGCAGGCACGCCATGGCCGTCCCCCGCCAG 540 
DNMT3b4         CAGGTCCCTGAGGCGAAGGACGGGATCCTCTGCAGGCACGCCATGGCCGTCCCCCGCCAG 540 
                ************************************************************ 
 
DNMT3b5         CCCCTACCTCACCATCGACCTCACAGACGAGGATGTGGTGCCGCAGAGCAGCAGCACGCC 600 
DNMT3b3         CCCCTACCTCACCATCGACCTCACAGACGAGGATGTGGTGCCGCAGAGCAGCAGCACGCC 600 
DNMT3b1         CCCCTACCTCACCATCGACCTCACAGACGAGGATGTGGTGCCGCAGAGCAGCAGCACGCC 600 
DNMT3b4         CCCCTACCTCACCATCGACCTCACAGACGAGGATGTGGTGCCGCAGAGCAGCAGCACGCC 600 
                ************************************************************ 
 
DNMT3b5         CTACGCCCGCCTGGGCCAGGACAGCCAGCAGGAGAGCATGGAGTCCTCGCAGCTGGACGC 660 
DNMT3b3         CTACGCCCGCCTGGGCCAGGACAGCCAGCAGGAGAGCATGGAGTCCTCGCAGCTGGACGC 660 
DNMT3b1         CTACGCCCGCCTGGGCCAGGACAGCCAGCAGGAGAGCATGGAGTCCTCGCAGCTGGACGC 660 
DNMT3b4         CTACGCCCGCCTGGGCCAGGACAGCCAGCAGGAGAGCATGGAGTCCTCGCAGCTGGACGC 660 
                ************************************************************ 
 
 
DNMT3b5         AGACGGCAGAGATGCAGACAGCACTGAGTATCAGGATGGGAAGGAGTTTGGAATAGGAGA 720 
DNMT3b3         AGACGGCAGAGATGCAGACAGCACTGAGTATCAGGATGGGAAGGAGTTTGGAATAGGAGA 720 
DNMT3b1         AGACGGCAGAGATGCAGACAGCACTGAGTATCAGGATGGGAAGGAGTTTGGAATAGGAGA 720 
DNMT3b4         AGACGGCAGAGATGCAGACAGCACTGAGTATCAGGATGGGAAGGAGTTTGGAATAGGAGA 720 
                ************************************************************ 
 
DNMT3b5         TCTTGTGTCGTGTGGGGGAAAGATCAAGGGTTTCTCCTGGTGGCCTGCCATGGTGGTGTC 780 
DNMT3b3         TCTTGTGTCGTGTGGGGGAAAGATCAAGGGTTTCTCCTGGTGGCCTGCCATGGTGGTGTC 780 
DNMT3b1         TCTTGTGTCGTGTGGGGGAAAGATCAAGGGTTTCTCCTGGTGGCCTGCCATGGTGGTGTC 780 
DNMT3b4         TCTTGTGTCGTGTGGGGGAAAGATCAAGGGTTTCTCCTGGTGGCCTGCCATGGTGGTGTC 780 
                ************************************************************ 
 
DNMT3b5         CTGGAAGGCCACCTCCAAGCGGCAGGCAATGTCTGGCATGCGGTGGGTCCAGTGGTTTGG 840 
DNMT3b3         CTGGAAGGCCACCTCCAAGCGGCAGGCAATGTCTGGCATGCGGTGGGTCCAGTGGTTTGG 840 
DNMT3b1         CTGGAAGGCCACCTCCAAGCGGCAGGCAATGTCTGGCATGCGGTGGGTCCAGTGGTTTGG 840 
DNMT3b4         CTGGAAGGCCACCTCCAAGCGGCAGGCAATGTCTGGCATGCGGTGGGTCCAGTGGTTTGG 840 
                ************************************************************ 
 
DNMT3b5         TGATGGCAAGTTCTCCGAGATTCCAGCAGATAAGTTGGTGGCATTGGGATTGTTCAGCCA 900 
DNMT3b3         TGATGGCAAGTTCTCCGAGATTCCAGCAGATAAGTTGGTGGCATTGGGATTGTTCAGCCA 900 
DNMT3b1         TGATGGCAAGTTCTCCGAGATTCCAGCAGATAAGTTGGTGGCATTGGGATTGTTCAGCCA 900 
DNMT3b4         TGATGGCAAGTTCTCCGAGATTCCAGCAGATAAGTTGGTGGCATTGGGATTGTTCAGCCA 900 
                ************************************************************ 
 
 142
DNMT3b5         GCACTTTAACTTGGCGACCTTCAATAAGCTGGTCTCTTACAGGAAGGCCATGTACCATGC 960 
DNMT3b3         GCACTTTAACTTGGCGACCTTCAATAAGCTGGTCTCTTACAGGAAGGCCATGTACCATGC 960 
DNMT3b1         GCACTTTAACTTGGCGACCTTCAATAAGCTGGTCTCTTACAGGAAGGCCATGTACCATGC 960 
DNMT3b4         GCACTTTAACTTGGCGACCTTCAATAAGCTGGTCTCTTACAGGAAGGCCATGTACCATGC 960 
                ************************************************************ 
 
DNMT3b5         TCTGGAGAAAGCCAGGATCCGGGCTGGCAAGATGTTCCCCAGCAGCCCTGGAGACTCACT 1020 
DNMT3b3         TCTGGAGAAAGCCAGGATCCGGGCTGGCAAGATGTTCCCCAGCAGCCCTGGAGACTCACT 1020 
DNMT3b1         TCTGGAGAAAGCCAGGATCCGGGCTGGCAAGATGTTCCCCAGCAGCCCTGGAGACTCACT 1020 
DNMT3b4         TCTGGAGAAAGCCAGGATCCGGGCTGGCAAGATGTTCCCCAGCAGCCCTGGAGACTCACT 1020 
                ************************************************************ 
 
DNMT3b5         GGAGGATCAGCTGAAGCCCATGTTGGAGTGGGCCCATGGAGGCTTTAAGCCCACTGGGGT 1080 
DNMT3b3         GGAGGATCAGCTGAAGCCCATGTTGGAGTGGGCCCATGGAGGCTTTAAGCCCACTGGGGT 1080 
DNMT3b1         GGAGGATCAGCTGAAGCCCATGTTGGAGTGGGCCCATGGAGGCTTTAAGCCCACTGGGGT 1080 
DNMT3b4         GGAGGATCAGCTGAAGCCCATGTTGGAGTGGGCCCATGGAGGCTTTAAGCCCACTGGGGT 1080 
                ************************************************************ 
 
DNMT3b5         CGAGGGTCTCAAACCTAACAACAAGCAACCAGAGAATAAGACGCGGAGACGCACAGCTGA 1140 
DNMT3b3         CGAGGGTCTCAAACCTAACAACAAGCAACCAGAGAATAAGACGCGGAGACGCACAGCTGA 1140 
DNMT3b1         CGAGGGTCTCAAACCTAACAACAAGCAACCAGAGAATAAGACGCGGAGACGCACAGCTGA 1140 
DNMT3b4         CGAGGGTCTCAAACCTAACAACAAGCAACCAGAGAATAAGACGCGGAGACGCACAGCTGA 1140 
                ************************************************************ 
 
DNMT3b5         CGACTCAGCCACCTCTGACTACTGCCCCCCACCCAAGCGCCTCAAGACAAATTGTTACAA 1200 
DNMT3b3         CGACTCAGCCACCTCTGACTACTGCCCCCCACCCAAGCGCCTCAAGACAAATTGTTACAA 1200 
DNMT3b1         CGACTCAGCCACCTCTGACTACTGCCCCCCACCCAAGCGCCTCAAGACAAATTGTTACAA 1200 
DNMT3b4         CGACTCAGCCACCTCTGACTACTGCCCCCCACCCAAGCGCCTCAAGACAAATTGTTACAA 1200 
                ************************************************************ 
 
DNMT3b5         CAACGGCAAGGACCGAGGAGAGGAGGACCAGAGTCGAGAACAAATGGCTTCGGATGTTGC 1260 
DNMT3b3         CAACGGCAAGGACCGAGGAGAGGAGGACCAGAGTCGAGAACAAATGGCTTCGGATGTTGC 1260 
DNMT3b1         CAACGGCAAGGACCGAGGAGAGGAGGACCAGAGTCGAGAACAAATGGCTTCGGATGTTGC 1260 
DNMT3b4         CAACGGCAAGGACCGAGGAGAGGAGGACCAGAGTCGAGAACAAATGGCTTCGGATGTTGC 1260 
                ************************************************************ 
 
DNMT3b5         CAGCAACAAAGGCAATCTGGAAGATAGCTGTTTGTCCTGTGGTAGGAAAAACCCCGTGTC 1320 
DNMT3b3         CAGCAACAAAGGCAATCTGGAAGATAGCTGTTTGTCCTGTGGTAGGAAAAACCCCGTGTC 1320 
DNMT3b1         CAGCAACAAAGGCAATCTGGAAGATAGCTGTTTGTCCTGTGGTAGGAAAAACCCCGTGTC 1320 
DNMT3b4         CAGCAACAAAGGCAATCTGGAAGATAGCTGTTTGTCCTGTGGTAGGAAAAACCCCGTGTC 1320 
                ************************************************************ 
 
DNMT3b5         CTTCCACCCTCTCTTTGAGGGTGGGCTCTGCCAGACATGCCGGGACCGCTTCCTCGAGCT 1380 
DNMT3b3         CTTCCACCCTCTCTTTGAGGGTGGGCTCTGCCAGACATGCCGGGACCGCTTCCTCGAGCT 1380 
DNMT3b1         CTTCCACCCTCTCTTTGAGGGTGGGCTCTGCCAGACATGCCGGGACCGCTTCCTCGAGCT 1380 
DNMT3b4         CTTCCACCCTCTCTTTGAGGGTGGGCTCTGCCAGACATGCCGGGACCGCTTCCTCGAGCT 1380 
                ************************************************************ 
 
DNMT3b5         CTTCTACATGTACGACGACGACGGCTACCAGTCGTACTGCACCGTGTGCTGCGAGGGCCG 1440 
DNMT3b3         CTTCTACATGTACGACGACGACGGCTACCAGTCGTACTGCACCGTGTGCTGCGAGGGCCG 1440 
DNMT3b1         CTTCTACATGTACGACGACGACGGCTACCAGTCGTACTGCACCGTGTGCTGCGAGGGCCG 1440 
DNMT3b4         CTTCTACATGTACGACGACGACGGCTACCAGTCGTACTGCACCGTGTGCTGCGAGGGCCG 1440 
                ************************************************************ 
 
DNMT3b5         CGAGCTGCTCCTGTGCAGCAACACGAGCTGCTGCCGGTGCTTCTGCGTGGAGTGTCTGGA 1500 
DNMT3b3         CGAGCTGCTCCTGTGCAGCAACACGAGCTGCTGCCGGTGCTTCTGCGTGGAGTGTCTGGA 1500 
DNMT3b1         CGAGCTGCTCCTGTGCAGCAACACGAGCTGCTGCCGGTGCTTCTGCGTGGAGTGTCTGGA 1500 
DNMT3b4         CGAGCTGCTCCTGTGCAGCAACACGAGCTGCTGCCGGTGCTTCTGCGTGGAGTGTCTGGA 1500 
                ************************************************************ 
 
 143
DNMT3b5         GGTGCTGGTGGGCGCGGGCACGGCGGCAGAGGCCAAGCTGCAGGAGCCCTGGAGTTGCTA 1560 
DNMT3b3         GGTGCTGGTGGGCGCGGGCACGGCGGCAGAGGCCAAGCTGCAGGAGCCCTGGAGTTGCTA 1560 
DNMT3b1         GGTGCTGGTGGGCGCGGGCACGGCGGCAGAGGCCAAGCTGCAGGAGCCCTGGAGTTGCTA 1560 
DNMT3b4         GGTGCTGGTGGGCGCGGGCACGGCGGCAGAGGCCAAGCTGCAGGAGCCCTGGAGTTGCTA 1560 
                ************************************************************ 
 
DNMT3b5         CATGTGTCTCCCGCAGCGTTGCCACGGCATCCTGCGGCGCCGCAAGGACTGGAGTGTGCG 1620 
DNMT3b3         CATGTGTCTCCCGCAGCGTTGCCACGGCATCCTGCGGCGCCGCAAGGACTGGAGTGTGCG 1620 
DNMT3b1         CATGTGTCTCCCGCAGCGTTGCCACGGCATCCTGCGGCGCCGCAAGGACTGGAGTGTGCG 1620 
DNMT3b4         CATGTGTCTCCCGCAGCGTTGCCACGGCATCCTGCGGCGCCGCAAGGACTGGAGTGTGCG 1620 
                ************************************************************ 
 
DNMT3b5         TCTGCAGGCCTTCTTCACCAGCGACCCCGGGCTCGAATATGAAGCCCCCAAGTTATACCC 1680 
DNMT3b3         TCTGCAGGCCTTCTTCACCAGCGACCCCGGGCTCGAATATGAAGCCCCCAAGTTATACCC 1680 
DNMT3b1         TCTGCAGGCCTTCTTCACCAGCGACCCCGGGCTCGAATATGAAGCCCCCAAGTTATACCC 1680 
DNMT3b4         TCTGCAGGCCTTCTTCACCAGCGACCCCGGGCTCGAATATGAAGCCCCCAAGTTATACCC 1680 
                ************************************************************ 
 
DNMT3b5         TGCGATTCCTGCAAACCGAAGGCGGCCTATTCGAGTCTTGTCACTGTTTGATGGAATTGC 1740 
DNMT3b3         TGCGATTCCTGCAAACCGAAGGCGGCCTATTCGAGTCTTGTCACTGTTTGATGGAATTGC 1740 
DNMT3b1         TGCGATTCCTGCAAACCGAAGGCGGCCTATTCGAGTCTTGTCACTGTTTGATGGAATTGC 1740 
DNMT3b4         TGCGATTCCTGCAAACCGAAGGCGGCCTATTCGAGTCTTGTCACTGTTTGATGGAATTGC 1740 
                ************************************************************ 
 
DNMT3b5         AACAGGGTACTTGGTCCTCAAAGAACTGGGCATCAAAGTGGAGAAATACGTGGCCTCCGA 1800 
DNMT3b3         AACAGGGTACTTGGTCCTCAAAGAACTGGGCATCAAAGTGGAGAAATACGTGGCCTCCGA 1800 
DNMT3b1         AACAGGGTACTTGGTCCTCAAAGAACTGGGCATCAAAGTGGAGAAATACGTGGCCTCCGA 1800 
DNMT3b4         AACAGGGTACTTGGTCCTCAAAGAACTGGGCATCAAAGTGGAGAAATACGTGGCCTCCGA 1800 
                ************************************************************ 
 
DNMT3b5         AGTGTGTGAAGAGTCCATTGCCGTTGGCACCGTTAAGCACGAGGGCAACATCAAATACGT 1860 
DNMT3b3         AGTGTGTGAAGAGTCCATTGCCGTTGGCACCGTTAAGCACGAGGGCAACATCAAATACGT 1860 
DNMT3b1         AGTGTGTGAAGAGTCCATTGCCGTTGGCACCGTTAAGCACGAGGGCAACATCAAATACGT 1860 
DNMT3b4         AGTGTGTGAAGAGTCCATTGCCGTTGGCACCGTTAAGCACGAGGGCAACATCAAATACGT 1860 
                ************************************************************ 
 
DNMT3b5         GAATGACGTCAGGAATATCACAAAGAAAAACATTGAAGAATGGGGCCCATTTGACTTGGT 1920 
DNMT3b3         GAATGACGTCAGGAATATCACAAAGAAAAACATTGAAGAATGGGGCCCATTTGACTTGGT 1920 
DNMT3b1         GAATGACGTCAGGAATATCACAAAGAAAAACATTGAAGAATGGGGCCCATTTGACTTGGT 1920 
DNMT3b4         GAATGACGTCAGGAATATCACAAAGAAAAACATTGAAGAATGGGGCCCATTTGACTTGGT 1920 
                ************************************************************ 
 
DNMT3b5         GATTGGTGGAAGCCCATGCAATGATCTCTCCAATGTGAACCCTGCCAGAAAAGGCCTGTA 1980 
DNMT3b3         GATTGGTGGAAGCCCATGCAATGATCTCTCCAATGTGAACCCTGCCAGAAAAGGCCTGTA 1980 
DNMT3b1         GATTGGTGGAAGCCCATGCAATGATCTCTCCAATGTGAACCCTGCCAGAAAAGGCCTGTA 1980 
DNMT3b4         GATTGGTGGAAGCCCATGCAATGATCTCTCCAATGTGAACCCTGCCAGAAAAGGCCTGTA 1980 
                ************************************************************ 
 
DNMT3b5         TGAGGGCACAGGCCGGCTCTTCTTTGAGTTCTACCACCTGCTGAATTACACTCGCCCCAA 2040 
DNMT3b3         TGAGGGCACAGGCCGGCTCTTCTTTGAGTTCTACCACCTGCTGAATTACACTCGCCCCAA 2040 
DNMT3b1         TGAGGGCACAGGCCGGCTCTTCTTTGAGTTCTACCACCTGCTGAATTACACTCGCCCCAA 2040 
DNMT3b4         TGAGGGCACAGGCCGGCTCTTCTTTGAGTTCTACCACCTGCTGAATTACACTCGCCCCAA 2040 
                ************************************************************ 
 
DNMT3b5         GGAGGGTGAAGACCGGCCTTTCTTCTGGATGTTTGAGAATGTGGTGGCCATGAAGGTTGG 2100 
DNMT3b3         GGAGGGTGAAGACCGGCCTTTCTTCTGGATGTTTGAGAATGTGGTGGCCATGAAGGTTGG 2100 
DNMT3b1         GGAGGGTGAAGACCGGCCTTTCTTCTGGATGTTTGAGAATGTGGTGGCCATGAAGGTTGG 2100 
DNMT3b4         GGAGGGTGAAGACCGGCCTTTCTTCTGGATGTTTGAGAATGTGGTGGCCATGAAGGTTGG 2100 
                ************************************************************ 
 144
DNMT3b5         CGACAAGCGGGACATCTCTCGGTTTTTGGAGTGTAACCCAGTGATGATTGATGCCATCAA 2160 
DNMT3b3         CGACAAGCGGGACATCTCTCGGTTTTTGGAGTGTAACCCAGTGATGATTGATGCCATCAA 2160 
DNMT3b1         CGACAAGCGGGACATCTCTCGGTTTTTGGAGTGTAACCCAGTGATGATTGATGCCATCAA 2160 
DNMT3b4         CGACAAGCGGGACATCTCTCGGTTTTTGGAGTGTAACCCAGTGATGATTGATGCCATCAA 2160 
                ************************************************************ 
 
DNMT3b5         AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAGGCC 2220 
DNMT3b3         AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAG--- 2217 
DNMT3b1         AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAGGCC 2220 
DNMT3b4         AGTGTCTGCTGCTCACAGAGCCCGATACTTCTGGGGCAACCTGCCCGGGATGAACAG--- 2217 
                *********************************************************    
 
DNMT3b5         TGTGATAGCATCCAAGAATGATAAGCTCGAGCTGCAGGACTGCCTGGAGTTCAAT----- 2275 
DNMT3b3         ------------------------------------------------------------ 
DNMT3b1         TGTGATAGCATCCAAGAATGATAAGCTCGAGCTGCAGGACTGCCTGGAGTTCAATAGGAC 2280 
DNMT3b4         ------------------------------------------------------------ 
                                                                             
 
DNMT3b5         ------------------------------------------------------------ 2259 
DNMT3b3         ------------------------------------------------------------ 2218 
DNMT3b1         AGCAAAGTTAAAGAAAGTACAGACAATAACCACCAAGTCGAACTCGATCAGACAGGGGAA 2340 
DNMT3b4         -------TTAAAGAAAGTACAGACAATAACCACCAAGTCGAACTCGATCAGACAGGGGAA 2270 
                                                                             
 
DNMT3b5         --------------------------------------------------------AGGA 2279 
DNMT3b3         ------------------------------------------------------------ 
DNMT3b1         AAACCAACTTTTCCCTGTTGTCATGAATGGCAAAGAAGATGTTTTGTGGTGCACTGAGCT 2400 
DNMT3b4         AAACCAACTTTTCCCTGTTGTCATGAATGGCAAAGAAGATGTTTTGTGGTGCACTGAGCT 2330 
                                                                             
 
DNMT3b5         CAGCAGGATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2339 
DNMT3b3         ------GATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2271 
DNMT3b1         AGAAAGGATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2460 
DNMT3b4         AGAAAGGATCTTCGGCTTTCCTGTGCACTACACAGACGTCTCCAACATGGGCCGTGTGGC 2390 
                       ***************************************************** 
 
DNMT3b5         CCGTCAGAAGCTGCTGGGAAGGTCCTGGAGA 2370 
DNMT3b3         CCGTCAGAAGCTGCTGGGAAGGTCCTGGAGA 2302 
DNMT3b1         CCGTCAGAAGCTGCTGGGAAGGTCCTGGAGA 2491 
DNMT3b4         CCGTCAGAAGCTGCTGGGAAGGTCCTGGAGA 2421 
                ******************************* 
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